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ABSTRACT
Abebe, Daniel Ghirmay. Ph.D. The University of Memphis. December 2014.
Temperature-Responsive Injectable Hydrogels: Design, Characterization and Application
as Localized Delivery Systems for Drug and Gene Therapy. Major Professor: Tomoko
Fujiwara, Ph.D.
In recent decades, block copolymers have found wide spread interest as drug
delivery systems (DDS). Improvements in synthetic techniques, polymer engineering and
nanotechnology have made it possible to design and construct a variety of DDS for
emerging therapeutics, such as gene therapy. Block copolymer gene carriers have several
advantages including improved biocompatibility, higher loading capacity and ease of
large-scale production. However, the successful clinical application of these delivery
systems has been plagued due to several shortcomings, such as poor stability in biological
environment, low loading efficiency of therapeutic agents and relatively high
cytotoxicity. The majority investigated block copolymer gene carriers rely on the
systemic delivery of encapsulated nucleic acids to a target cell or tissue. For systemic
delivery, nano-sized micelle particles are introduced into the blood stream and allowed to
circulate until they reach the target site. In recent years, localized gene therapy has found
increasing popularity due to its unique advantages, including reduced systemic toxicity,
sustained drug bioavailability and reduced administration frequency. In-situ forming
(injectable) hydrogels have attracted considerable attention as localized gene delivery
vectors due to their unique features; such as minimal invasiveness (no need for surgical
procedure), ability to deform and fit into defined shapes and crevices and they possess
excellent biocompatibility due to their highly hydrated structures.
The main hurdle in the development of injectable hydrogel for localized gene
therapy is the fine balance needed between high mechanical strength and
iv

biocompatibility. To produce high modulus hydrogel, relatively toxic chemical
crosslinking approaches are often needed, which has a negative effect on the
biocompatibility of the system. Stereocomplexation is an attractive alternative to
chemical crosslinking in the production of an injectable hydrogel with biological relevant
mechanical strength. Polyester polymers such as Polylactide (PLA) are able to undergo
stereocomplexation process, leading to the production of a biodegradable hydrogel matrix
Additionally, the elucidation of hydrogel formation mechanism and factors that influence
mechanical behavior can be utilized in design optimization of the system. Intrinsic
properties of a hydrogel, such as elastic modulus, phase transition temperature, and rate
of gel formation are directly influenced by the crosslinking behavior.
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PREFACE
The main body of this dissertation is written based on two journal article, which
have been submitted for publication to two separate journals. Chapter 2 is modified from
a paper published in Biomacromolecules, 2012, 13, 1828-1836 entitled, “Controlled
Thermoresponsive Hydrogels by Stereocomplexed PLA-PEG-PLA Prepared via Hybrid
Micelles of Pre-Mixed Copolymers with Different PEG Lengths”. Chapter 3 and Chapter
5 are based on two papers submitted to Macromolecular Bioscience and Macromolecules,
respectively. Chapter 4 is based on preliminary work currently ongoing. All of the work
of Chapter 2 and 5 was solely done by Daniel G. Abebe. The work presented in Chapter 3
and 4 are collaborative works performed with the members of Dr. Olivia Merkel’s lab at
Wayne State University.
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CHAPTER 1
INTRODUCTION
1.1 Motivation
Tremendous advancements in the fields of drug discovery and synthetic biology
have yielded a range of discoveries in the effective treatment of complex diseases such as
cancer, Alzheimer’s, cystic fibrosis, infectious and neurodegenerative diseases.1-4 Next
generation therapeutic agents which are actively being developed include highly potent
small molecule drugs, proteins, synthetic peptides and nucleic acids such as RNA
(siRNA, shRNA, miRNA), plasmid DNA, and antisense oligonucleotides. Conventional
methods of drug formulation, characterization and delivery cannot be adopted for these
next generation therapeutics agents due to a range of physicochemical and physiological
limitations. In the last two decades, a great deal of effort was spent in engineering novel
drug delivery systems capable of overcoming the many biological barriers which have
hindered effective treatments against complex diseases. The advent and maturation of
nanotechnology has contributed tremendously to the development of breakthrough
medical achievements and has ushered in the next era in the diagnosis, prevention and
treatment of diseases and traumatic injuries.4, 5
In conventional surfactant mediate drug delivery, the therapeutic agent of concern
is encapsulated within a micro-emulsion to yield a solution containing suspended
particles in the range of 1-10 micrometers. Systemic delivery of these microparticles
leads to rapid recognition by the body’s immune system and rapid clearance from the
blood environment. The bioavailability is further decreased by the blood filtration
mechanisms occurring predominately at the liver and spleen. Furthermore, the surfactant
1

materials used in the formulation such as Cremophor® EL have be shown to induce
hypersensitivity with significant side effects including dyspnea, flushing, rash and
urticarial.6 Next generation therapeutic agents such as nucleic acids are inherently unable
to pass drug transport membranes for cellular or tissue uptake due to their large sizes and
ionic nature.7, 8 Conventional drug delivery methods do not have the design features to
serve as practical routes for bio-drugs. Given the vast limitations of conventional
surfactant mediated drug delivery methods, the development of new generation drug
delivery approaches have become an interesting research topic.
Although there are a range of techniques and methods currently being
investigated, nanoparticulate mediated drug delivery has found wide spread interest in
both academia and industry. The US National Cancer Institute defines nanoparticles as
colloidal particles in the size range of 1-100 nanometers (nm). The size range of
nanoparticles is ideal for blood navigation and penetration through drug transport
membranes. Nanoparticles having a wide range of morphologies, sizes and architecture
can be prepared from different materials including lipids, synthetic polymers, natural
polymers and inorganic materials (Figure 1.1).2 ,4, 9 The sub-class of polymer based
materials; particularly block copolymer micelles, possess some unique characteristics
which sets them apart from the other nanoparticulate DDS. The advantages are outlined
as follows: (1) block copolymer can spontaneously self-assemble to micelle nanoparticles
in the size range of 10-100nm, (2) therapeutic agents can be encapsulated and effectively
shielded against the harsh physiological environment (3) the micelle architecture
theoretically provides unlimited capacity for incorporation of therapeutic agents, (4)
various chemical functionalities can be readily incorporated during the synthesis of the
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block copolymer to allow: biodegradability, biocompatibility, stimuli sensitivity for
controlled release, site/target specificity and self-assembly to supramolecular structures,
and (5) block copolymer micelles have excellent pharmaceutical features (such as ease of
scale-up, long term storage stability, and simple quality control protocols), allowing their
eventual transition from the research lab to commercial products.10, 11, 12

Figure 1.1. Classification of nanoparticule mediated drug delivery systems.9
Letchford, K.; Burt, H. European Journal of Pharmaceutics and Biopharmaceutics 2007,
65, 259.

A great deal of collaborative effort between academia, industry and government
institutions is currently on-going to develop next generation nanoparticulate delivery
systems. Researchers have focused on optimizing synthetic and formulation methods in
order to control structure-function properties. In the case of polymer based delivery
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systems, a library of novel monomers and polymers has been developed. Block
copolymers prepared by combination of different types of monomers have been
engineered to a variety of biomaterials; which are capable of delivering therapeutic
agents into a wide range of cells and tissues. Extensive physical and biological
evaluations are currently on-going in a number of clinical trials. Although polymer based
drug delivery systems have shown great potential, there is still a great need for design
optimization and overcoming several critical drawbacks. This dissertation will focus on
the development of superior polymer based therapeutic delivery systems. Existing and
new engineering concepts are exploited to overcome critical shortcomings with current
systems. Additionally, the work will focus on understanding basic structure-function
relationships, which can be applied to the design of robust systems.
1.2 Drug Delivery Approaches
Next generation delivery vectors such as block copolymer micelles can be
introduced to the body through similar administration routes as conventional therapy such
as oral, inhalation, intravenous, intramuscular, transdermal, topical, subcutaneous and
ocular. Block copolymer micelles can be readily formulated into a wide range of
pharmaceutical preparations including fluid emulsions and suspensions, spray, aerosol,
creams, ointments and gels.13, 14 The biodistribution of therapeutic agents in the body is
dependent on the type of administration route utilized and can be categorized as either
systemic or localized (Figure 1.2).
1.2.1 Systemic vs. Localized Drug Delivery Systems (DDS)
In the systemic method, the delivery vector is introduced into the body’s systemic
system through for example, intravenous injection. The delivery vector and therapeutic
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payload distribute throughout the body as they circulate in the blood and accumulate at
target site through either specific or non-specific targeting. The physicochemical
properties of the vector (such as size, surface charge, and shape) will greatly influence its
biodistribution, circulation and site/target accumulation behavior. In contrast, for
localized DDS, the delivery vector can be implemented as a topical formulation such as a
hydrogel. The biodistribution of the delivery vectors and therapeutic payload is
concentrated in a localized region (Figure 1.2). This delivery approach has some unique
advantages compared to the systemic method, including reduced systemic toxicity,
sustained drug bioavailability and reduced administration frequency.15 Researchers have
investigated a wide range of localized delivery vectors such as stints, carbon-nanotubes,
and hydrogels.16 Hydrogels have received wide spread interests and have been
extensively investigated in many biomedical applications. The popularity of hydrogels as
drug delivery vectors stems from their ability to provide (1) a stable environment for
entrapped therapeutic agents, (2) allow for controlled and prolonged release of
therapeutic agents, (3) reduce unnecessary side-effects by increasing proximity to target
site, and (4) reduce drug administration frequency due to the large loading capacity.17, 18
1.3 Application of Polymer Based DDS for Gene Therapy
In the recent decades there has been significant development in new therapeutic
approaches for the treatment of complex diseases and traumatic injuries. Nucleic acids
have received wide spread interest and their potential as effective therapeutic agents is
well documented. Despite their promising medicinal potential, the translation of nucleic
acid therapeutics from the laboratory setting to successful clinical applications has been
plagued by several formidable challenges. These biomolecules lack physical and
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chemical stability, as well as optimal physicochemical properties (such as appropriate
size, shape and charge) for effective translocation across various biomembranes. The
ionic character and large size of nucleic acids such as DNA inhibits passive diffusion
across the cellular membrane where therapeutic function would occur. Moreover, nucleic
acids in the biological environment are rapidly recognized by the host defense system and
enzymatically degraded by nucleases.7 Although the reason for the limited success in
clinical development is complex and multifaceted, the development of an effective
delivery mechanism would contribute greatly to the eventual commercialization.

Figure 1.2. Systemic and Localized drug delivery approaches.
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1.3.1 Gene Therapy
The use of therapeutic nucleic acids, such as plasmid DNA, RNA (siRNA,
shRNA, miRNA), and antisense oligonucleotides to treat diseases at the genetic level is
known as Gene therapy. This technique has the potential to treat a wide variety of
inherited and acquired genetic disorders, including diabetes, cystic fibrosis, certain
cancer, haemophilia, cardiovascular diseases, genetic disorders, and infectious diseases.8
The theoretical approach in gene therapy relies on the insertion of therapeutic nucleic
acids into a damaged cell or tissue to replace a defective or missing gene and correct a
health disorder. Additionally, a mutated gene can be down-regulated or “silenced” from
encoding aberrant proteins.19, 20 The mode of action in gene therapy can be either
permanent or transient. In permanent gene therapy, the host genome is altered for
continuous expression of a specific gene. This approach has the potential to cure inherited
diseases such as cystic fibrosis, haemophilia or familial hypercholesterolemia. However
there are major safety and ethical concerns associated with this approach.21
Alternatively, the transient expression of a gene is more favorable as therapy lasts only a
short period of time.22
1.3.2 Gene Delivery Vectors
Several delivery approaches have been investigated for cellular and tissue
delivery of nucleic acids. Current methods can be categorized as viral vectors, non-viral
vectors and physical force mediated delivery.23, 24 Physical methods of gene delivery
employ physical force to overcome the membrane barrier of a cell, increase permeability
and allow the biomolecule agent to directly enter the cell. Compared to viral and nonviral chemical mediated gene delivery, physical approaches do not involve any substance
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that could be cytotoxic or immunogenic and application is straightforward. However
these methods can cause considerable tissue/cell damage and the precision needed to
target specific cellular compartments (e.g. nucleus) is extremely labor intensive requiring
expensive instrumentation such as laser-based microscopic systems.
Viral mediated transfection utilizes recombinant viruses such as retrovirus,
lentivirus, adenovirus, adeno-associated virus, and herpes simplex virus to achieve
sustainable cell transfection owing to the viral nature of integration into the host genome.
Virus mediated delivery of nuclei acid are accomplished by removing the virus genome
and substituting it with therapeutic genes. Although viral transfection is the most
commonly used method in clinical research, there are several inherent drawbacks
including limited loading capacity, difficulty for mass scale production, immunogenicity
and cytotoxicity.
Non-viral chemical methods were developed to remedy the shortcoming of viral
transfection method, cationic polymers (natural and synthetic), cationic lipids and
cationic inorganic salts (e.g. calcium phosphate) are used to electrostatically complex the
ionically charged biological molecules into a compact particle able to enter the
intracellular target tissue compartment. Even though the efficiency of non-viral chemical
methods is relatively lower than viral systems, cationic vectors (e.g. polymers) possess
the potential advantage of unrestricted loading capacity, facile synthetic methods, low
immunogenicity, can be administered repeatedly. Due to these significant advantages,
non-viral vectors have found wide spread interest in contemporary research.
Polymeric non-viral gene vectors are mainly based on cationic polymers such as
poly(ethylene imine) (PEI), poly(L-lysine) (PLL), poly((2-dimethyamino)ethyl
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methacrylate) (pDMAEMA) and poly(amidoamine) (PAMAM).21 Cationic polymers
condense genetic material such as DNA through electrostatic interaction and produce
polyplex particles in the 10-100 nm range. Hydrophilic polymers such as polyethylene
glycol (PEG) are often incorporated with the condensing cationic polymers such as PEI
to yield block copolymers of PEI-b-PEG which are able to form core-shell structure. The
use of the hydrophilic block PEG has shown to drastically improve stability of the
polyplex particles.25 Figure 1.3 describes the typical polymer mediate gene delivery
approach.

Figure 1.3. Condensation of DNA by a cationic polymer produces a polyplex particle
with a size range ~10-100 nm capable of undergoing cell internalization.24
Merkel, O. M.; Zheng, M.; Debus, H.; Kissel, T. Bioconjugate Chemistry 2012, 23, 3.

1.4 Polymer Based DDS: Synthesis and characterization
1.4.1 Block Copolymer Synthesis
The field of synthetic polymer chemistry has evolved since the first mentions of
macromolecules in the early 1920s. Synthetic polymers are categorized into homo9

polymers, copolymers or block copolymers depending on the diversity of their
monomeric units and the manner of their arrangement. Block copolymers are composed
of sequences or blocks of one monomer alternating in a series with another. In the
simplest form, monomer A and B can be covalently bonded to each other to yield
different architectures, such as linear diblock (AB), triblock (ABA), pentablock
(ABABA), multiblock (AB)n and star diblocks (AB)nX. The incorporation of a third
monomer C expands the sequence and leads to arrangements such as ABC, ACB and
BAC having linear or three-armed star architectures.26 Controlled and living
polymerization (CLP) techniques through sequential addition of monomers have been
extensively developed in the last few decades (Figure 1.4).27 The term “living” describes
the absence of irreversible chain termination and chain transfer steps following the
initiation and propagation events. In order to produce polymers with well-defined
molecular weights (MW) and narrow weight distribution, the living polymerization must
afford a measure of controllability. The term “controlled” is used when the
polymerization technique can tolerate a minimum degree of chain breakage without
affecting the overall molecular features of the final polymer. In theory, provided that
initiation is complete and propagation due to exchange between species of various
reactivities is fast, the number average (Mn) molecular weight can be predicted by the
initial concentration of the reagents and a molar mass distribution close to unity is
achieved.
The change in Gibbs free energy (ΔG = ΔH-TΔS) accompanying chain
polymerization reactions at any temperature T are exoethalpic (negative ΔH) and
exoentropic (negative ΔS). The loss in entropy is due to loss of three degree of
10

translational freedom caused by connecting monomeric units together; therefore, the loss
in enthalpy must be sufficient enough for favorable reaction (ΔG <0). In the case of
alkenes, it is supplied by the isomerization of the double bond in the monomer to C-C
single bonds in the polymer. For cyclic monomers, the relief of ring strain by ring
opening is the driving force for polymerizations. Ring opening polymerization (ROP) of
numerous heterocylic compounds such as lactone, ether, amine, lactam, carbonate,
anhydride and oxazolines having rings sizes ranging from 3-8 have been utilized
extensively for the polymerization of many biomedical relevant block copolymers
(Figure 1.5).28, 29

Figure 1.4. Synthetic approaches for preparation of block copolymers of different
architectures.27
Tsuruta, T. Journal of Polymer Science Part a-Polymer Chemistry 2000, 38, 1749.
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The change in Gibbs free energy (ΔG = ΔH-TΔS) accompanying chain
polymerization reactions at any temperature T are exoethalpic (negative ΔH) and
exoentropic (negative ΔS). The loss in entropy is due to loss of three degree of
translational freedom caused by connecting monomeric units together; therefore, the loss
in enthalpy must be sufficient enough for favorable reaction (ΔG <0). In the case of
alkenes, it is supplied by the isomerization of the double bond in the monomer to C-C
single bonds in the polymer. For cyclic monomers, the relief of ring strain by ring
opening is the driving force for polymerizations. Ring opening polymerization (ROP) of
numerous heterocylic compounds such as lactone, ether, amine, lactam, carbonate,
anhydride and oxazolines having rings sizes ranging from 3-8 have been utilized
extensively for the polymerization of many biomedical relevant block copolymers
(Figure 1.5).28, 29

Figure 1.5. Cyclic monomers typically used for ROP of biomedical relevant polymers.28
Ohya, Y.; Takahashi, A.; Nagahama, K. Polymers in Nanomedicine 2012, 247, 65.
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The monomers shown in Figure 1.5 can undergo controlled ionic (anionic or
cationic) living polymerization mechanisms. Anionic living polymerization was one of
the earliest utilized techniques for producing block copolymers. It was first reported in
late 1950s and has been the most popular approach until the discovery of radical
controlled/living polymerization in the mid-1990s.30 Monomers able to undergo anionic
living polymerization are those bearing electron withdrawing groups; include non-polar
vinyl compounds, polar electrophilic vinyl compounds, protected acrylic/methacrylic
acids and cyclic ethers, esters and siloxanes. The high nucleophilicity of the initiators
(organometallic bases or electron transfer agents) and propagating chain ends (carbanion
and oxanion) requires anhydrous aprotic solvents (tetrahydrofurna, toluene, and hexane)
and precise control of polymerization conditions such as temperature and monomer
addition rate. The development of cationic living polymerization technique in the 1980s
allowed for the preparation of new types of block copolymers whose monomers were
either incompatible or needed extensive chemical modification to undergo anionic
polymerization.31 Monomers that can undergo living cationic block copolymerization are
those bearing electron donating groups, including styrenics, vinyl ethers, isobutylene and
oxazolines. As with anionic polymerization, the solvent effect has a crucial role in the
stability/reactivity of the cationic intermediates. In addition, relatively low temperatures
are required to minimize the occurrence of termination and transfer reactions.
Since the discovery of radical controlled/living polymerization in the mid-1990s,
there has been a tremendous amount of interest in the technique.32 Compared with ionic
polymerization techniques, free radical process offer the advantage of being applicable to
a wider variety of monomers and are not as demanding as other chain addition
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mechanisms with respect to the purity of the reagents used. Among radical CLP systems,
nitroxide-mediated polymerization (NMP),33 atom transfer radical polymerization
(ATRP)34 and reversible addition-fragmentation chain transfer (RAFT)35 have been
investigated extensively. The advantage of radical controlled/living polymerization
techniques for block copolymer preparation relies on its ability to incorporate hydrophilic
blocks in amphiphilic copolymers previously not accessible or needed extensive
protection/deprotection chemistry to accomplish.4, 27, 32
Over the last two decades, effort has been placed on synthesis and
characterization of block copolymer for application as drug delivery polymeric micelles.
The design criteria for these polymeric systems aside from efficiency in delivery were
biodegradability and biocompatibility. As a result, biodegradable polyesters such as
polylactide (PLA),26 poly(e-caprolactone) (PCL)36 and poly (lactide-co-glycolide)
(PLGA)37 are some of the most studied biodegradable polymers. The high hydrophilicity,
neutral charge, wide range of solubility and facile chemical functionalization of
poly(ethylene glycol) (PEG) has made it an ideal hydrophilic polymer.38 Although it is
not possible to provide a compressive review, some of the most prevalent systems and
their polymerization methods are shown in Figure 1.6.39
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Figure 1.6. Synthesis of biomedical relevant block copolymers through various controlled
and living polymerization techniques.39
Gaucher, G.; Dufresne, M. H.; Sant, V. P.; Kang, N.; Maysinger, D.; Leroux, J. C.
Journal of Controlled Release 2005, 109, 169.
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1.4.2 Block Copolymer Self-assembly
Amphiphilic block copolymers can self-assemble into different nanoparticulate
structures such as micelles, nanospheres, nanocapsules, crew-cut micelle like aggregates,
polymersome, and micelle-like aggregates.9 The type of structure formed is influenced
by the block composition, block length, molecular geometry and method of preparation
(Figure 1.7). In aqueous solutions, amphiphilic block copolymers undergo structural reorganization and form micelles in order to achieve a state of minimum free energy. The
unfavorable interactions between the hydrophobic blocks and water molecules lead to the
removal of the water incompatible blocks from the aqueous environment. This is
achieved through self-association (aggregation) of the hydrophobic blocks to form an
anhydrous core. The hydrophilic blocks populate the surface to stabilize and render the
particle water soluble. The core-shell architecture of block copolymer micelles can be
utilized to encapsulate and protect therapeutic agents within the anhydrous core; while
the hydrophilic shell provides a degree of solubility and stabilization in the biological
(aqueous) environment.10, 40, 41
1.4.3 Block Copolymer Micelles
For application as drug delivery systems, block copolymer micelles are generally
categorized in to three different categories as (1) micelle nanocarriers (2) micelle-forming
block copolymer-drug conjugates and (3) polyion complex micelles. These classifications
are based mainly on the type of encapsulation method used, which in turn influences type
of core-forming polymer utilized. Block copolymers micelles are an ideal nano-sized
carriers of hydrophobic small molecule drugs whose efficient delivery are otherwise
greatly reduced. For example, the chemotherapeutic agent paclitaxel is a very potent anti16

cancer drug often used in the treatment of breast and ovarian cancers. However, due to
its low water solubility and high toxicity when formulated with conventional surfactants
(e.g. cremophor®) paclitaxel has not reached its full therapeutic potential. The earliest
reported use of amphiphilic block copolymer micelle for solubilization and intravenous
formulation of paclitaxel was by Zhang et al. in 1996. The authors prepared a range of
MePEG-PDLLA diblock copolymers and showed the chemotherapeutic drug could be
encapsulated or solubilized in the micelle structure with an increase of about 5000 fold
compared to water, which translated to solubility increase of paclitaxel from 1ug/ml in
water to 5mg/ml in the diblock copolymer micelles.42

Figure 1.7. Factors governing the self-assembly of amphiphilic block copolymers.9
Letchford, K.; Burt, H. European Journal of Pharmaceutics and Biopharmaceutics 2007,
65, 259.
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For physical encapsulation as in the case of the above example, the degree of
hydrophobic drug fractionation into the core depends on several factors such as (1) the
hydrophobic drug’s molecular volume and interfacial tension against water, (2) MW and
length of the hydrophobic (core forming) and hydrophilic (shell forming) blocks of the
copolymer, (3) compatibility between the core forming block and the drug, (4) the
solution concentration of the block copolymer and the drug and (5) preparation
temperature. The compatibility between the drug and the core forming block is an
important parameter and has a large influence on the encapsulation efficacy. The
interaction potential can be determined using the Flory-Huggins interaction parameter
(Xsp) (Eq. 1).43 Another parameter which has a pronounced influence on the drug
encapsulation efficiency is the length/MW of core forming block. The drug entrapment
capacity of a block copolymer is shown to increase with the increasing hydrophobic
block, which is attributed to the increase in core radius thus an increase in available
volume for entrapment. The degree of drug entrapment (encapsulation efficiency) is
determined through the micelle-water partition coefficient which is the ratio of drug
concentration in the micelle to the drug concentration in water and is given by Eq. 2.43

𝜒𝑠𝑝 = (𝛿𝑠 − 𝛿𝑝 )2 𝑉𝑠 ⁄𝑅𝑇

(1)

δs = Scatchard-Hillbrand solubility parameter
of the solubilizate (e.g. paclitaxel)
δp = Scatchard-Hillbrand solubility parameter
of the core forming polymer (e.g.
PDLLA)
Vs = Molar volume of solubilizate
R = gas constant
T = temperature (kelvin)
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𝑃=

(𝑆𝑡𝑜𝑡 −𝑆𝑊 )

(2)

𝑆𝑊

P = Partition coefficient
Stot = Total drug solubility
SW = Water drug solubility

The physical encapsulation of drugs within polymeric micelles is generally a
more attractive approach and is widely utilized. Physical entrapment is mostly applicable
to hydrophobic small molecule drugs which do not bear reactive functional groups, e.g.
carboxyl, hydroxyl or amino groups, for chemical conjugation, or the free functional site
may be required for the pharmacological effectiveness of the drug.44 Moreover, many
block copolymers used in preparation of micelle delivery systems lack reactive or
ionizable functional groups capable of chemical conjugation or electrostatic
complexation of drugs.45 To overcome some limitations of physical entrapment, such as
low drug encapsulation efficiency and uncontrolled drug release, functional polymers
bearing free functional groups (e.g. carboxylic acid or amine) can be utilized to
covalently attach therapeutic agents to the micelle core. Although chemical conjugation is
shown to increase loading efficiency and reduce premature diffusive release of drugs, the
eventual release at the target site is shown to suffer due to the relatively stable amide
linkage used for conjugation. Researchers have investigated the use of more readily
hydrolysable (cleavable) chemical bonds, such as ester linkages. Monomers having
reactive side chain groups have been copolymerized with polyesters to yield functional
biodegradable block copolymers. Drug conjugate micelles of block copolymers
composed of reaction functional side groups, such PEG-(PCL-α-carboxy), PEG-(PLA-gcarboxy), PEG-trimethlene carbonate derivate were shown to be stable at neutral pH (7.4)
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but undergo controlled release of conjugated drugs at lower pH due to facile hydrolysis of
the ester linkages at both the drug-polymer site and polyester backbone.46
1.4.4 Physicochemical Properties of Micelles
The physicochemical properties of polymeric micelles such as hydrodynamic size,
shape, rigidity, surface charge, and ligand density have a direct influence on the ability of
the particle to navigate biological barriers, transport payload across various
biomembranes, achieve site and cell specific accumulation, and finally induce
physiological (cellular) responses by releasing the drug payload.47, 48 Particle size in the
range of 10-100 nm is thought to be most optimum for drug delivery systems, however
depending on the application, sizes up to 1000 nm have been investigated. Micelles
having sizes in the 10-100 nm range are large enough to prevent renal excretion and
leakage into blood capillaries; but are small enough to avoid (escape) capture by the
mononuclear phagocyte system (MPS) also known as the reticuloendothelial system
(RES).49 The MPS plays a major role in blood filtration and destroying toxic particles, as
well as identifying foreign objects and sequestering them for clearance by phagocytosis.
The MPS mediated detection and blood clearance has been a major bottleneck in
realizing the full potential of nanoparticule drug delivery systems. The majority of blood
filtration occurs in the liver and spleen; as a consequence the MPS is more predominate
in these organs. The size of the sinusoid in the spleen and fenestra of the Kuffer cells in
the liver varies from 150 to 200 nm, therefore during blood filtration any particle bigger
than these sizes will be filtered off. Unsurprisingly, in vivo experiments have revealed
that the majority of non-specific nanoparticulate accumulation occurs at these two organs
and in most instances lead to organ failure and low therapeutic efficacy.50
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The hydrodynamic size is shown to also influence the cellular uptake behavior of
polymeric micelles. Cells utilize the two main internalization pathways to uptake
nutrients and other materials (e.g. proteins, nanoparticles, etc.) and can be categorized as
either phagocytosis or endocytosis. Phagocytosis is primarily used by specialized cells
such as macrophages, monoctes, neutrophils and dendritic cells. Early studies have
indicated that particle sizes should be >500nm for it to undergo phagocytosis, however
recent studies have shown particles with sizes as low as 250nm could also be taken up by
phagocytosis.38 The alternative uptake mechanism of endocytosis can be divided into
four basic processes such as clathrin-mediated endocytosis (CME), caveolae-mediated
endocytosis (CvME), micropinocytosis and clathrin and caveolin independent
endocytosis.47 The uptake of particles by one of these endocytic pathways is achieved
through formation of specialized vesicles such as the endosome (CME), caveosome
(CvME) or macropinosome. These vesicles have fixed size capacity and will only
consume particles which have an effective size lower than their capacity. The reported
vesicle capacity sizes are caveosome ~50-80 nm, endosome ~100-120 nm, and
macropinosome 1 um-5 um. For polymeric micelle mediated drug delivery, researchers
have focused on utilizing the CME and CvME pathways in order to capitalize on the size
selectively towards nanoparticles.
The surface chemistry of polymeric micelles such as the chemical composition,
charge and energy dictate its interaction behavior with biological components and have a
direct influence on the MPS evasion and cellular uptake properties.38 The chemical
composition and charge at the superficial layers determines the ability of proteins to
adhere or absorb on the particle surface. The particle dissociation, stability and
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aggregation behavior in biological environments are governed by the surface charge and
energy, which are closely related parameters. The surface charge also has an effect on
receptor binding and physiological barrier penetration capabilities. In a similar fashion to
hydrodynamic size, the surface chemistry plays a major role in MPS mediated clearance
of polymeric micelles. A concurrent function of the MPS in addition to blood/particle
filtration is the recognition of foreign objects and clearance from the system through
phagocytosis. Foreign objects are cleared from the body through either opsonic or nonopsonic mediated phagocytosis.51 Non-opsonic phagocytosis is the ordinary phagocytic
pathway described above; which is mediated by cell surface receptor recognition and
preferentially engulfs large size particles. Nanoparticles such as polymeric micelles
however typically undergo the opsonic mediated phagocytosis due to their small sizes. In
order for phagocytic cells (e.g. macrophages) to recognize particle <200 nm in size, the
particle surface has to be coated with special molecules called opsonins, which can be
antibodies (IgG or IgM), complement proteins (C3b, C4b and iC3b) or other circulating
proteins (Mannose-binding lectin, C-reactive protein).
In general, the most important driving forces for protein adsorption are often
regarded to be ionic and hydrophobic interactions (combined with entropic gain caused
by conformational changes of the protein during adsorption).52 Polymeric micelles with
hydrophobic surface composition and negative surface charge are shown to undergo fast
MPS clearance. Opsonization on hydrophobically modified surfaces occurs at a much
higher rate than negatively or positively charged surfaces. This is attributed to the
“hydrophobic” or “van der Waals” interaction which most biological proteins utilize as
the primary mechanism of interaction; therefore they are detected at a much higher rate.
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Polymeric micelles with ionically charged surfaces undergo opsonization through
specialized proteins known as zymogens and the activation of the complement system.51
It is shown that positively charged particles are more readily flagged than negatively
charged particles. Researchers have shown that in the case of negatively charged
surfaces, the complement system is poorly activated which would suggest low binding
affinity of opsonins on negatively charged surfaces. Although particle surface charge is
detrimental for prolonged blood residence, it is shown to be advantageous for cellular
internalization of the particle.
Given that a particular polymeric micelle has the optimum size and surface
chemistry to avoid clearance by the MPS, the next mode of action is the successful
guidance of the payload to the intended target. The site and target specific accumulation
of polymeric micelle payloads can be achieved through either passive or active targeting
approaches.7 Polymeric micelles and other drug delivery nanoparticule systems passively
accumulate at target sites mainly through extravasation (leakage) in to abnormally
constructed vasculature tissues. The extravasate accumulation phenomena is highly
refined in the case of solid tumors due to the enhanced permeability and retention (EPR)
effect.53 The fast and abnormal growth behavior of tumors leads to the production of
defective hyperpermeable endothelial cells, lacking smooth muscle layer and functional
lymphatic drainage. As polymeric micelles continuously pass the location of the tumor,
they can extravasate through the leaky vasculature and accumulate at the tumor site. The
lack of efficient lymphatic drainage helps build the micelle concentration within the
tumor. Once accumulated at the target site, polymeric micelles can undergo passive
cellular internalization through non-receptor mediate endocytosis.
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Hydrophobic and charge interactions between the particle and cell membrane are
utilized to trigger endocytosis. There are several drawbacks with passive targeting;
prolonged circulation and blood residence is required to ensure adequate extravasation
and increased particle concentration at the target site. Furthermore, since non-receptor
mediated endocytosis is the dominate uptake mechanism occurring in all cells;
theoretically non-specific particle uptake can occur in any cell. As a result, high healthy
cell morbidity is observed with passive targeting approaches.7 The alternative method for
site and target specific accumulation relies on decorating the surface of polymeric
micelles with receptor-specific ligands; this approach is referred to as active targeting. It
is well known that majority of cells and tissue in a disease state overexpress certain
receptors which are needed for abnormal cell replication, evasion of apoptosis, induction
and sustainment of angiogenesis and much more. Particles whose surface is
functionalized with ligands specific for the overexpressed receptors undergo receptormediated interaction with the cell or tissue membrane and can be internalized through a
number of well-regulated processes. Researchers have investigated a variety of ligandreceptor systems and have shown that active targeting can increase preferential cell and
tissue uptake by several folds.54
The ideal delivery system should only release its payload at the target site and
premature release during circulation should be minimized or avoided. To achieve such a
feat, a system of controlled release to some type of internal or external stimuli is needed.
Stimuli-responsive delivery systems have been widely investigated and can be
categorized as exogenous and endogenous stimuli-responsive systems.55 Exogenous or
externally applied stimuli include temperature change, magnetic fields, ultrasounds, light
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and electric fields. Endogenous stimuli include variation in pH and temperature, redox
potential and specific enzymes. Two main responsive strategies often targeted are pH and
temperature gradients occurring between normal and pathophysiological states inside the
body. The local environment in tumors and inflammatory tissues has a mildly acidic
environment (pH~ 6.8), which is a slightly low value compared to normal tissue and
blood (pH ~ 7.4). Furthermore, the endosome vesicle where a micelle payload initially
resides after cellular internalization exhibits a relatively acidic environment (pH ~ 5.5).
There are two several approaches that have been used for developing pH sensitive
systems, including incorporation of a titrable group such as amines and carboxylic acids
into the backbone of the copolymer and functionalization with acid labile linkages such
as benzoic imine bonds which are cleavable in acidic conditions. The use of temperature
gradient as a responsive stimulus has also been extensively developed.55, 56 Similar to pH
gradient, tumor tissues possess abnormal temperature gradient as compared with those of
normal ones. The local temperature of some tumor tissue can range between 38-43°C
(hyperthermia). Micelles composed of temperature-sensitive components can undergo
structural transformation resulting in deposition of the payload and facile drug absorption
by cells. Depending on the stimuli applied varied responses may occur including,
structural transformations or disruption, volume phase transition, permeation rate,
hydration state, swelling/collapsing and complete micelle disintegration/dissociation into
unimers.55
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1.5 Hydrogels as Localized DDS
Hydrogels are hydrophilic polymer networks that can adsorb large quantities of
water due to crosslinking of individual polymer chains. The polymer chains are
commonly functionalized with hydrophilic groups such as –OH, –CONH–, –CONH2, –
COOH, and –SO3H which gives hydrogels the ability to adsorb water while remaining
insoluble in the aqueous solution.57 Hydrogels can be prepared from both synthetic and
natural polymers through a range of crosslinking routes. Natural polymers such as
chitosan, cellulose, xyloglucan, gelatin and proteins are known to produce hydrogels
having similar macromolecular properties to the natural extracellular matrix.58 They are
often utilized in tissue engineering application due to their ability to induce specific cellmaterial interactions. Synthetic polymers have the advantage that a broad range of
materials with controlled molecular weights and structure can be prepared, which leads to
hydrogels with well tunable mechanical strength.26 Hydrogels have found wide spread
application in many fields, such as contact lenses, coating materials in pills/capsules and
implants, bio adhesive carriers, transdermal drug delivery systems, electrophoresis gels,
wound healing, chromatographic packing material, cell culture, tissue engineering and
medical sensing.59 Applications such as contact lenses have found tremendous success,
while others are still at the developing stages.
Hydrogels can be prepared through chemical or physical crosslinking methods in
response to a variety of stimuli.57 Physical crosslinking describes the
association/entanglement of polymer chains through physical forces such as hydrogenbonding interaction, hydrophobic interaction, stereocomplexation, charge interaction and
superamolecular chemistry. In chemical crosslinking, covalent bonding of highly reactive
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chemical species is utilized by either introducing small molecule crosslinkers into a
polymer solution or modifying polymer segments with reactive functional groups. A
variety of environmental triggers can be used to induce crosslinking of polymer chains;
some of the commonly investigated triggers include change in physiological conditions
such as pH, temperature, specific ions and antigens. External triggers have also been
investigated including electromagnetic radiation (UV light), electrical field, magnetic
field and pressure changes.
1.5.1 Injectable Hydrogels
The traditional application of hydrogels in drug delivery applications have
exclusively relied on producing the hydrogel outside of the body, loading it with
therapeutic drugs and implanting the hydrogel/drug complex in the body.17 The main
disadvantage of such approach is that the complex must be implanted through surgical
means, since the high elasticity and defined dimensions exclude their extrusion through
needles. In recent decades, there has been a considerable interest in producing hydrogel
systems that exhibit solution like behavior outside of the body but form a gel when
placed inside the body. The solution like behavior allows for simple injection through a
needle and the immediate in-situ gelation produces the hydrogel. This approach would
successfully circumnavigate the need for a surgical procedure.18 Although there are a
numbers of injectable hydrogel systems currently available, temperature-sensitive
physically crosslinked hydrogels are the most commonly studied class of environmentally
sensitive polymer systems.57 The manipulation of the readily available and wellcontrolled physiological temperature without the need of complicated designs or
instrumentation is a major reason for the popularity of temperature-sensitive hydrogels.
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Furthermore, physical crosslinking methods are generally more biocompatible due to the
absence of relatively toxic reactive species commonly utilized in chemical crosslinking
methods.
1.5.2 Temperature responsive/physically crosslinkable hydrogels
The commonly investigated temperature-sensitive polymers utilized for the
preparation of physically cross-linkable hydrogels are shown in Figure 1.8. Polymers
such as poly(N-isoproplacrylamide) (PNIAAm) and Pluronic display a temperatureresponsive phase transition property known as lower critical solution temperature (LCST)
transition.60 Polymers which exhibit this behavior exists as fully solvated polymeric
molecules dispersed in a solution below the LCST but undergo physical crosslinking and
transform to a gel state above the LCST. In terms of biomedical application, the solutionto-gel (sol-gel) phase transition is most advantageous if it occurs at or below body
temperature. For hydrophilic homopolymers such as PNIAAm, hydrophobicity is
introduced through functional side groups such as methyl, ethyl and propyl groups. The
temperature induced sol-gel phase transition in LCST exhibiting polymers such as
PNIAAm is driven by the aggregation of the hydrophobic domains to minimize their
hydrophobic surface area contacting the bulk water. The amount of structured water
molecules solvating the hydrophobic domains is greatly reduced, which is entropically
favored. The more hydrophobic character a system has, the driving force for hydrophobic
aggregation becomes greater in order to reduce the entropic cost of structuring water
molecules, and as a consequence the gelation temperature is lowered.61
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Figure 1.8. Commonly used temperature responsive and physically crosslinkable
homopolymers and block copolymers.18
Yu, L.; Ding, J. Chemical Society Reviews 2008, 37, 1473.

Block copolymers such as Pluronic which also exhibit LCST transition behavior
follow a slightly dissimilar mechanism to PNIAAm during sol-gel phase transition. In
response to increase in temperature, the hydrophobic interaction among the PPO blocks
becomes dominate and as desolvation increases core-shell micelles having an anhydrous
PPO core and hydrated PEO shell are produced.62 Micelle formation is dependent upon
the block MWs, polymer concentration (CMC) and temperature of micellization (CMT)
which can range anywhere from 10-40°C. Unlike PNIAAm, sol-gel phase transition does
not occur as a result of inter-polymer hydrophobic aggregation, rather these solution
maintain their liquid micellar phase until the critical gel temperature (CGT) and critical
gel concentration (CGC) are reached. Above these critical points, the monomolecular
micelles pack to form multimolecular aggregates having a variety of ordered structures
such as cubic and hexagonal cylinders. Aqueous pluronic solution undergo sol-to-gel
29

transition by a shift in equilibrium from unimer to micelle, where at high micelle volume
fraction the ordered structures lead to what is referred to as hard-sphere crystallization
and yield the gel state.63
Biodegradable amphiphilic block copolymers have also been investigated as
thermo-gelling systems and the added feature of biodegradability has made these systems
well sought after. One of the early successful examples of a biodegradable thermo-gelling
system was based on the BAB triblock copolymers of PEG-PLGA-PEG.64 These
copolymers yield spherical micelles in aqueous solution at a much lower concentration
(CMC ~ mg/ml) due to the increased hydrophobicity of the PLGA block. The mechanism
of the sol-to-gel transition of an aqueous solution of a PEG-PLGA-PEG triblock
copolymer is believed to occur through temperature induced growth of individual
micelle, until the swollen micelles contact each other and associate through physically
entanglement.65 ABA type amphiphilic triblock copolymers, where A represents
hydrophobic blocks and B represents hydrophilic blocks undergo sol-gel phase transition
through a slightly different mechanism than BAB triblock copolymers such as PEO-PPOPEO and PEG-PLGA-PEG. The ABA block copolymers such as PLA-PEG-PLA66, 67 and
PGLA-PEG-PGLA68 self-assemble to yield “flower-like” micelles, where the
hydrophobic terminal blocks aggregate in the core and the hydrophilic PEG blocks makes
a loop on the surface. At above the CGC and CGT, these solutions form associative
network micelles where the hydrophobic blocks of one triblock chain reside in two
separate micelle cores and the PEG chain bridges between the two micelles.
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1.5.3 Characterization of Physical and Chemical Properties of Polymeric DDS
The physicochemical properties of block copolymer micelles and hydrogels have
profound influence on their function/behavior in biological environment. The complete
characterization and understanding of these properties is an important step in the design
of an effective drug delivery system.48, 47, 50 The commonly characterized properties for
block micelle include self-assembly behavior (concentration and temperature),
hydrodynamic size, morphology/shape, surface properties, purity/cytotoxicity, stability in
biological environment, and interaction between the micelle and the biological
environment. In the case of hydrogels researchers are interested in characterizing the
mechanical strength, degradation rate, localized toxicity/inflammation, degree of
crosslinking, phase transition behavior and rate of gelation. The characterization of
intrinsic properties is typically accomplished through physical methods such as
scattering, spectroscopy, microscopy, rheology, and colorimetric assays. Furthermore, the
physiological response or action of these drug delivery systems such as blood
circulation/residence time, avoidance of sequestration by MPS, site/target specific
accumulation, drug release behavior and the therapeutic efficacy are elucidated through
several in-vitro and in-vivo techniques. Table 1.1 shows the commonly used instrumental
techniques and their specific application.
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Table 1.1. Techniques commonly used to characterize size, shape, surface charge and
composition of polymeric DDS.48
Techniques

Physicochemical
characteristics
analyzed

Strengths

Limitations

Dynamic light
scattering
(DLS)

Hydrodynamic
size distribution

Nondestructive/invasive
manner. Rapid and
more reproducible
measurement
Measures in any liquid
media, solvent of
interest.

Insensitive correlation
of size fractions with
a speciﬁc composition.
Inﬂuence of small
numbers of large
particles.

Hydrodynamic sizes
accurately
determined for
monodisperse
samples
Fluorescence
correlation

Hydrodynamic
dimension

spectroscopy
(FCS)

Binding kinetics
Critical micelle
concentration
(CMC)

Modest cost of
apparatus. High spatial
and temporal
resolution.
Low sample
consumption.
Speciﬁcity for
ﬂuorescent probes.

Limit in polydisperse
sample measures
Limited size
resolution.
Assumption of
spherical shape
samples
Limit in ﬂuorophore
species.
Limited applications
and inaccuracy due to
lack of appropriate
models

Method for studying
chemical kinetics,
molecular diffusion,
concentration effect,
and conformation
dynamics
Zeta potential

Stability
Referring to
surface charge

Simultaneous
measurement of many
particles (using ELS)

Electro-osmotic effect.
Lack of precise and
repeatable
measurement

Lin, P.-C.; Lin, S.; Wang, P. C.; Sridhar, R. Biotechnology Advances 2014, 32, 711.
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Table 1.1. Techniques commonly used to characterize size, shape, surface charge and
composition of polymeric DDS.48
Techniques

Physicochemical
characteristics
analyzed

Strengths

Limitations

Scanning
electron
microscopy
(SEM)

Size and size
distribution Shape

Direct measurement of
the size/size
distribution and shape
of nanomaterials High
resolution

Conducting sample or
coating conductive
materials required.
Dry samples required.
Sample analysis in
non-physiological
conditions (except
ESEM)

Aggregation
Dispersion

Environmental
SEM (ESEM)

(down to subnanometer)
Images of
biomolecules in natural
state provided using
ESEM

Biased statistics of size
distribution in
heterogeneous
samples Expensive
equipment
Cryogenic method
required for most NPbioconjugates Reduced
resolution in ESEM

Transmission
electron
microscopy
(TEM)

Size and size
distribution Shape
heterogeneity
Aggregation
Dispersion

Direct measurement of
the size/size
distribution and shape
of nanomaterials with
higher spatial
resolution than SEM
Several analytical
methods coupled with
TEM for investigation
of electronic structure
and chemical
composition of
nanomaterials

Ultrathin samples in
required Samples in
nonphysiological
condition. Sample
damage or alternation.
Poor sampling
Expensive equipment

Lin, P.-C.; Lin, S.; Wang, P. C.; Sridhar, R. Biotechnology Advances 2014, 32, 711.
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Table 1.1. Techniques commonly used to characterize size, shape, surface charge and
composition of polymeric DDS.48
Techniques

Physicochemical
characteristics
analyzed

Strengths

Limitations

Atomic force

Size and size
distribution

3D sample surface
mapping

Shape

Sub-nanoscaled
topographic.

Overestimation of
lateral dimensions.
Poor sampling and
time consuming.
Analysis in general
limited to the

microscopy
(AFM)

Structure
Sorption
Dispersion
Aggregation

Resolution Direct
measurement of
samples in dry,
aqueous or ambient
environment

exterior of
nanomaterials

Surface properties
(modiﬁed AFM)
Small-angle Xray and neutron
scattering
scattering
(SAXS)

Size/size
distribution Shape
Structure

Non-destructive
method Simpliﬁcation
of sample preparation.
Amorphous materials
and sample in solution
accessible

Relatively low
resolution

Lin, P.-C.; Lin, S.; Wang, P. C.; Sridhar, R. Biotechnology Advances 2014, 32, 711.

Researchers are increasingly relying on theoretical methods to assist in design
optimization of drug delivery systems. Advances in computational methods, molecular
modeling, and high energy scattering techniques have contributed greatly in elucidating
fundamental structure-function relationships.69-72 Small angle neutron and x-ray
scattering (SANS, SAXS) are two powerful techniques for the in-situ investigation of
physicochemical properties of a vast range of materials. They utilize high flux, high
penetration radiation sources and are capable of probing structures from near angstrom to
near micrometer sizes (~1nm-1um). These techniques have found wide-spread
application in characterizing soft materials such as bio-macromolecular assemblies,
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polymeric colloids, complex fluids, aerogel, and virus; as well as particulate and nonparticulate materials such as zeolites, liquid crystals, quantum dots, emulsion and
implants.73 SANS has found wide-spread popularity in characterizing block copolymer
micelles because it can provide direct information about the size, shape, orientation and
inter-particle interaction forces of a population of micelles in a particular solvent at
different conditions in a non-destructive manner. Moreover, SANS can elucidate ordered
crystal and nano-structures, three-dimensional microstructures, as well as the mechanism
and hierarchical of self-assembly in block copolymers systems.74
The self-assembly and morphological transitions of Pluronic nanostructures in
response to changes in temperature was monitored in real-time using SANS.74,75 In
agreement with other techniques such as DLS, the temperature induced dehydration of
the PPO blocks and subsequent self-assembly into a micelle can be observed by the
unique change in scattering profile after crossing the cloud point. Further increase in
temperature leads to structural rearrangement and transitions across a range of transitions
can be observed from the scattered profiles. In a different study, Tew and coworkers
showed SANS could be used to study the ordered crystal structure of stereo-specific
amphiphilic triblock copolymers and its resulting micellar nanostructures.76 The SANS
technique was able to differentiate between the different ordered crystal and nanostructures. Although basic information of the system can be extracted from scattered
profile (e.g. shape of curve, intensity, etc.); the model-dependent analysis of the data can
lead to a wealth of information. Predictive models in particle and polymer physics have
been well developed in the last half century and have been shown to be well suited in
analyzing nanoparticulates such as micelles and other polymeric colloids. The
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determination of the different morphological transitions and ordered crystal/nanostructure is only possible with model dependent analysis of the scattered data. The SANS
technique has also been successfully applied to investigate hydrogel nano/macro
structures and mechanism of gelation. SANS analysis was used to elucidate the distance
and ordering (position) of the scattering particles, in terms of: each other, locally, or
regionally to build a three-dimensional picture of the system.77 Detailed structural
information can results in design modification and optimization of hydrogel
physicochemical properties such as mechanical strength, degradation rate and many
others.
1.5.4 Scope of Dissertation and Outline
This document explores the rational design of an injectable hydrogel system to be
utilized as a robust, biocompatible and biodegradable local drug delivery system based on
associative network micelles. The influence of micelle dynamics on the mechanism of
hydrogel formation is explored as a function of micelle design and environmental factors.
The hydrogel is specifically functionalized for use as a gene delivery vector by
entrapping DNA/PEI polyplex particles. Syntheses of a well-defined polyionic block
copolymer and a novel technique for efficient condensation and entrapment of DNA/PEI
polyplex within the hydrogel matrix is described.
Chapter 2 explores the synthesis, design, and characterization of a robust PLAPEG-PLA thermo-responsive injectable hydrogel using a hybrid micellar system.
Previous studies have shown the PLA-PEG-PLA amphiphilic triblock copolymers
undergo sol to gel transition at around body temperature (37°C). The mechanism of
hydrogel formation was elucidated to occur through physical cross-linking of stereo36

regular PLLA and PDLA segments which undergo stereocomplexation. Although these
hydrogel systems showed great potential as injectable hydrogels, their application as drug
delivery systems failed due to their low mechanical strength.
Chapter 3 investigates the synthesis of a polyionic block copolymer composed of
PLA/PEI. A range of triblock (PLA-b-PEI-b-PLA) and diblock (PLA-b-PEI) copolymers
could be obtained using a simple amine protection/de-protection procedure to yield a
range of copolymers with well-define MW of PLA and PEI. Multi-layered micelle
particles were prepared using a novel method for the efficient condensation of high MW
DNA biomolecule using low MW non-toxic PLA/PEI block copolymers. The DNA
loaded multi-layered micelle particles were shown to have exceptional stability in
biological conditions (e.g. pH 7.4, plasma), undergo receptor mediated cell
internalization and show high release rate of DNA.
Chapter 4 describes the formulation of the PEI/DNA multi-layered micelles for
application as injectable hydrogels for gene therapy. The hybrid micelle controlled
gelation system reported in chapter 2 is utilized in producing stereocomplexed hydrogel
exhibiting a sol-to-gel transition around body temperature. Furthermore, cell penetration
studies are conducted to determine the phagocytosis mediated uptake of entrapped DNA
and its potential application in targeting antigen-presenting cells, such as macrophages.
Chapter 5 details the structural and mechanistic studies conducted on ABA
triblock copolymers of PLA-PEG-PLA associative micelle system utilized in preparation
of the robust injectable hydrogels in chapter 2. SANS was utilized to elucidate the realtime structural transformation as a function of time and temperature. The variation in
PEG block length was shown to affect the chain exchange dynamics and aggregation
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behavior of micelles. Model dependent analysis revealed that stereocomplexation
between PLLA/PDLA blocks lead to non-equilibrium chain exchange behaviors, while
homo-crystallization between PLLA/PLLA lead to equilibrium chain exchange.
Chapter 6 summarizes the overall effort of design, characterization and
application of block copolymer as drug delivery vectors. Modification of already existing
micellar systems through optimization of intrinsic properties could lead to improved
physicochemical properties. Elucidating structure-function relationship using real-time
non-destructive techniques can contribute to design optimization of well-known systems.
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CHAPTER 2.
Well-Controlled Temperature Responsive and Robust Hydrogels by
Stereocomplexed PLA-PEG-PLA Derived from Unique Micelle Structure of PreMixed Copolymers with Different PEG Block Length
2.1 Introduction
Thermo-responsive biodegradable hydrogels have been actively studied for drug
delivery systems and temporary implants.78-81 Generally, poly(lactide) (PLA) or
poly(lactide-co-glycolide) (PLGA) is copolymerized with poly(ethylene glycol) (PEG) to
obtain amphiphilic micelles in aqueous solution, which transform into a hydrogel due to
physical crosslink by swelling, hydration, and self-assembly of polymers responding to
temperature. Kim and Lee have developed injectable microparticles for DDS from
various AB and BAB type block copolymers from PLLA and PEG, or PLGA and PEG.82,
83

The sol/gel phase diagrams of those reported gels are highly complicated, thus

many factors must be adjusted to find the useful hydrogel at right temperature. Sol-gel
transition behavior and mechanical properties of hydrogels are particularly important
to apply for clinical use. The block length and type84 and the crystallinity76 of PLAPEG copolymers were systematically studied by mixing ABA type and AB type
copolymers or mixing crystalline PLLA-PEG and amorphous PDLLA-PEG copolymer
systems. There are several techniques used for photo-crosslinking hydrogels of PLAPEG block copolymer systems. For example, methacrylate capped triblock copolymer
MA-PLLA-PEG-PLLA-MA and its’ degradation properties were studied, and reported
that the degradability of this high modulus gel can be controlled by tailoring the
composition.85, 86
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The use of stereocomplexation of PLLA and PDLA was applied earlier to form
hydrogels using p(HEMA)-graft-oligo(lactide)87 and dextran-graft-oligo(lactide)88, 89
systems. While, this stereocomplex mechanism was first introduced to specifically
prepare the thermo-sensitive hydrogels from triblock copolymers, PLA-PEG-PLA by
Fujiwara and Kimura in 2001.66

Aqueous micelle solutions from enantiomeric

triblock copolymers with particular molecular weight, PLLA-PEG-PLLA (1300-46001300) and PDLA-PEG-PDLA (1100-4600-1100) exhibited sol-to-gel transition between
25 and 37°C, which was considered as a promising injectable hydrogel. The
mechanism of this gelation was believed to occur as interaction of micelles by
exchange of PLA blocks in the micelle core and formation of stereocomplexation
between PLLA and PDLA blocks. This PLA-PEG-PLA stereocomplex hydrogel,
however, showed relatively low storage modulus (ca. 1,000 Pa), and thus was
insufficient for many applications as injectable implant material.
There have been a few reports using similar materials for this hydrogel system.
Vert et al. have obtained hydrogels from increased molecular weights of PLA-PEG-PLA
triblock copolymers , but have not observed thermo-responsive sol-gel transition.90
Furthermore, graft polymers91 and star-block copolymers by enantiomeric PLA are
synthesized,29 and used with chemical crosslinking for gelation process to obtain more
robust gels.93, 94 Despite many studies, there was no report for mechanically strong and
controllable thermo-responsive hydrogels driven by solely stereocomplaxation of PLAs.
As hydrogels from enantiomeric PLA-b-PEG are promising safe biomaterials without use
of any other materials or chemical crosslinking, improvement of physical properties and
deployable gelation behaviors are crucial. The micelle formation mechanisms and the
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properties of hybrid micelles comprising more than two different block copolymers
have been reported. For example, Munk discussed thermodynamic stability of hybrid
micelles which are depending on many factors such as core block sizes, total MW,
medium, hydrophilic-lipophilic balance, and interaction parameter of two blocks.95
Chaibundit studied mixture of two different corona block size of PluronicTM (PEGPPG-PEG) to form co-micelles and then hydrogels.96 To obtain novel properties and
functions, designing hybrid micelles from multiple components is an attractive
approach. In this paper we report the improved injectable hydrogels by preparing
unique hybrid micelles from two different sizes of PLA-PEG-PLA triblock
copolymers. These ‘pre-mixed copolymer micelles’ exhibit noticeably different
properties from ordinary micelles, and controllable sol-to-gel transitions at wide
temperature range between 4 and 80°C. The gelation mechanism and physical
properties of those new systems are investigated.
2.2 Experimental
2.2.1 Materials
The monomers, L-lactide and D-lactide with the trademarked names of
PURASORB L and PURASORB D, respectively, were purchased from Purac
Biochem (Netherlands). Poly (ethylene glycol) (PEG) with a number average molecular
weight (Mn) of 2000 Da (PEG-2000) and 3350 Da (PEG-3350), toluene (extra dry), and
tin (II) 2-ethylhexanoate (SnOct2) were purchased from Sigma Aldrich (St. Louis, MO).
The monomers, L-lactide and D-lactide were purified by recrystallization from toluene,
dried in a vacuum oven at room temperature for 48hrs, and stored at -20°C under
N2 environment before use. The macroinitiator PEG was lyophilized from benzene
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and stored at -20°C under N2 atmosphere before use. Dichloromethane (DCM), and
tetrahydrofuran (THF) were purified using Vacuum Atmosphere Solvent Distillation
System. All other reagents were used as received.
2.2.2 Synthesis of Poly(L-lactide)-Poly(ethylene glycol)-Poly(Lactide) Triblock
Copolymers
The ABA- type triblock copolymers of PLLA-PEG-PLLA and PDLA-PEGPDLA were prepared by the ordinary ring-opening polymerization of L-lactide and Dlactide respectively in the presence of PEG-diol by the catalysis of Sn(Oct)2 (5
mol% relative to each hydroxyl group of PEG). The typical bulk polymerization was
carried out as follows: PEG-2000 (5g, 2.5 mmol) and L-lactide (4g, 28 mmol) were
placed in a reaction flask, equipped with a reflux condenser, stir bar and addition
funnel. The reaction flask was sealed and evacuated to remove moisture, then
converted to N2 gas. The catalyst Sn(Oct)2 (0.1g. 0.25 mmol) at a 0.1g/mL
Toluene solution was added to the reaction mixture after homogenizing the reactant
at 100°C for 1hr. The reaction temperature was raised to 120°C and allowed to react
overnight. The cooled solid was dissolved in dichloromethane (50 mL) to give a
slightly cloudy solution and added dropwise into 1:1 diethyl ether/hexane (500 mL)
to precipitate the product. The average molecular weight (Mn) and PLA/PEG block
ratio were calculated from the 1HNMR spectra obtained in CDCl3. The chemical shifts
are assigned as follows: δ 1.56-1.6 (d, CHCH3), δ 3.6-3.7 (m, OCH2CH2), δ 4.24.3 (m, COOCH2 for the oxymethylene connecting with lactate repeating units), δ
4.3-4.4 (m, CHOH, end group CH of the lactate repeating units) and δ 5.1-5.2 (q,
CHCH3, of lactate repeating units) and 1HNMR spectrum and structure are shown in
Figure 2.1.
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Figure 2.1.1HNMR spectrum of PLLA-PEG-PLLA triblock copolymer

2.2.3 Micelle and Hydrogel Preparation
Figure 2.2 describes the micelle and hydrogel formation procedure. The micelle
solutions of PLLA-PEG-PLLA and PDLA-PEG-PDLA triblock copolymers were
separately prepared. As depicted in the schematic, the copolymer was dissolved in THF, a
water miscible solvent. Each of the transparent polymer/THF solution was then added
dropwise into deionized water with ultrasonic wave applied at ~4°C to obtain a
suspension.

43

Figure 2.2. Micelle and hydrogel preparation procedure,(a) homo-copolymer (b) premixed copolymer micelles.

THF is evaporated from the suspension under reduced pressure at 10°C to obtain
an aqueous micelle solution. Figure 2.2(a) shows the single copolymer micelle
preparation procedure. Alternatively the ‘pre-mixed copolymer micelle’ preparation
procedure is depicted in Figure 2.2(b); the copolymers composed of same PLA stereoisomer (e.g PLLA) but different PEG sizes (MW: 800-2000-800 + 800-3350-800) were
combined and dissolved in THF to give a homogenous solution. This is the only
difference in otherwise identical procedure as described above. Micelle concentrations
ranging from 0.01-20% were prepared for characterization and hydrogel studies.
Controlled hydrogel formation is achieved by blending equal volumes of the
PLLA-PEG-PLLA and PDLA-PEG-PDLA micelles. Micelle solution of PLLA-PEGPLLA and PDLA-PEG-PDLA were equilibrated at 4°C using an ice bath initially. To an
empty scintillation vial immersed in 4°C ultrasonic bath, equal volume of each micelle
solution was added followed by gentle ultrasonic agitation. The mixture is allowed to
sonicate at 4°C for 30 minutes or until a homogeneous solution is obtained. The vial is
then transferred to a temperature controlled circulating water bath and the temperature of
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the bath is gradually ramped from 4°C to 80°C with 1 hr hold at each temperature
interval. The vials were sealed with a screw cap to prevent water evaporation. The
physical state of the mixture was reported at each temperature interval by tilting the vial.
If the mixture flowed then it was reported as a solution, and if it did not flow for at least 8
seconds it was reported as a gel. The results are then plotted as phase diagrams to
illustrate the sol-gel transition temperatures.
2.2.4 Instrumentation
Nuclear Magnetic Resonance (1HNMR) was used to characterize all
copolymers in CDCl3 at room temperature on a FT-NMR-Joel GSX-270 MHz. Gel
Permeation Chromatography (GPC) was performed on a Shimadzu LC-20AD with two
Jordi DVB 500Å (250 x 10 mm) columns calibrated with polystyrene standard at 35°C.
The flow rate was 1.0 mL/min with THF as the mobile phase. Differential
Scanning Calorimetry (DSC) was performed on a NETZSCH DSC 200 PC Phox
Polymers as synthesized were first heated to 190°C (PLLA-PEG-PLLA) or to 240°C (1:1
blend of PLLA-PEG-PLLA and PDLA-PEG-PDLA) at the rate of 20°C/min, cooled to 50°C at the cooling rate of 100°C/min, and then re-heated (2nd scan) from -50 to 190
(PLLA-PEG-PLLA) or 240°C (1:1 blend of PLLA-PEG-PLLA and PDLA-PEG-PDLA)
at the rate of 10°C/min. Dynamic Light Scattering (DLS) was used to measure a micelle
size on a Malvern Zetasizer Nano ZS90 at 1, 0.1 and 0.01% concentrations at room
temperature in triplicates. Wide Angle X-ray Diffraction (WAXS) was performed on a
Bruker AXS D8 Advance X-Ray Diffractometer for lyophilized powder samples. The
instrument was operated at 40kV and 40mA and sample scanned in the 2θ range of 5-40°.
Rheology measurement was performed on a TA AR 550 Rheometer using a cone and
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plate geometry with a 4° cone, 40mm diameter plate and 61 mm gap. Frequency sweep
was performed from 0.01-40 Hz at 37°C.
2.3 Results and Discussion
2.3.1 PLA-PEG-PLA Block Copolymers
Based on the molecular weight of previously reported triblock copolymers,
PLA-PEG-PLA (e.g., 1100-4600-1100),66 several groups examined a series of larger
sized copolymers.90 We also have prepared larger triblock copolymers using PEG
(MW: 10000) as an initiator, e.g., PLLA-PEG-PLLA and PDLA-PEG-PDLA (130010000-1300, 2500-10000-2500, etc). Similarly to other attempts, a ‘temperatureresponsive hydrogel’ by self-organized PLA stereocomplexation mechanism was not
observed, although gels were formed more easily by using mixture of enantiomeric
copolymer micelles than from single homopolymer micelles at same concentration. In
this study, relatively low molecular weight copolymers with both short PLA and PEG
blocks were designed. The triblock copolymers were obtained by the ring-opening
polymerization (ROP) of L- or D-lactide from PEG (MW: 2000 and 3350)
macroinitiator at 120°C in the presence of Sn(Oct)2. Table 2.1 gives a summary of the
block copolymers used for this study; Mn, Mw, and polydispersity index were
calculated from GPC (polystyrene conversion) and 1HNMR. Narrow polydispersity was
obtained for all block copolymers.
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Table 2.1. Molecular weight and polydispersity of PLA-PEG-PLA block copolymers
ID

Block Copolymer

(block MW)

Theoretical

Mn

MW(g/mol)

(NMR)

Mn (GPC) Mw (GPC)

PDI

L7E45L7

PLLA-PEG-PLLA

(500-2000-500)

3000

2870

2500

2676

1.07

D7E45D7

PDLA-PEG-PDLA

(500-2000-500)

3000

2854

2466

2676

1.08

L11E45L11 PLLA-PEG-PLLA

(800-2000-800)

3600

3611

3695

4133

1.11

D11E45D11 PDLA-PEG-PDLA

(800-2000-800)

3600

3616

4023

4653

1.15

L11E76L11 PLLA-PEG-PLLA

(800-3350-800)

4950

4963

5812

6634

1.14

D11E76D11 PDLA-PEG-PDLA

(800-3350-800)

4950

4949

5883

6549

1.11
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Table 2.2 Thermal properties of PLA-PEG-PLA block copolymers by DSC (2nd scan)*a
ID (wt%)
Tm (scΔHm (scXc
Tm
Tm
ΔHm
(PEG)

(°C)

(PLLA)\

(°C)

Xc (scb

b

PLA)

(PLLA)

PLA)

(PLLA)

(°C)

(J/g)

(J/g)

(%)

(%)

PLA)

L7E45L7

37

ndc

-

0

-

0

-

L11E45L11

33

nd

-

0

-

0

-

L11E76L11

45

117

-

0.8

-

0.6

-

nd

nd

0

0

0

0

35-50d

L7E45L7
(50:50)

+

D7E45D7

L11E45L11
(50:50)

+

D11E45D11

31

nd

132

0

3.1

0

2.1

L11E76L11
(50:50)

+

D11E76D11

47

nd

156

0

7.9

0

5.4

a

all data shown are detected at the second scan from -50 to 190 (LEL) or to 240°C (stereo-blend) at the heating rate 10°C/min.
crystallinities of homo and stereocomplex crystals were calculated using reported ΔHm for the crystals having an infinite
thickness, ΔHm(100%)= 135 J/g for PLLA26 and 146 J/g for PLA stereocomplex.25
c
nd: not detected
d
multiple peaks observed
b
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Thermal properties of synthesized copolymers were examined by DSC. Table 2.2
lists melting temperatures and enthalpies of crystals formed via second scan at the
heating rate of 10°C/min. Melting points (Tm) of the imperfect crystals from these
short PLA blocks displayed at much lower temperatures compared to the Tm of
typical high molecular weight homopolymers, PLLA (160-170°C) and stereocomplex
PLA crystal (220-230°C). From the first scan of as-synthesized and vacuum-dried
copolymers, for example, L11E45L11 and L11E76L11, broad melting peak of PLLA
was clearly detected at the range of 106-110°C with crystallinities ca. 2-4 % (data not
shown). Given the short PLA blocks with unit repeating number 7 or 11,
crystallization process from the melt- quench state (second scan) was slow, and all
copolymers showed none or low PLA crystallinities. de Jong et al.99, 100 prepared
nonblended and equimolarly blended PLA ologomers, and found that PLLA or
PDLA were crystallizable for repeating monomer unit above 11, while an equimolar
mixture formed stereocomplex crystallites for unit number above 7, meaning high
stability of the stereocomplex crystallites compared with that of homo-crystallites.
DSC data of the block copolymers in our studies showed consistent results as short
PLLA copolymer (L7E45L7) did not form crystals, and L11E45L11 crystallized very
slowly; whereas, stereocomplex formation was favored as crystallinity of blend
polymers was higher than crystallinity of corresponding PLLA copolymer, based on
enthalpies of crystal melting calculated using theoretical values.97, 98
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2.3.2 Characterization of Micelles
Flower-type micelles with a spherical morphology are expected to generate
from PLA-PEG-PLA block copolymers. The hydrophobic PLA segments associate in
the micelle core surrounded by the hydrophilic PEG segments in aqueous medium.
The three types of micelle structures particularly focused on the hydrogel studies are
illustrated in Figure 2.3. Among copolymers with constant length of PLA blocks
(800), the shorter PEG copolymer (L11E45L11 or D11E45D11) and the longer PEG
copolymer (L11E76L11 or D11E76D11) form different micelles which are abbreviated
as (Mshort) and (Mlong), respectively. The third micelle (Mmix) in Figure 2.3 was
prepared by the pre-mixture of shorter and longer PEG copolymers (i.e., L11E45L11+
L11E76L11 or D11E45D11+ D11E76D11). As Figure 2.3 depicts, the ‘pre-mixed
copolymer micelle’ (Mmix) is considered to be co-associated by both sizes of
copolymers. Co-micellization of two block copolymers has been studied by several
researchers.95, 96, 101 Munk discussed thermodynamic stability of hybrid micelles with
di and triblock copolymers, which are depending on many factors such as core block
sizes, total MW, medium, hydrophilic-lipophilic balance (HLB), interaction parameter
of two block and so on.95 Some combination prevents hybridization particularly at low
core stability, and some form uniform hybrid micelles. In such a situation, the
solvent phase that is saturated by both unimers, may become supersaturated with
respect to the hybrid micelles and their nucleation may occur. Chang used different
corona block of copolymers with similar MW and block ratio on silicon wafer. It is a
clever experiment using AFM and pH change to demonstrate that hybrid micelles are
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formed by pre-mixed copolymer method and post-mixed micelles consist of the mixture
of two different micelles.101

Figure 2.3 Proposed micelle structures influenced by PEG block length.

For (Mshort) and (Mlong) micelles, micelle size and stability are shown to
be primarily influenced by the PEG block length. The hydrodynamic diameters of
(Mshort-L) and (Mlong-L) by DLS gave 63nm and 42 nm, respectively, as shown in
Table 2 . 3. The (Mshort-L) micelle from PLLA-PEG-PLLA with shorter PEG (8002000-800) displayed a larger hydrodynamic size than the (Mlong-L) micelle from the
copolymer with longer PEG (800-3350-800). The increase in PEG block length leads
to smaller micelle, which means a fewer numbers of polymers associate in the micelle
core due to the large corona volume.
The hydrodynamic diameters of (Mmix) micelles with varied copolymer ratio
measured by DLS are listed in Table 2.3. The sizes of ‘pre-mixed copolymer micelles’
were all similar sizes with indication of some aggregation samples. There was no specific
trend observed in micelle sizes, however, polydispersity of ‘mixed copolymer micelles’
were slightly wider than single polymer micelles, (Mshort) and (Mlong). The
similar average sizes and DLS curves obtained for the mixtures (Mmix) indicate
comicellization of the two copolymers. Chaibundit et.al, reported the micelle
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properties and gelation behavior of mixed copolymer micelles of PluronicTM (PEGPPG-PEG) with two different lengths of PEG blocks.96 Their mixed copolymer
micelles with varied ratios have shown slightly larger hydrodynamic diameters and
wider polydispersity then the single copolymer micelles, which is consistent with
results of our PLA-PEG-PLA system. The static light scattering study of their
Pluronic copolymers revealed that the association number of ‘mixed copolymer
micelles’ linearly increased as a ratio of longer corona polymer decreases, whereas
the micelle diameters for all mixed copolymer micelles were slightly larger than both
single polymer micelles. They concluded that stable ‘comicellization’ occurred for
Pluronic system with constant sized micelle core blocks. This is similar system with
our “pre-mixed copolymer micelles” except these are BAB type copolymers (as A:
hydrophobic core block). For our ABA type copolymers, the size of hydrophobic PLA
is constant (800) and only length of PEG is different (2000 and 3350). It is
reasonable to form hybrid micelles with stable core PLA and two sizes of PEG
corona layer for pre-mixed copolymers.
The fourth micelle system investigated but not shown in Figure 2.3 is the ‘postmixed micelles’ (Mshort + Mlong) which are prepared by simply mixing existing
micelle solutions. The response of mixed micelles however is not as unique as that of
the mixed copolymers (Mmix). These ‘mixed micelles’ behave similarly to either
(Mshort) or (Mlong) depending on the major component.
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Table 2.3. Hydrodynamic diameter of the micelles determined by DLS (0.1wt%)
Micelle ID

Copolymers (weight ratio, %)

Size (nm)

Polydispersity

Mshort-L

L11E45L11
L11E76L11

62.84

Index
0.112

42.82

0.106

Mmix-L (10%) (10%) L11E45L11 + (90%)

81.39

0.193

Mmix-L (20%) (20%) L11E45L11
L11E76L11
Mmix-L (30%) (30%) L11E45L11
L11E76L11
Mmix-L (40%) (40%) L11E45L11
L11E76L11
Mmix-L (50%) (50%) L11E45L11
L11E76L11
Mmix-L (60%) (60%) L11E45L11
L11E76L11
Mmix-L (70%) (70%) L11E45L11
L11E76L11
Mmix-L (80%) (80%) L11E45L11
L11E76L11
Mmix-L (90%) (90%) L11E45L11
L11E76L11

+ (80%)

23.6,115.7

0.298

+ (70%)

52.77

0.206

+ (60%)

51.13

0.150

+ (50%)

70.41

0.231

+ (40%)

65.78

0.205

+ (30%)

60.68

0.195

+ (20%)

75.31

0.219

+ (10%)

134.5

0.217

Mlong-L

L11E76L11
2.3.3 Thermo-Responsive Hydrogel Formation
Hydrogels were prepared by mixing equal volumes of the enantiomeric micelle
solutions at various polymer concentrations. As the sol-gel transition temperature is
reached, the micellar solution changes from a solution to a gel state. This
phenomenon is easily witnessed by tilling the vial. Stereocomplexed PLA-PEG-PLA
thermo-responsive hydrogels are considered to form by physical crosslinking induced by
chain exchange between micelles, which is governed by temperature increase as
illustrated in Figure 2.4.66 These hydrogels are irreversible due to the robustness and
insolubility of the PLA stereocomplex crystals formed inside micelle cores.
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Figure 2.4. Previously proposed stereocomplexed hydrogel mechanism

The sol-gel transition temperatures for single copolymer micelle systems are
summarized in phase diagram plots in Figure 2.5. The mixture of enantiomeric micelles
comprised of short PLA blocks, L7E45L7 (MW: 500-2000-500) and D7E45D7 (MW:
500- 2000-500), did not form a hydrogel at any given temperature or concentration as
shown in Figure 2 . 5 a . It has been known that the PLA block length must be
greater than 7 repeating monomer units for successful formation of strereocomplexation
between PLLA and PDLA.102 The block copolymers represented in Figure 2.5a have
slightly below 7 repeating lactate units and therefore no gelation is observed. This result
agrees with DSC data shown in Table 2.2, in which no stereocomplex formation has
been detected from the polymer blend of L7E45L7 and D7E45D7.
Figure 2.5b and 2.5c show the phase diagrams for enantiomeric mixture of the
micelle solutions from constant PLA size (MW: 800) polymers with different PEG sizes,
(Mshort-L + Mshort-D) and (Mlong-L + Mlong-D), respectively. The sol-to-gel
transition temperature for the (Mshort-L + Mshort-D) micellar solutions is as low as
4°C at polymer concentration 8% or higher. The micellar solutions of (Mlong-L +
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Mlong-D) however, showed the contrast response upon temperature treatment. These
micelles were stable over the dehydration temperature of the PEG block which is about
60-70°C. The increase in PEG block length from Mw of 2000 to 3350 has significant
effect on micelle stability. The stability of the micelles (Mlong) is due to their smaller
hydrodynamic diameter and longer PEG corona providing increased aqueous
solubility. Consequently, exchange of PLA blocks between micelles is suppressed by
relatively thicker corona layer. It should be noted that the controlled experiments for all
types of PLLA-PEG-PLLA block copolymer micelles (single enantiomer micelles) did
not turn into gel state at any temperatures and concentrations shown in Figure 2.5,
although some solutions were viscous at high concentrations.

Figure 2.5. Phase diagram of the 1:1 stereo-mixtures of micelle solutions prepared by
different sized block copolymers by tilt method upon increase of temperature for each
concentration; PLLA-PEG-PLLA and PDLA-PEG-PDLA micelle solutions, (a)
MW:500-2000-500, (b) MW:800-2000-800 (Mshort-L + Mshort-D), and (c) MW:8003350-800 (Mlong-L + Mlong-D). Plots represent solution state (open squares) and gel
state (filled triangles).

The stereo-mixture of the ‘pre-mixed copolymer micelles’ (Mmix-L and MmixD) exhibited dramatically different sol-to-gel phase transition behaviors. The sol-to-gel
phase diagram in Figure 2.6 shows a linear response in sol-gel transition temperature as a
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factor of short-PEG and long-PEG block copolymer ratio. The concentration of the
micelles was kept as 10% for this series. Most interestingly sol-gel transition around body
temperature can be achieved by simply adjusting the copolymer ratio. These mixed
copolymer micelles have physiological relevant thermo-responsive properties and can be
used as injectable thermo-sensitive hydrogels. Again, the mixed copolymer micelle
solutions from single enentiomer, Mmix-L did not exhibit any hydrogel formation at
the same given conditions.

Figure 2.6. Sol-gel transition temperature of equimolar enantiomeric blends of the premixed copolymer micelles (Mmix-L + Mmix-D). The x-axis shows the weight fraction of
the short PEG copolymer (MW:800-2000-800) in the pre-mixed copolymer micelle
(MW:800-2000-800 + 800-3350-800). The micelle solutions are maintained at 10%
concentration. Plots represent solution state (open squares) and gel state (filled triangles).
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The SEM image of the resulting hydrogel (Mmix-L and Mmix-D) shows a
porous network that is vastly interconnected (Figure 2.7, left). From the tilt method,
this mixed copolymer hydrogel didn’t flow at all immediately after the heat
treatment of micelle solutions, which is promising for a robust injectable gel. The
mechanism of sol-gel transition and mechanical strength of the resulting hydrogels is
further discussed below.

10µm

Figure 2.7. Hydrogel obtained by the mixture of enantiomeric PLA-PEG-PLA from premixed copolymer (50:50% short/long PEG copolymers) micelle solutions (Mmix-L +
Mmix-D); A SEM micrograph of the freeze-dried hydrogel (left), and a photo of the
hydrogel in a vial immediately after heat treatment above body temperature (right).

As a contrast experiment, the enantiomeric mixture from the post-mixed micelles
((Mshort+Mlong)-L and (Mshort+Mlong)-D) was investigated in same method. This
stereo- mixture that contains different sizes of micelles did not have any unique
response at any given ratios, and behaved similarly to the major component of
copolymer micelles. The resulting hydrogels were apparently much weaker than ‘premixed copolymer micelle’ gels by tilt observation. Therefore the exceptional properties
of the ‘pre-mixed copolymer micelles’ can be attributed to the unique micellar
structures formed and not on the sole presence of both block copolymers.
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Chain exchange process between micelles has been studied by researchers. Earlier,
Wang et al. studied polystyrene-b-poly(ethylene oxide) micelle chain exchange kinetics
experimentally and theoretically and raised complexity of factors.103 Lund,104, 105
and recently Bates106 reported micelle chain exchange of model block copolymers using
time-resolved SANS technique. Although factors of chain exchange kinetics have not
reached conclusion from those studies, it is believed that the micelle core plays a key
role, such as distribution of core block lengths, interactions between core block
segments and solvent, and core block mobility. The chain exchange kinetics of our
system, Mshort, Mlong, and Mmix (pre-mixed) is unknown at this point, and may not
be directly corresponding to the sol-gel phase behavior. However, difference of phase
behavior between stereo-blend of pre-mixed micelles and that of post-mixed micelles
will be based on kinetics and thermodynamics of original micelle core dynamics that
will need to be further investigated. Another significant effect we believe is the core
stability change after chain exchange occurs. As our triblock copolymer forms bridges
between micelles by chain exchange, the formation of stable stereocomplex crystals is
essential driving force of this hydrogel.
2.3.4 Crystallization of Hydrogels
As depicted in Figure 2.4, the typical stereo- mixture gelation for (Mshort) and
(Mlong) micelles proceeds through the stereocomplexation between the PLLA and
PDLA segments after chain exchange between micelles occurs.66 At some particular
temperature polymer mobility in the micelle increases, and PLA blocks start to
exchange between the micelles. PEG act as a physical crosslinker to establish hydrogel
network. Although chain exchange occurs for PLLA-PEG-PLLA micelles, single
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micelle solutions do not exhibit sol-to-gel transition at any given concentrations and
temperature. As DSC results agreed with literatures, stereocomplex formation is
favored than homo-crystals formation in terms of limitation of chain length.
Additionally, it has been reported that critical concentration and critical temperature of
stereocomplex formation are lower than homo-crystals.

Figure 2.8. (a) WAXS profile for (Mshort-L) micelle (I), (Mshort-L + Mshort-D)
50/50% mixture at 10°C (II), 50°C (III), 80°C (IV). (b) WAXS profile for (Mmix-L)
micelle (V), (Mmix-L + Mmix-D) 50/50% mixture at 10°C (VI), 50°C (VII), 80°C
(VIII). (H) and (S) represent homopolymer crystal and stereocomplex crystal,
respectively.
Copolymer compositions in each micelle are Mshort-L: L11E45L11 (800-2000-800);
Mshort- D: D11E45D11 (800-2000-800); Mmix-L: L11E45L11 (800-2000-800) +
L11E76L11 (800-3350-800), 50/50wt%; and Mmix-D: D11E45D11 (800-2000-800) +
D11E76D11 (800-3350-800), 50/50wt%.

The crystallization of these types of triblock copolymers has been studied using
wide-angle X-ray diffraction patterns. Enantiomeric PLLA and PDLA are both
crystallizable in an orthorhombic or pseudo-orthorhombic unit cell with a 103 helical
conformation (α-form). It has been reported that a racemic mixture forms the
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stereocomplex between the PLLA and PDLA by alternate packing of β-form 31-helices
of the opposite absolute configuration (left- and right-handed, respectively) side by side
with van der Waals contact.107 The homopolymer crystal of PLLA or PDLA displays
the XRD diffraction peaks at 2θ = 17° and 19°, while the stereocomplex crystal of the
stereo- mixture shows the diffraction peaks at 2θ = 12° and 21°. The triblock copolymer
hydrogels generated from (Mshort) and (Mlong) give comparable diffraction peaks. The
diffraction spectra in Figure 2.8a show the XRD profile for (Mshort) micelle and
hydrogels. The diffraction spectra (I) for the (Mshort) micelle shows PLLA homo-crystal
peaks at 2θ = 17° and 19°, as well as crystalline PEG at 2θ = 19° (overlapped with PLLA
peak) and 23°. The diffraction at 2θ = 19° is primarily from PEG, therefore the peak at 2θ
= 17° will be used to monitor PLLA or PDLA homo-crystal changes. The diffraction
spectra (Figure 2.8a, II-IV) show stereocomplex peaks at 2θ = 12° and 21°. Both peaks
are shown to increase as temperature increases, indicating continued chain exchange
which leads to increased interaction between PLLA and PDLA segments. The increase in
stereocomplex intensity exhibited sigmoid curve as a function of temperature, which was
consistent with the previously reported results for the original hydrogel system by
synchrotron WAXS.66, 108 The peak at 2θ = 17° for the homo-crystal of PLLA or
PDLA blocks is shown to decrease as the stereocomplex crystal is increasing.
It is proposed that the new micellar systems comprised of mixed sized copolymers
form hydrogels through the same stereocomplexation mechanism as described above.
Figure 2.8b shows the XRD profiles for the mixed copolymer micelles and resulting
hydrogel. The diffraction spectrum (V) for (Mmix-L) micelle
(L11E45L11/L11E76L11=50/50), shows the PLLA homo-crystal and crystalline PEG
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diffraction peaks equivalent to Figure 2.8a (I). The diffraction spectra (VI-VIII) for the
racemic mixture (Mmix-L(50%) + Mmix-D(50%)) taken at varying temperatures
show stereocomplex crystal diffraction peaks at 2θ = 12° and 21°. Chain exchange
between the (Mmix-L and Mmix-D) micelles is shown to occur as low as 10°C,
however as shown in the phase diagram in Figure 2.6, sol-gel transition for the
racemic mixture of L11E45L11/L11E76L11 = 50/50 pre-mixed copolymer micelles
and corresponding D copolymer micelles was not observed until around 40°C. The
stereocomplex peaks are shown to increase and the PLLA or PDLA homo-crystal peaks
to decrease as temperature rises. In parallel to the (Mshort) hydrogels in Figure 2.8a,
chain exchange between the (Mmix-L) and (Mmix-D) micelle followed by
stereocomplexation is also the driving factor for cross-linking and hydrogel formation in
the mixed copolymer systems.
2.3.5 Nanostructures of Hydrogels.
As hypothesized in illustration (Figure 2.3), we suggest that the micelle form
retains after a successful chain exchange between micelles and stereocomplex
formation in the cores. To examine structural information, we performed the SAXS
measurement for the micelle solution and hydrogel samples using a synchrotron
radiation. For the amphiphilic block copolymer micelles, SAXS data are expected to
exhibit hydrophobic PLA core information because fully hydrated and low-electrondensity PEG corona would not be detected. Figure 2.9 shows SAXS proﬁles of (a) 10 wt
% of Mmix-L(70%) and (b) 10 wt % of (Mmix-L(70%) + Mmix-D(70%)) (50:50
racemic mixture), which are the solution and hydrogel states at room temperature,
respectively. The experimental intensity plots are correlated to the equation q = 4π sin
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θ/λ, where q is the scattering vector, 2θ is the scattering angle, and λ is the wavelength
of the X-ray. The radius of gyration (Rg) was estimated by Guinier and Porod ﬁttings.
The calculated core mean diameters for Mmix-L(70%) micelle and (Mmix-L(70%) +
Mmix-D(70%)) micelle were 16 and 7 nm, respectively. Although the size of the
stereocomplexed PLA core in the hydrogel is smaller than the core of the single
enantiomer micelle, which is in a solution state for these particular set of samples, the
distinctive peak in SAXS proﬁle indicates that cross-linked the PLA core structure
retains after the gelation process. To discuss particle sizes and the gelation mechanism of
the hybrid micelles in detail, we will need further systematic SAXS studies as well as
other analysis techniques such as microscopies and surface labeling.

Figure 2.9. SAXS proﬁle for (a) Mmix-L(70%) micelle solution and (b) (Mmix-L(70%)
+ Mmix-D(70%)) 50:50 wt % mixture at room temperature. Polymer concentrations are
10 wt % for both samples. Copolymer compositions in each micelle are Mmix-L(70%):
L11E45L11 (800−2000−800) + L11E76L11 (800−3350−800), 70/30 wt %, and MmixD(70%): D11E45D11 (800−2000−800) + D11E76D11 (800−3350−800), 70/30 wt %.
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2.3.6 Mechanical Properties of Hydrogels
Mechanical properties of these hydrogels were characterized by Rheology.
Figure 2.10 shows the storage modulus (G’) and loss modulus (G”) of the
stereocomplexed hydrogels as a function of frequency (Hz) at 37°C. The racemic
micelle mixture of short PEG copolymers (Mshort-L + Mshort-D) showed the lowest
mechanical modulus (square). Both G’ and G” are less frequency dependent, which
means this hydrogel is stable even though it is the weakest. This is reasonable that the
short PEG micelles turns to gel immediately after mixing of L and D at any condition
higher than 8% concentration. The micellar blend of the longer PEG copolymers
(Mlong- L + Mlong-D) showed modest mechanical strength (triangle). Initial higher
values of G” explain the fluid-like characteristic of this hydrogel, however, upon
further stereocomplexation, both moduli become stable. The racemic mixture of
‘mixed copolymer micelles’ (Mmix-L + Mmix-D) exhibited the highest mechanical
strength as the storage modulus immediately reached about 6000Pa (diamond). The
higher value of G’ indicates that this ‘mixed copolymer micelle’ hydrogel possesses a
more solid-like, rigid micro-structure. The loss modulus (G”) showed unstable profile at
relatively lower frequency, which was reproducible for this particular hydrogel. This
result indicates chain exchange and structural reorganization occur in different way
from single size copolymer hydrogel. The mechanical strength of this gel is a great
improvement from the originally reported stereocomplexed PLA-PEG-PLA thermoresponsive hydrogel (ca. 1000Pa).66
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Figure 2.10. The plots of storage modulus (G’) and loss modulus (G”) as a function of
frequency at 37°C for 1:1 stereo-mixture of micelle solutions: (closed diamond) G’ of
(Mmix-L + Mmix-D); (open diamond) G” of (Mmix-L + Mmix-D); (closed triangle) G’
of (Mlong-L + Mlong-D); (open triangle) G” of (Mlong-L + Mlong-D); (closed square)
G’ of (Mshort-L + Mshort-D); (open square) G” of (Mshort-L + Mshort-D).
Concentration of micelles; Mmix: 20%, Mlong: 20%, and Mshort: 15%.
Copolymer composition in each micelle are Mmix-L: L11E45L11 (800-2000-800) +
L11E76L11 (800-3350-800), 50/50wt%; Mmix-D: D11E45D11 (800-2000-800) +
D11E76D11 (800-3350-800), 50/50wt%; Mlong-L: L11E76L11 (800-3350-800); MlongD: D11E76D11 (800-3350-800); Mshort-L: L11E45L11 (800-2000-800); Mshort-D:
D11E45D11 (800-2000-800).

Alternatively Figure 2.11 shows a comparison of the moduli (G’ and G”) of
racemic mixture of ‘pre-mixed copolymer’ micelles (Mmix-L + Mmix-D) (diamond)
and post-mixed micelles ((Mshort+Mlong)-L + (Mshort+Mlong)-D) (triangle). The
post-mixed micelle hydrogel consists of two different sizes of micelles (50:50wt%),
and shows similar rheological behavior to the (Mshort-L + Mshort-D) micelles shown
in Figure 2.11 as both G’ and G” are low values and frequency independent. Although
polymer composition of these two mixtures in Figure 2.11 are exactly same, the postmixture of different sizes micelles does not show a high mechanical strength (ca. 2000
Pa) compared to the pre-mixed copolymer micelles (diamond, ca. 6000 Pa). The
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difference of ‘pre- mixed copolymer micelle’ and ‘post-mixed micelle’ was also clearly
seen for the sol-gel phase transition behavior (vide supra).

Figure 2.11. The plots of storage modulus (G’) and loss modulus (G”) as a function of
frequency at 37°C for 1:1 stereo-mixture of micelle solutions: (closed diamond) G’ of
(Mmix-L + Mmix-D); (open diamond) G” of (Mmix-L + Mmix-D); (closed triangle) G’
of ((Mshort+Mlong)-L and (Mshort+Mlong)-D); (open triangle) G” of ((Mshort+Mlong)L and (Mshort+Mlong)-D). Concentration of micelles: 20%.
Polymer compositions in each micelle are Mmix-L: L11E45L11 (800-2000-800) +
L11E76L11 (800-3350-800), 50/50wt%; Mmix-D: D11E45D11 (800-2000-800) +
D11E76D11 (800-3350-800), 50/50wt%; (Mshort+Mlong)-L: L11E45L11 (800-2000800) + L11E76L11 (800-3350-800), 50/50wt%; (Mshort+Mlong)-D: D11E45D11 (8002000-800) + D11E76D11 (800-3350-800), 50/50wt%.

Furthermore, the stress sweep of this ‘pre-mixed copolymer micelle’ gel (MmixL + Mmix-D) was examined at various temperatures to establish the linear
viscoelastic region which is a characteristic of a gel material. The racemic mixture
(50:50 wt%) of ‘mixed copolymer micelle’ solutions at concentration 20% turns to
gel at lower temperature than the 10% solution shown in phase diagram in Figure
2.6. As seen in Figure 2.12, there was no stress-hardening or weakening observed for
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this hydrogel. It is observable that the complete destruction of the gel structure (crossover of G´ and G´´ plots) occurs at oscillatory stress values about 100 Pa at 37°C, and
higher than 100 Pa at room temperature. The Rheology results in this study support
that the unique ‘mixed copolymer micelle’ structure offers additional factors on
gelation mechanism and/or the network structure towards a controlled thermoresponsive and robust hydrogel system. Biodegradability and drug loading and release
studies of new hydrogels from pre- mixed copolymer hybrid micelles are underway.

Figure 2.12. Stress sweep modulus profiles of the ‘pre-mixed copolymer micelle’
hydrogel (Mmix-L + Mmix-D, 50:50 wt%) with 20% concentration measured at 25ºC,
37ºC, 42ºC, and 50ºC.

2.4 Conclusion
The properties of PLA-PEG-PLA micelles and hydrogels were shown to change
in response to variations of PEG block length and micellar structures. A unique micelle
structure comprising of two different sizes of hydrophilic corona blocks was achieved
from PLA-PEG-PLA triblock copolymers. Hydrogels prepared form the racemic mixture
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of these micelles can be tailored to have sol-gel transition at desired temperature by
simply adjusting the copolymer ratio. These mixed copolymer micelles have
physiologically relevant thermo-responsive properties and improved mechanical strength,
which can be used as a promising injectable thermo-sensitive hydrogels. As a solely
physical network governed by self-reorganization of biodegradable micelles, this new
system will be of great interest to both biomaterials and theoretical gel studies. Detailed
gelation mechanism, thermodynamics, and physical properties of the unique ‘mixed
copolymer’ micelles will be further investigated in future studies.
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CHAPTER 3.
Three-Layered Biodegradable Micelles Prepared by Two-Step Self-Assembly of
PLA-PEI-PLA and PLA-PEG-PLA Triblock Copolymers for Efficient Gene
Delivery System
3.1 Introduction
Advancements in the fields of recombinant DNA technology and ability to
transfer and express exogenous genes in mammalian cells have underpinned the
emergence of gene therapy as a treatment for complex disease states and traumatic
injuries.109, 110 Although virus mediated gene delivery affords high transfection
efficiency, viral vectors raise serious safety concerns such as high immunogenicity after
repeated administration and potential oncogenicity due to insertional mutagenesis.111
Given the limitations of viral vectors, the development of non-viral gene delivery
methods has become an emerging need.112 Cationic polymers have found widespread
interest as non-viral gene delivery vectors.21 Polyethyleneimine (PEI) is one of the most
studied cationic polymers and has shown high condensation and superior transfection
efficiencies.113 The superiority of PEI compared to other polycations such as poly(Llysine) arises from its high charge density and chain flexibility.69 PEI electrostatically
condenses high molecular weight (MW) DNA to polyplex nanoparticles (10-100 nm)
capable of adsorptive endocytosis. To achieve high performance in gene delivery, the
MW of the PEI block must be high (e.g. 25k Da) for both DNA loading and transfection
efficiency. However, high MW PEI is known to cause critical cytotoxicity.114-118
Furthermore, PEI/DNA polyplex nanoparticles show low in vivo stability due to
aggregation and rapid detection/clearance by the immune system.119
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To overcome these drawbacks, PEI has been conjugated with poly(ethylene
glycol) (PEG) to yield a range of block copolymer assemblies.25, 120-122 Hyperbranched
(hy)PEI-graft-PEG is one of the most studied polymeric gene carriers that produces
sterically stabilized micelle nanoparticles with a PEI/DNA polyplex core and a brush
corona layer of PEG on the surface. The neutral and highly hydrophilic character of PEG
enhances blood circulation half-life by preventing polyplex aggregation and decreases
interaction with opsonin proteins.123, 124 Although PEG grafting has advantageous
physicochemical properties, such as increased biocompatibility and bioavailability, the
method is not without limitations. The PEGylation of (hy)PEI is typically accomplished
using chemical bonds which are relatively stable in the intracellular environment.120-122
The lack of biodegradability of (hy)PEI-g-PEG block copolymers prevents timely release
of internalized DNA from the complex due to steric interferences of the still associated
PEG chains.25, 125-127 Furthermore, steric interference of PEG chains reduces PEI’s ability
to condense DNA into a compact polyplex particle,128, 129 which coincidently reduces the
polyplex micelles’ stability in the presence of competing polyanions such as
glycosaminoglycans.130 Approaches to overcome these challenges include the
incorporation of hydrophobic components to introduce biodegradability, enhance cell
interaction and tissue permeability, improve micelle stability, and modulate the release
profiles.131-134 Researchers have developed ABC type block copolymers using poly(εcaprolactone), (PCL), linear (l)PEI-b-PCL-b-PEG, and (hy)PEI-g-PCL-b-PEG, as
potential gene delivery carriers. The hydrophobic PCL block affords a degree of
biodegradability and contributes to micelle stability through charge shielding effects.132,
135, 136
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Although complete condensing vectors such as PEI and its copolymer derivatives
are an alternative to viral vectors, some inherent drawbacks have limited their application
for systemic delivery. The high MW of PEI needed for compact condensation of DNA
not only causes serious toxicity problems, but also prevents the intracellular unpacking of
DNA due to the strong electrostatic complexation. As a result, complexed DNA is unable
to undergo transcriptional processes in the cell, which leads to low levels of gene
expression. Amiji et al. and others have proposed the use of non-condensing lipids and
polymers to encapsulate nucleic acids by either physical entrapment within the matrix or
via hydrogen bonds between polymer and nucleic acids.137 Various emulsion techniques
have been investigated for the physical entrapment of DNA into polymeric matrixes such
as poly(D,L-lactic-co-glycolic acid) (PLGA),138-141 PEG-poly(L-lactic acid) (PEGPLLA)142, 143 and Pluronic®.144 These studies have shown that the stable DNA-loaded
nano/micro particles can be successfully prepared, while maintaining DNA’s structural
and functional integrity as well as its transfection capacity. However, burst release of
physically entrapped DNA was observed during serial dilution under physiological
conditions. Additionally, high MW hydrophobic polymers are required to increase the
DNA encapsulation efficiency. The increase in MW of hydrophobic polymers decreases
the DNA release rate, as degradation is the primary release mechanism.
In this study, we prepared a multilayered micelle by combing A-B-A and A-C-A
block copolymers, where A is a hydrophobic PLLA block, B is a polycationic PEI block,
and C is a PEG block. We used low MW linear PEI (2000 and 4000 Da) to reduce
cytotoxicity. The combination of electrostatic interaction and solvent-induced
condensation is utilized for the formation of a compact polyplex particle. Furthermore,
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the amphiphilic triblock copolymer, PLLA-PEG-PLLA is used to physically encapsulate
the polyplex particle for the formation of a 3-layered micelle (3LM). The hydrophilic
PEG protective shell stabilizes the 3LM in the aqueous solution. The physical properties
of the 3LM are characterized here through a range of techniques.
3.2 Experimental
3.2.1 Materials
The monomer 2-methyl-2-oxazoline (2-MeOx) 98%, trans-1,4-dibromo-2-butene
(99%), acetonitrile (anhydrous, >99.8%), tin(II) 2-ethylhexanoate (SnOct2),
chlorobenzene (extra dry), methanol (extra dry), trifluoroacetic acid (TFA) (reagentPlus,
99%), di-tert-butyl dicarbonate (ReagentPlus, 99%), poly(ethylene glycol)-diol (PEG)
with a number average molecular weight of (Mn) of 2000 (PEG-2000) were purchased
from Sigma Aldrich (St. Louis, MO). The monomer L-lactide (PURASORB L®) was
purchased from Purac Biochem (Netherlands). Regenerated cellulose dialysis tube with
MWCO (50K) was purchased from Spectrum Labs (Rancho Dominguez, CA). The
oxazoline monomer, 2-MeOx was purified by vacuum distillation using CaH2 as the
drying agent to yield a colorless liquid. The trans-1,4-dibromo-2-butene initiator was
purified by sublimation under reduced pressure at room temperature to yield white
crystals. L-Lactide was purified by recrystallization from dry toluene, then dried in a
vacuum oven at room temperature for 48 h. The macroinitiator PEG-diol was lyophilized
from benzene. All monomers and initiators were stored at -20 °C under N2 atmosphere
prior to use. All other reagents were used as received. Salmon sperm DNA was obtained
from Sigma Aldrich (St. Louis, MO), Free PEI (Lupasol G100, MW: 5k) for the control
experiments was purchased from BASF (Ludwigshafen, Germany).
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3.2.2 Measurements
The chemical structure and number-average molecular weight (Mn) of the PLLAb-PEI block copolymers were determined using proton nuclear magnetic resonance (1H
NMR) on a JOEL 270 MHz and Varian 500 MHz instruments with CDCl3 and DMSO-d6
as the solvents. The micelle size and zeta potential were determined by dynamic light
scattering (DLS) on a Malvern Zetasizer Nano ZS90 at different concentrations at room
temperature and the measurements were done in triplicates. A size of the organo-micelles
was measured in THF, and a size and zeta potential of the 3LM were determined in
water. Additional size and morphology analysis of the micelles were done using
transmission electron microscopy (TEM) on a JEOL JEM 1200EX II equipped with a
digital AMT CCD camera. A drop of the micelle solutions was placed on a carbon-coated
copper grid and allowed to dry in air. Images were taken with the instrument operating
from 80 kV to 120 kV at different magnifications. To observe the location of DNA within
organo-micelles and 3LM, 3 mg of DNA in 600 μL were metalized during incubation
with 30 μL of AgNO3 (0.1 M) for 2 h at 25 °C before preparing the micelles at N/P 12.145
DNA encapsulation efficiency of the micelles was determined by isolating the
encapsulated DNA followed by quantifying its concentration from absorbance
measurement on a NanoDrop 2000c UV-Vis spectrophotometer (NanoDrop
Technologies, Inc., USA). The accessibility of DNA in the particle was analyzed by a dye
binding assay using SYBR Gold (Molecular Probes) as described below. Stability of
DNA loaded micelles in the presence of polyanions and different pH conditions were
analyzed using a competition assay and SYBR Gold detection which is described in
detail below. Both the dye binding and polyanions competition assays were quantified
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using a fluorescence measurement at 495 and 537 nm excitation and emission
wavelengths, respectively, on a Synergy 2 multi-mode microplate reader (BioTek
Instruments, Winooski, VT).
3.2.3 Synthesis of poly(2-methyl-2-oxazoline) (PMOX)
The monomer 2-MeOx undergoes living cationic ring-opening polymerization to
yield PMOx. α,ω-Dihydroxy PMOx was synthesized by using the bifunctional initiator
trans-1,4-dibromo-2-butene. The typical polymerization was carried out as follows:
trans-1,4-dibromo-2-butene (0.5 g, 2.3 mmol) was placed into a 3-neck reaction flask
equipped with a reflux condenser, a stir bar, and an addition funnel. The reaction flask
was sealed and evacuated to remove moisture, then converted to N2 gas. The monomer 2MeOx (9.6 g, 112.8 mmol) was added to the reaction flask using an addition funnel,
followed by anhydrous acetonitrile (50 mL). The reaction mixture was placed in an oil
bath and temperature was gradually raised to 90 °C and allowed to react overnight. The
resulting viscous reaction mixture was cooled to room temperature and 5% methanolic
KOH was added to the reaction flask and allowed to stir at room temperature for 5 h. The
resulting crude mixture was added dropwise to a diethyl ether (500 mL) to precipitate the
product which was recovered by vacuum filtration. The number-average molecular
weight (Mn) and degree of polymerization were calculated from 1H NMR spectra.
1

H NMR (500 MHz, CDCl3, δ): 2.0-2.2 (m, NCOCH3), 3.3-3.6 (m, NCH2CH2, repeating

units of PMOx main chain), 5.5-5.6 (s, CH2CHCHCH2, initiator protons, used for Mn
calculations).
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3.2.4 Synthesis of linear poly(ethylene imine) (L-PEI)
Linear PEI was obtained upon basic hydrolysis of the amide groups of PMOx.
The typical hydrolysis reaction was carried out as follows: PMOx (4 g, 0.96 mmol) was
placed into a single neck reaction flask equipped with a reflux condenser and a stir bar.
To the reaction flask, 200 mL of 2 M NaOH solution was added and the mixture was
allowed to reflux for 48 h. The reaction mixture was allowed to cool to room
temperature, which resulted in formation of a white precipitate. The precipitated mixture
was diluted with 1 L of DI-H2O and heated to 80 °C until a clear solution was obtained.
The solution was allowed to cool slowly to room temperature and further cooled in an ice
bath to recrystallize PEI. The yellow solid was recovered by vacuum filtration and rinsed
extensively with DI-H2O and was dried in vacuo at 60 °C for 48 h. The degree hydrolysis
was determined using 1H NMR. 1H NMR (500 MHz, MeOH-d4, δ): 2.7-2.8 (m,
NCH2CH2, repeating units of PEI main chain).
3.2.5 Synthesis of boc protected PEI (PEI-N-t-boc)
The secondary amines of linear PEI were protected using di-tert-butyl
dicarbonate. The typical protection reaction was carried out as follows: PEI (1.5 g, 0.75
mmol) was placed into a 3-neck reaction flask equipped with an addition funnel and a stir
bar. The reaction flask was sealed and evacuated to remove moisture, then converted to
N2 gas. Anhydrous methanol (100 mL) was added and reaction mixture was stirred at
room temperature until a homogenous solution was obtained. Di-tert-butyl dicarbonate
(15.7 g, 72 mmol) was dissolved in anhydrous methanol (100 mL) and added into the
addition funnel. The reaction flask was placed into an ice bath and the solution in the
addition funnel was added dropwise in 10 increments. The ice bath was removed and
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solution allowed to warm to room temperature after the addition of each increment,
reaction rate could be monitored by the rate of CO2 formation and escape as bubbles
through the bubbler. The reaction flask was immersed into the ice bath periodically to
slow down the reaction rate to prevent overflow of reaction mixture. Once CO2 formation
slowed down, the next increment was added and above process repeated. The once
transparent methanol solution began to turn cloudy and precipitates to form as the rate of
Boc protection increased, which resulted in the decreased solubility of the PEI-N-Boc
block in the polar protic solvent. To ensure full amine protection, anhydrous chloroform
was added through the side neck until a clear homogenous solution was obtained. After
all increments were added reaction was allowed to stir at room temperature for 5 h, after
which the solvent was removed under reduced pressure and the resulting off-white solid
was dissolved in chloroform (50 mL) and added dropwise to hexane (500 mL) to
precipitate the product. The product was recovered by vacuum filtration and dried in
vacou at 60 °C for 24 h. The precipitation process was repeated more than twice to
remove completely the unreacted di-tert-butyl dicarbonate. 1H NMR (500 MHz, CDCl3,
δ): 1.4-1.5 (s, (C(CH3)3), tert-butyl group of carbamate protecting group), 3.3-3.4 (m,
NCH2CH2, repeating units of PEI-N-Boc main chain).
3.2.6 Synthesis of Poly(L-lactide)-Poly(ethylene imine-N-tboc)-Poly(L-lactide)
Triblock Copolymers (PLLA-PEI-N-tboc-PLLA)
The ABA type triblock copolymer, PLLA-(PEI-N-Boc)-PLLA was prepared by
ring-opening polymerization (ROP) of L-lactide, in the presence of the hydroxyl endcapped homobifunctional macroinitiator PEI-N-Boc. The organo-metallic catalyst,
Sn(Oct)2 was used to catalyze the reaction at 5 mol% relative to each hydroxyl group of
PEI-N-Boc. The typical polymerization was carried out as follows: PEI-N-Boc (4 g, 0.58
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mmol) and L-lactide (2.32 g, 16.1 mmol) were placed in a reaction flask and equipped
with a reflux condenser, stir bar, and an addition funnel. The reaction flask was sealed
and evacuated to remove moisture, then converted to N2 gas. Anhydrous chlorobenzene
(30 mL) was added and reaction temperature was raised to 100°C. The solubility of PEIN-Boc in chlorbenzene increases with increasing temperature and a transparent solution
is obtained at 100 °C. The catalyst, Sn(Oct)2 (23 mg, 0.058 mmol) dissolved in dry
chlorobenzene (1 mL) was added to the reaction mixture. The reaction temperature was
raised to 130 °C and the reaction was allowed to proceed overnight. The reaction mixture
was then cooled to room temperature. The mixture turned turbid and product precipitated,
chloroform (30 mL) was added to yield a clear slightly orange solution which was added
to 1:1 diethyl ether/hexane (500 mL) to reprecipitate the product. The product was
recovered by vacuum filtration and dried in vacuo at 60 °C for 24 h. The precipitation
process was repeated more than twice to completely remove the catalyst, which was
confirmed by NMR. The number-average molecular weight (Mn) and PLLA-(PEI-NBoc)-PLLA block ratio were calculated from the 1H NMR spectra. 1H NMR (500 MHz,
CDCl3, δ): 1.4-1.5 (s, C(CH3)3), 1.56-1.6 (d, CHCH3), 3.3-3.4 (m, NCH2CH2), 4.2-4.3
(m, COOCH2 for the oxymethylene connected to lactate repeating units), 4.3-4.4 (m,
CHOH, end group CH of the lactate repeating units) and 5.1-5.2 (q, CHCH3, of lactate
repeating units).
3.2.7 Synthesis of Poly(L-lactide)-Poly(ethylene imine)-Poly(L-lactide) triblock
copolymers (PLLA-PEI-PLLA)
Deprotection of Boc gives the desired PLLA-PEI-PLLA block copolymer with
controlled block length and composition. The protecting group Boc was removed using
trifluoroacetic acid (TFA), the typical deprotection reaction was carried out as follows:
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PLLA-(PEI-N-Boc)-PLLA (4 g, 0.39 mmol) was placed into a single neck flask,
equipped with a stir bar and chloroform (100 mL) was added. To the clear, slightly
orange solution, TFA (5 mL, 65 mmol) was added to the reaction mixture dropwise and
allowed to stir for 1 h. The resulting solution was cloudy and phase separated with a clear
TFA rich bottom layer and cloudy product rich top layer. The solvent and excess TFA
was removed under reduced pressure to yield a sticky solid, which was further dissolved
in dimethyl sulfoxide (10 mL) and added dropwise to diethyl ether (200 mL) to
precipitate the product. The product was recovered by vacuum filtration and dried in
vacuo at 60 °C for 24 h. 1H NMR (500 MHz, CDCl3, δ): 1.56-1.6 (d, CHCH3), 5.1-5.2 (q,
CHCH3). 1H NMR (500 MHz, DMSO-d6, δ): 1.4-1.5 (d, CHCH3), 3.3-3.9 (NCH2CH2),
5.1-5.2 (q, CHCH3).
3.2.8 Exchange of TFA counter-ions with chloride to yield TFA-free PLLA-PEIPLLA triblock copolymer
The TFA assisted deprotection procedure for the preparation of PLLA-PEI-PLLA
copolymer renders the PEI block positively charged with trifluoroacetate as the counter
ion. The presence of high concentrations of TFA could induce cell cytotoxicity; therefore
we developed a method to replace the TFA ions with chloride counter ions. The exchange
procedure was carried out as follows: The PLLA-PEI-PLLA (100 mg) was placed in a
flask equipped with a stir bar and Acetone (5 mL) was added to yield a fully soluble light
orange solution. TEA (10 % v/v) was added to the solution dropwise and allowed to stir
at room temperature for 3 h. The mixture was transferred to a dialysis tube (MWCO 5k)
and dialyzed against distilled H2O (500 mL) for 6 h, the H2O reservoir was replaced
twice. The slightly turbid aqueous solution inside the dialysis tube was recovered and
acidified to pH ~ 3 using 1M HCl solution. The PLLA-PEI-PLLA copolymer having
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chloride counter ions was recovered by freeze drying. The removal of TFA was
characterized using FT-IR.
3.2.9 Synthesis of Poly(L-lactide)-Poly(ethylene glycol)-Poly(L-lactide) triblock
copolymer (PLLA-PEG-PLLA)
The ABA-type triblock copolymer of PLLA-PEG-PLLA was synthesized using
the ROP of L-lactide in the presence of PEG-diol catalyzed by Sn(Oct)2 (5 mol % relative
to each hydroxyl group of PEG) as reported previously.67 1H NMR (500 MHz, CDCl3,
δ): 1.56-1.6 (d, CHCH3), 3.6-3.7 (m, OCH2CH2), 4.2-4.3 (m, COOCH2 for the
oxymethylene connected to lactate repeating units), 4.3-4.4 (m, CHOH, end group CH of
the lactate repeating units) and 5.1-5.2 (q, CHCH3, of lactate repeating units).
3.2.10 Synthesis of Poly(L-lactide)-Poly(ethylene glycol)-Folate diblock copolymers
(PLLA-PEG-Folate)
Folate conjugated PEG-PLLA diblock copolymers were prepared using the wellestablished NHS-ester activated/amine coupling method. The PLLA-PEG diblock
copolymer was prepared by ROP of L-lactide on FMOC-PEG-OH macroinitiator, which
subsequently underwent deprotection to yield PLLA-PEG-NH2. Coupling of amineterminated PLLA-PEG diblock to NHS activated folic acid yielded the final conjugated
product. The typical conjugation process was carried out as follows: Fmoc-PEG-PLLA
(1g, 0.33 mmol) and DMAP (0.163mg, 1.33 mmol) were placed into a single neck flask
equipped with a stir bar; DMF (10 mL) was added and a clear solution was obtained. The
solution was allowed to stir at room temperature, aliquots were taken at several time
intervals and 1HNMR was conducted to determine progress of reaction. The deprotection
was completed after 18 h, the reaction mixture was added dropwise to a 1:1 mixture of
diethyl ether/hexane (250 mL) to precipitate the PLLA-PEG-NH2 intermediate product.
The product was recovered by vacuum filtration and dried in vacuo at room temperature
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for 24 h. Activation of folic acid with NHS was done following a method reported
elsewhere. Briefly, folic acid (2g, 4.5 mmol) and TEA (1 mL, 7.2 mmol) were placed into
a 3-neck reaction flask equipped with a stir bar. The flask was sealed and evacuated to
remove moisture, then converted to N2 gas. Anhydrous DMSO (40 mL) was added and
mixture was allowed to stir in the dark overnight. DCC (1.02g, 4.95 mmol), and NHS
(0.57g, 4.95 mmol) were dissolved in the anhydrous DMSO (5 mL) and added to the
reaction flask. The reaction was allowed to stir in the dark for additional 12 h. The
conjugating polymer, PLLA-PEG-NH2 was dissolved in anhydrous DMSO (5mL) and
added to the reaction flask. The conjugation reaction was allowed to continue for 24 h.
The reaction mixture was filtered to remove the byproduct dicyclohexylurea (DCU), the
solution was concentrated under reduced pressure. The product was precipitated in cold
diethyl ether (200 mL) to yield a sticky solid. To further purify the product, it was
dissolve in CHCl3 (50 mL) and washed in a separatory funnel with 1% HCl, brine
solution and neutral H2O; the resulting organic phase was dried with Na2SO4. The final
product was precipitated into 1:1 diethyl ether/hexane (200 mL), the light orange solid
was recovered by vacuum filtration and dried in the vacou at room temperature for 24 h.
3.2.11 Preparation of DNA loaded 3-layered micelles
The micelle preparation was done in a 2-step process. The first step describes the
solvent-induced DNA encapsulation in terms of the organo-micelle formation. To
encapsulate DNA at N/P = 12, 4.25 mg of PLLA-PEI(2k)-PLLA triblock copolymer was
dissolved in 1 mL DMSO and allowed to equilibrate for 10 min. A solution of 200 µL
bulk DNA at 1 mg/mL concentration was added to the polymer/DMSO solution dropwise under sonication. The resulting transparent solution was allowed to stir at room
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temperature for 60 min. Next, 4 mL of THF were added dropwise into the polymer/DNA
solution, and the resulting transparent solution was transferred into a dialysis tube (3.5K
MWCO) and dialyzed against 500 mL THF to completely remove the remaining DMSO.
The resulting transparent THF solution containing the organo-micelle was characterized
for size and morphology using DLS and TEM respectively.
The second step in the overall micelle preparation process is the formation of
aqueous stable 3LM incorporating the DNA/PEI polyplex. For this step, 5 mg of the
amphiphilic triblock copolymer PLLA-PEG-PLLA was placed in a vial, the organomicelle THF solution (ca. 3-4 mL) obtained from the above step was added to the vial,
and the amphiphilic polymer was dissolved in THF. After incubating at room temperature
for several minutes, the THF solution was added dropwise to 10 mL of nano-pure water
under sonication at 4 °C. The organic solvent was then removed by evaporation under a
stream of compressed air, and subsequently the aqueous solution was concentrated to the
desired volume (e.g. 1 mL). The resulting viscous and homogenous micelle solution was
turbid due to some degree of aggregation, although no visible precipitates formed. The
3LM were characterized for size and zeta potential using DLS, and the morphology was
determined by TEM as described above.
3.2.12 DNA Condensation and Encapsulation Efficiency
To determine the encapsulation efficiency, we used a heparin extraction
procedure previously reported146 with some modifications. We isolated the encapsulated
DNA from the micelles via heparin assisted dissociation of the DNA/PEI polyplex and
subsequently pelleted the DNA using Trizol according to the manufacturer’s protocol
(Invitrogen). The concentration of isolated DNA was determined using UV absorbance at
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wavelengths of 260/280 nm. For a typical isolation, 100 µL of 3LM were pipetted in a
scintillation vial and were diluted with 500 µL of TE buffer containing 12.5 mg/mL of
heparin. Subsequently, 200 µL chloroform and 500 µL Triazol (Invitrogen) reagent were
added. The vial containing the mixture was tightly sealed and stirred vigorously at 37 °C
for 60 min. The mixture was centrifuged at 12, 000 RCF for 15 min at 4 °C to obtain a
bottom red organic layer (chloroform-phenol), a cloudy interphase and a transparent
aqueous top layer. The aqueous layer was discarded and 300 µL of 100% ethanol were
added to the remaining phases. After several minutes of incubation at 25 °C, the mixture
was centrifuged at 2000 RCF for 5 min at 4 °C to pellet the DNA. The supernatant was
discarded and the cloudy white DNA pellet was washed with 75% ethanol solution by
gentle inversion and centrifuged at 2000 RCF for 5 min at 4 °C. The wash step was
repeated several times to rinse off traces of phenol (contained within the Triazol reagent)
to avoid interference with UV absorption measurements. The DNA pellet was resuspended by dissolving in 200 µL of 8 mM NaOH solution, any insoluble material was
removed by centrifuging at 12,000 RCF for 10 min at 4 °C. The DNA concentration was
measured using a Nanodrop instrument and concentrations are reported in ng/µL.
3.2.13 Encapsulation of DNA as determined by dye exclusion assay
For the SYBR Gold Assay, 3LM with different N/P ratios (4, 8, 12 and 20) were
prepared. As a comparison, DNA/PEI polyplexes (N/P ratios: 1.25, 2.5, 5, 7.5, 10, 15 and
20) as well as solutions containing free DNA only were used. All formulations were
diluted with a 5% glucose solution to reach final DNA concentrations of 1 g/100 L.
This volume was added to the appropriate cavities of a 96 well plate (Thermo Scientific)
and additional control wells were filled with 100 L glucose solution only. After adding
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30 L of a 4× SYBR Gold solution to all wells, the plate was incubated for 10 min at 25
°C in the dark. Consecutively, fluorescence was measured on a Synergy 2 multi-mode
microplate reader (BioTek Instruments) at 485 nm and 528 nm excitation and emission
wavelengths. The released DNA in percent was calculated as the ratio between the
fluorescence of a sample and the value of the controls containing free DNA only,
regarding those as a release of 100%. All results are shown as the mean value of
triplicates.
3.3.14 Micelle Stability and Release Kinetics in presence of polyanions
For dextran sulfate assays, polyplexes were prepared at an N/P ratio of 12 as
described above. In addition, experiments were performed in the presence of two
different media to compare the stability of the polyplexes at different pH and ionic
strengths. The media used were a 5% glucose solution (pH 7.4) and sodium acetate buffer
(pH 4.5). Solutions containing either the micelles, free DNA, or DNA/PEI polyplexes
were prepared and diluted to reach final DNA concentrations of 1 g per 90 L, and this
volume was added to the appropriate cavities of two 96 well plates. Additional control
wells were filled with 90 µL of media only. Subsequently, a 4× SYBR Gold solution (30
μL/well) was added to all wells and plates were incubated for 10 min. A master solution
of dextran sulfate was prepared and diluted to achieve concentrations of 5-50 g per 10
l. This volume was added to each well with increasing dextran sulfate concentrations.
Control wells were treated with 10 µL of media only. After different incubation times
with dextran sulfate (30 min, 1, 2, and 3 h) at 25 °C, fluorescence was measured on a
Synergy 2 multi-mode microplate reader (BioTek Instruments) at 485 and 528 nm
excitation and emission wavelengths, respectively. The relative stability of the polyplexes
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was determined by normalizing the fluorescence intensity of the intercalating SYBR
Gold dye to SYBR gold only (0%) and to SYBR gold with free DNA (100%). Results are
analyzed by GraphPad Prism 5.0 software (GraphPad Software, La Jolla, CA).
3.2.15 Cell Culture
RAW 264.7 cells are derived from an ascites of a tumor induced in male BALB/c
mice by intraperitoneal injection of Abselon Leukaemia virus (A-MuLV). The cells were
cultured in DMEM cell culture medium (SIGMA Life Science) supplemented with 10 %
fetal bovine serum (Thermo Scientific Hyclone), 1 % HEPES and 1%
penicillin/streptomycin. They were grown in 75 cm2 cell culture flasks (Thermo
Scientific) at 37 °C and 5% CO2 and subcultured with medium changes every 2 to 3 days.
3.2.16 Copolymer cytotoxicity: MTT Assay
MTT assays have been used to determine the cytotoxicity of polymers.118, 147, 148
Living cells with metabolically active mitochondria can enzymatically convert the watersoluble MTT to insoluble formazan particles whose purple color can subsequently be
detected. Therefore, RAW 264.7 mouse macrophage cells (obtained from ATCC,
Manassas, VA) were seeded in 96-well plates (Thermo Scientific) with 8000 cells per
well in 100 L of growth medium and incubated for 24 h at 37 °C and 5% CO2 in a
HERAcell 150i CO2 incubator (Thermo Scientific). The medium was replaced with 100
L of 3LM solutions in different concentrations (0.0078125 – 4 mg/mL) prepared with
different inner polymers, PLLA-PEI(2k)-PLLA or PLLA-PEI(4k)-PLLA, diluted in fresh
medium. As a control, the experiment was also performed with PEI solutions containing
the same concentrations of polymer. After additional 24 h incubation, the medium was
changed again and 10 L of a sterile-filtered MTT solution (5 mg/mL, Molecular Probes)
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were added to each well. The plates were incubated for 4 h, the medium was removed
and 200 L of DMSO per well were added. After incubating for 10 min at room
temperature, the optical absorbance was measured at 540 nm with a Synergy 2 multimode microplate reader (BioTek Instruments). The cell viability in percent was
calculated as the ratio between the absorbance of one sample and the value of the
corresponding untreated control cells. The results are shown as the mean value of
quadruplicates. IC50 values were determined by non-linear regression using GraphPad
Prism 5.0 software (GraphPad Software, La Jolla, CA).
3.3 Results and Discussion
3.3.1 Synthesis of amphiphilic cationic block copolymers
The synthesis of the linear PLLA-PEI-PLLA triblock copolymer was
accomplished as shown in Figure 3.1. The synthetic approach uses amine protection
chemistry to yield controllable block copolymers with the desired architecture. The
synthesis of PLA/PEI block copolymers has been reported previously. ROP 149, 150 and
reactive terminal coupling methods151-153 were used to yield copolymers with a range of
architectures such as graft, crosslinked, and linear structures. The ROP of lactide on PEI
macroinitiator leads to a graft copolymer since both primary and secondary amines are
capable of initiating the polymerization reaction. For the purposes of our study, PEIgraft-PLLA copolymers would not be useful due to the steric interference of grafted
PLLA blocks with PEI/DNA complex formation.126, 129, 136 The coupling approach to
prepare PLA-block-PEI copolymers typically uses the modification of PLLA end-group
with reactive electrophilic functional groups, such as NHS activated esters, acyl-halides,
and isocyanates; which then undergo substitution or rearrangement reaction with PEI’s
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primary or secondary nucleophilic amines. Coupling methods require extensive
purification steps to remove excess activating agents or uncoupled polymers from the
final product. Moreover, from our observations, the relatively nucleophilic (basic)
environment needed for a proper activation of the PEI amines for the coupling reactions
leads to a hydrolysis of the polyester backbone. Therefore, the amine protection/living
polymerization approach we report in this paper is an efficient and high yielding method
to prepare block copolymers of PEI/PLLA having well-defined molecular weights and
architecture.
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Figure 3.1. Synthesis of PLLA-PEI-PLLA triblock copolymer.
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To control the end-group functionalities, we started our synthetic efforts by
polymerizing PMOx. The living cationic ROP of 2-oxazoline was first reported by
Kagiya et al.. The propagating oxazolinium salt is relatively stable, and under appropriate
conditions, the polymerization reaction is not disturbed by chain transfer and
termination.154 We polymerized a series of mono and bi-functional PMOx from the
monomer 2-MeOx; the chemical structure of the polymers and number average molecular
weight (Mn) were determined through 1H NMR analysis and are summarized in Table
3.1.

Table 3.1. Molecular weight of intermediate and final polymers
PLLA-PEI(2k)-PLLA
Intermediate and Final
polymers

PLLA-PEI(4k)-PLLA
Theoretical

MW (g/mol)

Observed
Mn
(NMR)

MW (g/mol)

Observed
Mn
(NMR)

PMOx di-hydroxy

4000

5185

8000

7692

PEI di-hydroxy

2000

2509

4000

5019

PEI-N-t-Boc di-hydroxy

6800

7902

13700

13572

(1700-68001700)

9911

17100

16740

5400

NDa

7400

NDa

Theoretical

10200
PLLA-(PEI-N-t-Boc)PLLA
PLLA-PEI-PLLA

(1700-20001700)

(1700-40001700)

a

Not determined. Mn cannot be accurately calculated from 1H NMR due to broadness
of the PEI peak and overlap of the solvent peaks.
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The representative 1H NMR spectra of the intermediates with peak assignments
are shown in Figure 3.2. Termination of the polyoxazoline reaction was done using
methanolic KOH to introduce primary hydroxyl groups, which are necessary for ROP of
lactide on step 4 (Figure 3.1). Hydrolysis of the acetyl side groups of PMOx (step 2) was
done to yield linear PEI. Basic hydrolysis was shown to be more efficient and to result in
a simpler work-up procedure. Additionally, >90% hydrolysis rate was achieved in ~48 h
as determined by comparing the repeating methylene units (NCH2CH2) to the remaining
methyl peaks (NCOCH3). Protection of the secondary amines on PEI using t-Boc
anhydride leads to the derivative, PEI-N-Boc. The reaction was monitored by the shift of
methylene units (NCH2CH2) from δ 2.7-2.8 ppm to 3.3-3.4 ppm. Additionally, we
observed a new peak at δ 1.4-1.5ppm corresponding to the tert-butyl (C(CH3)3)
hydrogens of the side-group (Figure 3.2d inset). The protection procedure served for
multiple purposes: (i) the polymer became soluble in organic solvents suitable for the
following living polymerization, (ii) the initiation of lactide ROP from the PEI backbone
amines was inhibited, and (iii) the hydrolysis of the polyester backbone was prevented
leading to well-defined MWs.
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Figure 3.2. 1H NMR spectra of (a) 2-MeOx monomer in CDCl3, (b) bi-functional PMOx
in CDCl3, (c) Linear bi-functional PEI in D2O, and (d) PEI-N-tboc in CDCl3.

The protected PEI-N-Boc was used as a macroinitiator for the living ROP of Llactide monomer to yield the block copolymer PLLA-b-(PEI-N-Boc). The monomer
conversion rate was ~85%, where the polymerization progress was monitored by the shift
in the methine (CHCH3) hydrogen of the polymer backbone at δ 5.1-5.2 ppm (Figure
3.3a) compared to cyclic monomer, which has a chemical shift at 4.8-4.9 ppm (not
shown). The end group and connection peaks appeared at slightly higher field δ 4.3-4.4
and 4.2-4.3 ppm, respectively. The de-protection of the Boc protecting groups was next
accomplished using mild conditions. The de-protection was done in 5% TFA/chloroform
solution at 25°C, the volatile TFA reagent was removed under reduced pressure. As a
result of the acid mediated de-protection step, the protonated PEI block was rendered
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cationic with trifluoroacetate as the counter ion. The trifluoroacetate counter ions were
replaceable with other anions such as Cl- through simple ion exchange procedures. The
methylene protons of PEI after deprotection were not detectable in the CDCl3 spectrum
(Figure 3.3b). The protonated cationic PEI block was insoluble in the organic solvent,
thus a spontaneous self-assembly occurs to form a micelle with a frozen PEI core and
PLLA outer shell. In contrast, when the spectrum was collected in DMSO-d6, a common
solvent for both blocks, we observed a broad peak at δ 3.1-3.8 ppm originating from the
methylene protons of PEI (Figure 3.3c).
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Figure 3.3. 1H NMR spectra of (a) PLLA-PEI-N-tboc-PLLA in CDCl3, (b) PLLA-PEIPLLA in CDCl3, and (c) PLLA-PEI-PLLA in DMSO-d6.
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As a result of the acid mediated de-protection step, the protonated PEI block is
rendered cationic with trifluoroacetate as the counter ion. In the final step, the
trifluoroacetate ions are exchanged with chloride ions through a facile procedure to yield
the target copolymer, PLLA-PEI-PLLA. FT-IR analysis confirmed trifluoroacetate ions
are successfully exchanged (removed). Figure 3.4a shows the FT-IR spectra for the
PLLA-PEI-PLLA copolymer consisting of TFA counter ions. The trifluoroacetate acetate
ion has a strong C=O stretching at ~1670 cm-1 and C-F stretching is shown between
~720-760 cm-1. The C=O stretching from PLLA also has a strong IR absorbance ~1760
cm-1 and C-N stretching from PEI can be observed at ~1122 cm-1. The TFA removal
procedure utilized the base TEA to initially deprotonate PEI and forms a salt with TFA.
The TFA-TEA salt has good solubility in Acetone, thus does not precipitate out of
solution. Solvent exchange with DI-H2O assists to remove the TFA-TEA salt by escaping
through the pores of the dialysis membrane while the PLLA-PEI-PLLA remains trapped
inside the dialysis tube. Complete removal of TFA from the copolymer is evidenced by
the disappearance of the C=O and C-F stretches arising from TFA (Figure 3.4b).
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Figure 3. 4: FT-IR spectra showing the exchange/removal of TFA counter-ion to yield
TFA-free PLLA-PEI-PLLA triblock copolymers. (a) PLLA-PEI-PLLA triblock with
TFA counter ions (b) PLLA-PEI-PLLA with Cl- counter ions.

3.3.2 Preparation of 3-layered micelles.
The process of DNA encapsulation and formation of stable 3-layered micelle is
shown in Figure 3.5. The overall process was accomplished in two consecutive steps. The
first step describes the process of DNA condensation and encapsulation, accomplished
via formation of an organo-micelle. Self-assembly of the organo-micelle occurs
spontaneously as the polar DMSO solvent is replaced with the less-polar THF which is a
good solvent to PLLA. This is followed by the aggregation of the ionic DNA/PEI
complex in the core of the micelle to reduce interaction with the less-polar solvent. The
organo-micelle can be described as a core-shell structure, where the core is composed of
DNA/PEI polyplexes stabilized by a shell of PLLA segments with THF as a dispersant.
We used this solvent-induced encapsulation technique for the following reasons;
Relatively low MW PEI is incapable of efficiently condensing DNA into a compact
particle by charge neutralization alone,155 therefore solvent-induced collapse of the
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molecular structure of DNA further assists to form a compact condensate.156-159 In the
conventional aqueous system, encapsulation of hydrophilic bioactive molecules within a
hydrophobic compartment suffer from low loading efficiency due to the high solubility of
these molecules in aqueous solutions.160 Thus we performed the encapsulation step in an
organic solvent (THF) which is a non-solvent for DNA, PEI or the DNA/PEI complex.
The drastic change in solubility drives the aggregation of the polyplex and preferential
fractionation of DNA into the micelle core. Using this method, we were able to achieve
an encapsulation efficiency of approximately 50%. The DNA loading results are
comprehensively discussed below.
The DNA loaded organo-micelles were subsequently formulated as a stable
aqueous dispersion, in the second step of the complete micelle preparation procedure
shown in Figure 3.5. We used the amphiphilic triblock copolymers, PLLA-PEG-PLLA,
to form a protecting and coating layer on the surface of the organo-micelles. The
resulting micelle is a multilayered system composed of three regions; core: DNA/PEI
polyplex, inner shell: hydrophobic PLLA segments, and outer shell: hydrophilic PEG
segments.
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Figure 3.5. Schematic preparation scheme of the DNA loaded 3LM. Step 1: the solventinduced polyplex formation process to yield the organo-micelles in THF, Step 2: the
outer copolymer assembly process to form an aqueous stable 3LM. The surface of the
3LM can be further modified by attachment of targeting ligand. The PLLA-PEG-Folate
diblock copolymer is combined with PLLA-PEG-PLLA during step 2. The folate
targeting ligand (green circle) occupies the surface of the 3LM since it is conjugated to
the hydrophilic PEG block.

Appearance of the micelle dispersions at different settings are shown in Figure
3.6. In the first step, the DNA loaded organo-micelle solution was obtained in THF
without any precipitation (Figure 3.6a). The formation of aqueous stable 3LM in the
second step was evidenced by the absence of precipitation when PLLA-PEG-PLLA outer
layer was used (Figure 3.6b). In contrary, when the stabilizing outer copolymer is omitted
from the formulation, we observed immediate sedimentation of the DNA loaded organomicelle in the aqueous environment (Figure 3.6c). The spontaneous dissociation of the
DNA loaded organo-micelle to its individual components, PLLA-PEI-PLLA and DNA,
did not occur due to the presence of a hydrophobic polyplex core. The stability of the
DNA loaded organo-micelle was further corroborated by the facile reversibility of the
organo-micelle when DNA was not incorporated in the core. As shown in Figure 3.6d,
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the DNA-free organo-micelles spontaneously formed a flower micelle with PEI as the
corona and PLLA in the core when placed in an aqueous dispersant, which led to a
transparent micellar solution. Hydrophobic interactions between the PLLA segments are
expected to drive the 3-layered micelle self-assembly. As shown schematically in Figure
3.5, the inner shell of the micelle (orange) is populated with PLLA blocks of the organomicelle and the stabilizing triblock, PLLA-PEG-PLLA.

(a)

(b)

(c)

(d)

Figure 3.6. The photos of various micelle solutions: (a) 0.5% (w/v) DNA loaded organomicelle solution taken after dialysis (OM_12), (b) 1% (w/v) 3LM, (c) Precipitated DNA
loaded organo-micelle after adding into an aqueous solution without the stabilizing
PLLA-PEG-PLLA copolymer, (d) 0.5 % (w/v) PLLA-PEI-PLLA flower micelle in
aqueous solution produced from DNA free organo-micelle.

3.3.3 Characterization of 3-layered micelles.
The ability of a cationic polymer to condense DNA is primarily influenced by the
charge density of ionizable groups (i.e. amines) and flexibility of the molecular
structure.69 The DNA condensation ability of PEI depends on the MW of the polymer,
which dictates the charge density. Increase in MW typically leads to better condensation
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of DNA and formation of a compact polyplex particle (< 100 nm).116 Moreover, the
overall MW and architecture of the condensing polymer can further influence the
formation of a polyplex particle. Polycations such as PEI are often copolymerized with
hydrophilic or hydrophobic blocks in order to afford some degree of stability, reduce
toxicity and control the release behavior. The MW of the hydrophilic or hydrophobic
block and their manner of connection with PEI (e.g. graft, di/tri-block, or star-block) are
shown to influence PEI’s ability to efficiently condense DNA. We have synthesized
PLLA-PEI-PLLA with two sizes of PEI, MW 2000 and 4000 to use for the preparation of
micelles. No significant difference in micelle size was observed between those similar
PEI-length copolymer micelles (data not shown). Thus, PLLA-PEI(2k)-PLLA
copolymer, which would be less toxic but has lack of condensation ability if used only by
itself, was used for most of the inner core of the micelle formulations evaluated in this
study. To optimize the encapsulation of DNA into the core of the micelles, the effects of
the N/P ratio on size and morphology of DNA loaded organo-micelles and 3LM were
investigated. Table 2 shows the DLS measurements of hydrodynamic diameters obtained
for the PLLA-PEI(2k)-PLLA triblock derived organo-micelles and its 3LM. The organomicelles and 3LM are abbreviated with the N/P ratio as OM_4, 8, 12, 20, and 3LM_4, 8,
12, 20, respectively. For organo-micelles, variation in N/P ratio did not affect
significantly to the individual micelle diameters; we obtained individual micelles with
diameters about 100 nm. We obtained slightly higher hydrodynamic diameters for the
lowest N/P ratio of 4. These polyplexes are expected to be relatively loose, which would
lead to larger size particles at the relatively low N/P ratio.155
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For the DNA encapsulated 3LM consisting of PLLA-PEI(2k)-PLLA as inner and
PLLA-PEG-PLLA as outer copolymers, the expected increase in micelle diameter from
organo-micelles was observed. The obtained hydrodynamic diameters were in the range
of ca. 200 nm for individual micelles at all N/P ratios investigated. We characterized the
zeta potential of 3LM using electrophoretic light scattering (Table 2). The zeta potential
was shown to reach a value close to zero (neutral) with increasing N/P ratio. The micelles
prepared at N/P 4 and 8 showed a slight negative charge most likely due to loose/weak
encapsulation of DNA within the core. At N/P ratio of 12 and 20 however, the surface
charge is neutral indicating the complete segregation of the PEI/DNA polyplex within the
core.

Table 3.2. DLS size and zeta potential for DNA encapsulated organo-micelles of PLLAPEI(2k)-PLLA in THF and DNA encapsulated 3LM of inner core polymer, PLLAPEI(2k)-PLLA and outer layer polymer, PLLA-PEG-PLLA (800-2000-800) at different
N/P ratios.
Micelle ID

N/P ratio

Z-Ave Diameter (nm)

Zeta-potential

Polydispersity

OM_4

4

153

n/a

0.363

OM_8

8

91

n/a

0.356

OM_12

12

102

n/a

0.231

OM_20

20

97

n/a

0.299

3LM_4

4

209

-9.10

0.314

3LM_8

8

218

-3.41

0.338

3LM_12

12

213

-0.947

0.314

3LM_20

20

234

-0.966

0.349
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The morphology (shape) of gene delivery vectors is another important
physicochemical property. The effects of shape on the physiological behavior of delivery
vectors have been well characterized both experimentally and computationally.161 We
determined the morphology of both the organo-micelle and 3LM using TEM. Figure
3.7(a, b) shows TEM images obtained for organo-micelles with N/P ratio of 12 (OM_12).
We observed spherical particles having sizes in the range of 50-60 nm, (Figure 3.7a). In
order to selectively observe the morphology and size of the encapsulated DNA, the DNA
was pre-stained using silver nitrate before the encapsulation.145 As shown in Figure 3.7b,
the TEM image has an improved contrast and the Ag impregnated DNA phase is
selectively visualized. From these images, it is evident that DNA is condensed into a
compact spherical particle. The morphology of the 3LM is shown in Figure 3.7 (c, d).
Again, we observed spherical morphology (Figure 3.7c) with diameters about 100 nm for
3LM_12. Inconsistencies in micelle dimensions between TEM observation and
hydrodynamic diameter by DLS measurements are correlated to the variations in
measurement environment. Micelles are visualized in their dehydrated states under TEM,
which leads to decrease in their effective diameter. For the 3LM encapsulating AgNO3
pre-stained DNA, the TEM image (Figure 3.7d) has a distinct contrast and the Ag
impregnated DNA phase is selectively visualized. We observed high contrast spherical
DNA polyplex particles embedded in what is realized as the core region of low contrast
polymers (i.e. PLLA-PEG-PLLA). This data confirmed our multi-layer hypothesis
introduced above.
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(a)
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100 nm

Figure 3.7. TEM images of organo-micelles and 3LM: (a) unstained organo-micelles , (b)
AgNO3 pre-stained organo-micelees, (c) unstained image of 3LM , and (d) AgNO3 prestained 3LM.

3.3.4 Encapsulation efficiency
Entrapments of hydrophilic bioactive molecules within the hydrophobic core of
polymeric nanoparticles typically lead to poor encapsulation efficiencies. In aqueous
solutions, the vast majority of amphiphilic block copolymers utilized as delivery vectors
have low critical micelle concentrations (CMC) and fast micellization kinetics. Although
these nanostructures are stable and allow for prolonged circulation lifetime, the fast
micellization kinetics limit the amount of hydrophilic molecules entrapped. Furthermore,
hydrophilic bioactive molecules are often highly water-soluble ionic species;
accumulation into the hydrophobic core is thermodynamically unfavorable. A common
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approach for higher encapsulation efficiency is the use of double emulsion techniques.
However, this method needs precise control to obtain the uniform nano-scale particles.
The method we report here is a facile method for the encapsulation of highly
water-soluble DNA molecules within the hydrophobic capsule of a three-layered micelle.
We obtained spherical micelles ca. 200 nm (Table 2) in diameter and show the DNA is
encapsulated as a compactly condensed core (Figure 3.7). Our method is unique in its
approach and tries to circumnavigate the problems associated with poor encapsulation
efficiency. In principal, the core-shell structure of our organo-micelles contains an ionic
or ion complex core and a hydrophobic shell. The incorporation of the DNA molecule
within the ionic core is now thermodynamically favorable. Second, micellization of the
organo-micelles occurs via chain re-organization as the insoluble PEI/DNA complex
aggregate and further solvent-induced condensation of DNA occurs.
Although we have not yet studied the micellization kinetics, we expect chain reorganization to occur on a timescale long enough to allow internalization of the ionic
PEI/DNA complex into the core. The encapsulation efficiency of the 3LM was
investigated as described above. The amount of isolated DNA was related to the initial
feed amount to determine the encapsulation efficiency. We investigated the encapsulation
efficiency as a function of differing N/P ratios. Figure 3.8 show the % encapsulated DNA
in the 3LM with N/P of 4, 8, 12 and 20. We observed an increase in percentage of DNA
encapsulated as the N/P ratio increased, with a highest value of 53.6% obtained for N/P
20. The percentage of DNA encapsulated is shown to increase by 82% from N/P 8
(26.5% encapsulation) to N/P 12 (48.3% encapsulation), indicating sufficient charge
condensation could be achieved at N/P >12. Increasing the N/P ratio to 20 (almost double
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of N/P 12) seems to have a minimal effect as the percentage of encapsulation increased
by only 11% to a total of 53.6% encapsulation. Detailed investigations on the dual
mechanism of PEI and solvent-induced condensation are needed to fully understand the

% DNA Encapsulation

micellization process and encapsulation of DNA within the core.
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Figure 3.8. Encapsulation efficiency of 3-layered micelles for PLLA-PEI(2k)-PLLA
determined at N/P ratio of 4, 8, 12, and 20.

3.3.5 Stability and release rates
The successful application of polyplex micelles as blood circulating gene delivery
vehicles requires the circumvention of numerous biological obstacles that limit their
stability. Polyplex micelles encounter high concentrations of polyanionic species in blood
and can dissociate through polyion exchange reactions. The stability of polyplex micelles
against competing polyanions is a paramount feature, which all delivery vectors must
address. To confirm the PEI/DNA polyplex was truly shielded, we performed dye
exclusion assays by incubating the fluorescent dye SYBR Gold with the 3LM (Figure
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3.9). The SYBR Gold dye fluoresces only when it intercalates within the base pairs of
DNA. For PEI/DNA polyplexes, the dye fluorescence was quenched with increasing N/P
ratio indicating increased condensation of DNA and exclusion of the intercalating dye.
Although the majority of the fluorescence was quenched at N/P >10, we observed a
residual signal most likely due to DNA that was still accessible for SYBR Gold
intercalation. For the 3LM, we did not observe more than 15% free DNA at the very
highest. From these results, we can conclude that the PLLA inner shell does in fact create
a barrier which effectively shields the condensed DNA. However, it needs to be kept in
mind that only up to 50% of the DNA was encapsulated in the first place.
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Figure 3.9. SYBR Gold to determine % exposed DNA.
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We then investigated the stability of the 3LM using a dextran sulfate competition
assay. The percentage of DNA release from the 3LM (N/P = 12) is shown in Figure 3.10
as a function of increasing dextran sulfate concentration under neutral conditions (pH
7.4). Compared to PEI/DNA polyplex, the 3LM show excellent stability and negligible
release of DNA over the measured timescale. For the PEI/DNA polyplex, we observed a
sharp increase in percentage of DNA released at polyanion concentration >30 μg/well.
While PEI/DNA polyplexes released 16-36% of their encapsulated DNA at 30 μg dextran
sulfate per well, the release from the 3LM was only 1.8-4.6%. However, it has to be
noted that, as shown in Figure 3.10, the release profile for the PEI/DNA polyplex is time
dependent. For example, at 50 μg dextran sulfate per well, 93.8% of the DNA is released
within 30 min, while re-organization of the DNA in presence of PEI and dextran sulfate
occurs during incubation. At the latest time point of 3 h post dextran sulfate treatment,
only 45.6% of the DNA is present as released DNA. A similar trend was found for the
3LM as well. However, most interestingly, the 3LM did not release more than 9.4% of
their encapsulated DNA at the highest dextran sulfate concentration. The observed
stability of the 3LM can be attributed to the “inaccessibility” of encapsulated DNA. For
the common PEI/DNA polyplex, the polycation does not possess a specifically strong
affinity towards DNA, even though PEI does have the ability to condense DNA into a
compact particle. Therefore, in the presence of high concentrations of competing
polyanions, the PEI/DNA polyplex will dissociate, leading to low stability in these
conditions.119 PEGylation of the polyplex surface has been shown to have minimal effect
on the stability towards competing polyanions.162, 163 However, the complete shielding of
the polyplex using a barrier that is impermeable for polyanions has been shown to
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dramatically increase polyplex stability.164, 165 In our system, the hydrophobic PLLA
inner shell provides this impermeable barrier and increases micelle stability in neutral
pH.

Figure 3.10. Dextran Sulfate competition assay used to determine stability of 3LM in 5%
glucose at pH 7.4

Once circulating, polyplex micelles are internalized by target cells, the DNA
payload must be released from the endosome before it merges with the lysosome to avoid
degradation.in an acidic environment. We examined the release profile of the 3LM using
the polyanions competition assay mentioned above in sodium acetate buffer at slightly
acidic conditions (pH 4.5) to simulate the environment of the late endosome, from which
the polyplex micelle needs to be released to avoid degradation of the DNA. The release
profile as a function of increasing dextran sulfate concentration is shown in Figure 3.11.
We observed excellent DNA release of up to 100% from the 3LM and PEI complexes.
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The release behavior is not solely pH mediated but increases rapidly upon addition of
polyanions and remains almost constant with increasing polyanion concentration. The
trend of decreasing amounts of free DNA during incubation with dextran sulfate was
confirmed at the acidic pH also. Most importantly, however, as postulated above, the
hydrophobic PLLA inner shell formed an impermeable barrier and effectively shielded
the polyplex core from competing polyanions at neutral pH. As a result, we saw no
appreciable DNA release at neutral pH at all polyanion concentration measured.
However, a decrease in pH from 7.4 to 4.5 led to a dramatic shift in the release behavior.
We can explain this behavior in terms of a detachable PEG coating layer. The outer layer
of the 3-layered micelle composed of PLLA-PEG-PLLA copolymer readily starts to
dissociate upon deformation/degradation of PLLA layer in acidic environment. As a
result, the hydrophobic PLLA inner shell (impermeable barrier) breaks down exposing
the polyplex to the environment, which leads to a dissociation of DNA/PEI complex by
the proton sponge effect. A disadvantage of covalently PEGylating polyplex micelles is
that the PEG chains interfere with the DNA release and continue to entrap the DNA in
the endosome, which subsequently undergoes endoso-lysosomal nuclease degradation.125,
166

Several groups have investigated the use of detachable PEG coating via attachment of

readily hydrolyzable chemical bonds and physical association of the PEG molecule on
the surface.164, 167 Detachment of the coating PEG layer prior to endosomal entry or
during intercellular trafficking has been shown to greatly enhance DNA release abilities.
Consequently, our unique 3LM design proved the hypothesis based on those references
for the effective DNA release.

105

Figure 3.11. Dextran Sulfate competition assay used to determine stability of 3LM in
sodium acetate buffer at pH 4.5.

3.3.6 Cell cytotoxicity
A major drawback of PEI-based gene delivery vectors is the often observed high
cell toxicity. PEI toxicity increases with increasing MW and branching density.116 Cell
toxicity is caused when normal cell activities are inhibited by accumulation of high
cationic charges at the cell surface or internal compartments. We investigated the
potential toxicity of the 3LM using a cell viability assay. The results are shown in Figure
3.12 for 3LM prepared with PLLA-PEI(2k)-PLLA and PLLA-PEI(4k)-PLLA triblock
copolymers. The toxicity of all 3LM tested is considerably lower than what is observed
for the standard PEI/DNA polyplex. At the lowest tested concentrations, we observed
>70% cell viability for both 3LM(2k) and 3LM(4k), while standard PEI/DNA polyplex
showed ~50% cell viability. Increase in polymer concentration led to decrease in cell
viability as expected. However both 3LM(2k) and 3LM(4k) gradually decreased cell
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viability, while PEI/DNA polyplex showed sharp decrease of cell viability reaching a
minimum plateau of ~15% cell viability. The toxicity results can also be discussed in
terms of IC50 values, which is related to the polymer concentration needed to cause
toxicity for 50% of the cells measured. As shown in Figure 3.12, 3LM(2k) and 3LM(4k)
showed IC50 larger than the control. We, however, observed larger IC50 value for the
3LM(4k) compared to that of 3LM(2k). This order of toxicity could be related to the
processing efficiency such as DNA loading rate into organo-micelles. Optimization of the
toxicity study is needed to fully understand the correlation between different PEI MWs.
Additionally, the toxicity of the materials, for example, uncondensed block copolymers
(without DNA) will need to be characterized to evaluate toxicity of the new 3LM
systems.

Figure 3.12. MTT Assay of 3LM prepared with PLLA-PEI(2k)-PLLA and PLLAPEI(4k)-PLLA triblock copolymers to determine the cell toxicity. PEI homopolymer MW
5k is used as control.
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3.4 Conclusion
Linear triblock copolymers, PLLA-PEI-PLLA were successfully synthesized by a
multi-step synthetic method. The macroinitiator PEI-N-Boc was prepared by simple
amine protection of PEI using Boc-anhydride as the protecting reagent. The bifunctional
PEI-N-Boc macroinitiator underwent conventional ROP of L-lactide to yield linear
intermediate block copolymer, PLLA-(PEI-N-Boc)-PLLA. Deprotection of the Boc
groups under mild acidic conditions yielded the final PLLA-PEI-PLLA triblock
copolymers. The block copolymers were subsequently utilized as condensing vectors for
DNA encapsulation and delivery.
The DNA encapsulation method here utilized a combination of electrostatic
interaction and solvent-induced condensation to entrap high concentration of DNA within
the core of the micelle. We obtained compact polyplex particles having spherical
morphologies and diameters in the size of ca. 100 nm as organo-micelles. The polyplexcore micelles were successfully processed into stable aqueous dispersions through
physical encapsulation within the amphiphilic PLLA-PEG-PLLA triblock copolymer.
The resulting 3LM were shown to have exceptional stability in neutral pH in the presence
of high concentrations of polyanions.
The stability of these 3LM is attributed to the complete isolation of the PEI/DNA
polyplex in an impermeable hydrophobic capsule. However, under acidic conditions, we
observed immediate release of encapsulated DNA. The physically adsorbed PLLA-PEGPLLA outer layer is readily destabilized under acidic conditions and allows dissociation
of the complex. This is considered to be an important feature of the 3LM, which could
readily allow endosomal escape of internalized DNA. Low MW PEI used in this study
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shows low cytotoxicity to cells as expected. Continuing efforts are underway to further
characterize the 3LM system. Additionally, complete biological evaluations of the DNA
loaded delivery vector are also ongoing.
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CHAPTER 4.
Temperature-Responsive Stereocomplexed Injectable Polyplex Hydrogels as a
Localized Gene Delivery System
4.1 Introduction
In recent decades, localized gene therapy approaches have found increasing
popularity in the fields of tissue engineering, immune therapy, localized disease therapy,
long term depots for drugs, and localized site production “factories” for proteins.15, 168, 169
For localized gene therapy, hydrogels have been utilized as coating materials for
implants, intravascular stents, thin films (membrane), porous scaffolds, and in-situ
forming (injectable) hydrogel depots. Traditionally, hydrogels system are produced
outside of the body (after incorporating genetic material), and then implanted into the
body. The disadvantage of such approach is that the matrix must be implanted through
surgical means. The development of injectable hydrogels, which undergoes solution to
gel transformation in the body have attracted considerable attention. Some of the
advantages of these injectable delivery systems include: (1) minimal invasiveness, (2)
reduce surgery related complication, and (3) can be molded to fit specific shapes and
crevices.170, 171 Researchers have focused on the development of temperature responsive
hydrogels and have utilized both synthetic and natural polymers. Temperature responsive
hydrogels are highly desirable systems as the well regulated physiological temperature is
the only stimuli needed for sol-to-gel transition.
The encapsulation and delivery of pDNA and siRNA have been reported using
physically crosslinkable injectable hydrogels derived from natural polymers such as
alginate, fibrin and gelatin.172-174 The poor degradation properties and uncontrolled
release profiles for these hydrogels have promoted researchers to develop block
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copolymer based injectable hydrogels. Some of the commonly utilized physically
crosslinkable block copolymer system include PLGA-PEG-PLGA, PDLLA-PEGPDLLA, and pluronic.175-177 The low mechanical strength typically associated with
physical crosslinking has promoted the development of chemically crosslinkable systems.
Reactive functional groups such as furmate, methacrylate, and acrylates are typically
conjugated to gelling block copolymer or hydrophilic homopolymer systems (PEG is a
commonly utilized hydrophilic homopolymer).178-181 Although chemical
functionalization yields robust hydrogels, there are serious safety and biocompatibility
concerns. The relative reactive cross-linkable groups and their degradation byproducts
are known to cause serious localized toxicity and necrosis.182
The hydrogel systems described so far incorporate the genetic material (pDNA,
siRNA, etc.) in their naked form; the mechanism for loading of the genetic material relies
simply on physical entrapment during the sol-to-gel transition process. These systems
typically show low therapeutic efficiency, due to lack of special ability to retain the gene
inside and prevent rapid diffusive and uncontrolled release. Moreover, the released
genetic material has low in-vivo half-life due to degradation by nucleases and inability to
successfully cross the cell membrane.183 To overcome these drawbacks, researchers have
used cationic polymers such as PEI to condense DNA into a polyplex particle and entrap
it within the hydrogel matrix.184, 185 The condensing cationic polymers have also been
incorporated into the block architecture of the gel forming block copolymers. Injectable,
gene loaded hydrogels have been reported from ionic block copolymer systems such as
L-PEI-poly(organophsphazene) conjugate,186 pluronic-PDMAEMA,187 and MePEG-PCLPDEAEM.188
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The main hurdle in the development of injectable hydrogel for localized gene
therapy is the fine balance needed between high mechanical strength and
biocompatibility. To produce high modulus hydrogel, relatively toxic chemical
crosslinking approaches are often needed which has a negative effect on the
biocompatibility of the system.182 Stereocomplexation is an attractive alternative to
chemical crosslinking in the production of an injectable hydrogel with biological relevant
mechanical strength.66, 67 The stereocomplex crystal is produced through physical
association of enantiomeric blocks of a thermogelling system (crosslinking junction). The
crystal has relatively high thermal/physical stability, which allows it to act as a permanent
crosslinker similar to what is produced by chemical methods.102 Additionally, polyester
polymers such as PLA are able to undergo stereocomplexation process, leading to the
production of a biodegradable hydrogel matrix.
In this study, block copolymers composed of thermo-gelling PLA and DNA
condensing PEI blocks were investigated as possible injectable hydrogel systems for
localized gene therapy application. The triblock copolymer, PLLA-PEI-PLLA, was
reported to produce nano-sized three-layered micelles (3LM), where the DNA/PEI
polyplex is localized within a hydrophobic capsule. The 3LM were shown to incorporate
high concentrations of DNA with the use of relatively less toxic low MW PEI.
Additionally, the 3LM is shown to possess high stability in neutral pH, while its
encapsulated payload can be released through a pH mediated trigger allowing for
controlled release properties. Overall, these systems show a promising potential as nonviral gene delivery vectors. In this study, we investigated the development of an
injectable hydrogel system incorporating the 3LM assembly. The biopolymer dextran
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sulfate was used as a model polyanions (DNA analogous). The sol-to-gel transition
behavior as a function of block MW and 3LM loading ratio was studied and results are
reported here.
4.2 Experimental
4.2.1 Preparation of Stereocomplexed Hydrogels
The hydrogel formation procedure is similar to that reported for the standard
PLA-PEG-PLA associative network micelles. 3-layered micelles incorporating Dextran
Sulfate/PEI complex in the core and PLLA-PEG-PLLA shielding triblock outer layer
were prepared using the procedure described in Chapter 3. The counter-thermogelling
flower-micelles composed of PDLA-PEG-PDLA was prepared using the procedure
described in Chapter 2. Controlled hydrogel formation is achieved by blending equal
volumes of the 3-layered micelle and counter-gelling PDLA-PEG-PDLA flower micelle
(Figure 4.1). The separately prepared micellar solutions were mixed at equal volumes
with ultrasonic wave applied at 4°C in a scintillation vial. The mixture was allowed to
sonicate at 4°C for 30 minutes or until a homogeneous solution is obtained. The vial is
transferred is then transferred to a temperature controlled circulating water bath and the
temperature of the bath is gradually increased with 1 hr. hold at each temperature
interval. The vial tilting method was used to determine sol to gel transition behavior, if
the mixture flowed then it was reported as a solution and if it did not flow for at least 8
seconds it was reported as a gel.189, 190 The results are shown as a phase diagram to
illustrate the sol-gel transition behavior.
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Figure 4.1. Enantiomeric solutions prepared individually are blended at 1:1 ratio. Upon
increase in temperature of the mixture a hydrogel was obtained. The tube-inversion
method is used to determine the sol-gel transition temperature.

4.3 Results and Discussion
4.3.1 Stereocomplexed hydrogel formation
Hydrogels were prepared by mixing equal volumes of the enantiomeric micelle
solutions of PLLA containing 3LM and PDLA-PEG-PDLA counter gelling micelles. As
the sol-to-gel transition temperature is reached the free flowing micellar solution was
observed to increase in viscosity and eventually solidify to give a hydrogel. The
mechanism of stereocomplexation and hydrogel formation between enantiomeric
PLLA/PDLA composed micelles is described in details in Chapter 2 and will not be
discussed here. As a model preliminary study, the sol-to-gel transition of dextran sulfate
loaded 3LM is investigated.
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Figure 4.2. Phase diagram of the 1:1 stereo-mixture of 3LM and PDLA-PEG-PDLA
micelles. The 3LM contains increasing ratio of PLLA-PEG-PLLA outer shell relative to
PLLA-PEI-PLLA inner shell.

Figure 4.2 shows the phase diagram obtained for a series of 3LM obtained at
increasing ratio of the PLLA-PEG-PLLA outer stabilizing layer. The sol-gel transition
temperature is shown to decrease with increasing amount of PLLA-PEG-PLLA outer
layer polymer. Additionally, the sol-gel temperature shows a linear response to the outer
layer concentration. The optimum formulation for hydrogel formation around body
temperature (37°) can be obtained by simply extrapolating the line fit.
Although rheological (elastic modulus) characterization are not performed as of
yet, we utilized the test-tube inversion method to obtain an idea of the mechanical
strength of the hydrogels. Figure 4.3 shows the test-tube inverted images taken for the
different hydrogel formulations discussed above. As shown, the hydrogels maintain their
shape and their downward flow are largely suppressed. However, we observed slight
physical agitation (e.g. flicking of tube) leads to downward flow of the hydrogels as
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shown in Figure 4.3 (a and d). This behavior is characteristic of a mechanically weak gel.
Detailed rheological characterizations are needed to fully elucidate the mechanical
strength and influence of the different formulations used.

Figure 4.3. Test-tube inversion method to determine sol-to-gel transition temperature and
non-qualitative determination of hydrogel mechanical strength.

Next, we investigated the influence of PEG block MW on the sol-gel transition
behavior and mechanical strength of these hydrogels. In a previous work (Chapter 2) we
showed that enantiomeric PLA-PEG-PLA block copolymer micelle composed of
different PEG MW (hybrid micelles) possessed well controllable sol-gel transition across
a wide range of temperature (4-90°C). Additionally, these hydrogel showed relatively
high elastic modulus compared to previously reported stereocomplexed injectable
systems. We prepared hybrid micelles for the counter thermo-gelling (PDLA-PEGPDLA) micelles at different short PEG wt % (0, 30%, 50%, 70% and 100%). Figure 4.4
shows the phase diagram obtained for the resulting hydrogels. The 3LM used for this
study were kept at a constant ratio of 1:4 for the PLLA-PEG-PLLA outer layer. The solgel transition showed a linear response to the composition of the hybrid micelle. In close
agreement to the previously reported system (Chapter 2), the sol-gel transition
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temperature decreased with increasing short PEG wt %. Again, we used the test-tube
inversion method with physical agitation to get an idea of the mechanical strength of the
hydrogels. We observed improved mechanical strength for these hybrid micelle
formulated hydrogels. The downward flow of the hydrogels was noticeably lower than
those shown in Figure 4.3. The increases in mechanical strength observed for the hybrid
micelles are comparative to those previously reported.

GEL

SOL

Figure 4.4. Phase diagram of the 1:1 stereo-mixture of 3LM and hybrid micelle solution
composed of PDLA-PEG-PDLA having different MW of PEG (2000/3350). The 3LM
solution is kept at a constant (1:4) ratio between the inner and outer PLLA-PEI-PLLA
and PLLA-PEG-PLLA.

4.4 Conclusion
Stereocomplexed hydrogel system can be obtained incorporating the 3LM. The
sol-gel transitions of the resulting hydrogels were observed to vary according to several
varying formulations. We observed that a hydrogel system with a sol-gel transition
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around body temperature can obtained by increasing the amount of stabilizing PLLAPEG-PLLA triblock copolymer during the 3LM formation. Further, we showed that the
mechanical strength of the hydrogels can also be improved through the use of hybrid
micellar systems. These results are promising, in that the incorporation of the non-viral
gene vector, 3LM, within an injectable hydrogel matrix can be readily prepared through
stereocomplexation between enantiomeric PLLA/PDLA thermo-gelling systems.
However, a detailed study is needed to optimize the formulation procedure and as well as
characterize hydrogel properties (mechanical strength and gelation mechanism).

118

CHAPTER 5.
Time-Resolved SANS Analysis of Micelle Chain Exchange Behavior: Thermal
Crosslink Driven by Stereocomplexation of PLA-PEG-PLA Micelles
5.1 Introduction
Block copolymer micelles self-assembled in a selective solvent have been utilized
for various purposes, such as in the emerging fields of controlled drug delivery.12 The
stability and dynamic behavior of these micelle systems are important factors to
determine their applicability. In particular, the chain exchange between micelles in
solution is the subject of investigations for each copolymer system. While several
techniques have been used to study polymeric micelle dynamics,96, 191-193 small angle
neutron scattering (SANS) has been used with considerable success in elucidating the
chain exchange behavior of polymeric micelles. Lund et al. studied the equilibrium chain
exchange kinetics of several di- and triblock copolymers using SANS which relied on
mixing hydrogenated (h) and deuterated (d) micelles under zero average contrast
conditions.104, 105, 194 The exchange of chains between the (h)/(d) micelles then leads to
decrease in contrast and decay of the scattered neutron intensity. Using time-resolved
SANS (TR-SANS) they obtained relaxation time constants for the chain exchange
processes. They concluded that the exchange occurred through an expulsion/insertion
mechanism involving only single chain at a given time, of which the chain expulsion is
the rate-determining step.
The block copolymer micelles from biodegradable poly(lactic acid) (PLA) and
poly(ethylene glycol) (PEG) have been widely studied to use as biomaterials, such as
injectable drug delivery carriers. A few groups have reported SANS studies for PLAPEG micelles. Riley and Davis investigated the nanostructure and chain conformation
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using SANS.195 Contrast match studies using selectively deuterated PLA(d)-PEG diblock
copolymers were shown to form spherical core-shell particles, where the hydrophobic
PLA blocks aggregate to form a homogeneous core of uniform scattering length density
and the hydrophilic PEG block forms the stabilizing shell (corona) of the particle. Both
particle size and conformation of the PEG chains were shown to depend on the PLA
block length. Tew et al., in contrast, used all hydrogenated triblock copolymers, PLAPEG-PLA, to study the infinity structure of their micelles in deuterium oxide (D2O) using
SANS. They investigated the effects of stereo-regularity and block length of PLA on
particle morphology and size.76 The stereo-regular PLLA block (semi-crystal) and
racemic PDLLA block (amorphous) led to non-spherical lamellar core micelle and
spherical micelle, respectively. The variation in the block lengths of PLLA and PDLLA
were seen to affect micelle dimensions, such as the core radius, aggregation number, and
crystallite thickness. The effect of polymer concentration was also examined; at higher
concentrations macro-aggregation was observed due to chain exchange between nearby
micelles, resulting in network and gel formation.
Hydrogels derived from PLA-PEG micelles are promising biomaterials as drug
delivery carriers and temporary implants.78, 80-84 Fujiwara and Kimura applied new
gelation mechanism of stereocomplex crystal formation using copolymers of
enantiomeric PLAs, PLLA-PEG-PLLA and PDLA-PEG-PDLA, and found a thermoresponsive sol-to-gel transition behavior.66, 108 Recently, we developed stereocomplex
hydrogels with high mechanical properties and temperature controllable sol-to-gel
transitions.67 The sol-to-gel transition mechanism of stereo-mixture (1:1 mixture of pure
L micelles and pure D micelles) is hypothesized as the formation of stereocomplex
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crystals by PLLA/PDLA blocks in the micelle core after micelle chain exchange
occurred. Physicochemical properties of PLLA/PDLA stereocomplex crystals are
considerably different from PLLA or PDLA homo-crystals; for example, the
stereocomplex possesses a tighter packing crystal lattice, higher melting point, and lower
solubility in most solvents compared to homo-crystals. Therefore, chain mobility of the
micelles after stereocomplex formation should be restrained, which would be a driving
force for transition into a hydrogel network structure. In this study, we used TR-SANS to
study the dynamic chain exchange behavior of enantiomeric micelle mixture of all
hydrogenated PLLA-PEG-PLLA and PDLA-PEG-PDLA in D2O during the sol-to-gel
transition process. Moreover, we compared the mobility of the PLA blocks in the core by
varying the length of PEG (MW = 2000 and 3350) in the triblock copolymer. Model
dependent analysis of the SANS data was performed and calculated parameters are
presented. Table 1 lists the triblock copolymers and ‘ID’ of their micelles used in this
report.
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Table 5.1. Triblock copolymers used for the SANS study
Copolymer

Theoretical MW (Da)

Mn
(NMR)

Mn
(GPC)

PDI
(GPC)

Micelle
ID

PLLA11-PEG45-PLLA11

800-2000-800

3419

4033

1.23

L-short

PDLA11-PEG45-PDLA11

800-2000-800

3506

3971

1.17

D-short

PLLA11-PEG76-PLLA11

800-3350-800

4835

6591

1.15

L-long

PDLA11-PEG76-PDLA11

800-3350-800

5053

6555

1.12

D-long

5.2 Experimental
5.2.1 Materials
The monomers, L-Lactide and D-lactide with the trademarked names of
PURASORB L and PURASORB D, respectively, were purchased from Purac Biochem
(Netherlands). PEG with a number-average molecular weight (Mn) of 2000 (PEG-2000)
and 3350 Da (PEG-3350), toluene (extra dry), and tin(II) 2-ethylhexanoate (SnOct2) were
purchased from Sigma Aldrich (St. Louis, MO). The monomers L-lactide and D-lactide
and PEG macroinitiator were purified by recrystallization and lyophilization,
respectively, as reported previously.67 All other reagents were used as received.
5.2.2 Synthesis of PLA-PEG-PLA triblock copolymers
The ABA-type triblock copolymers of PLLA-PEG-PLLA and PDLA-PEG-PDLA
were prepared by the ordinary ring-opening polymerization (ROP) of L-lactide and Dlactide as reported previously.67 Briefly, L or D-lactide and PEG-diol were placed in a
reaction flask and were homogenized at 100°C under an inert environment. The catalyst
Sn(Oct)2 (5 mol% relative to each hydroxyl group of PEG) was added as a 0.1 g/mL
toluene solution. The reaction temperature was raised to 120°C and allowed to react
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overnight. The reaction mixture was dissolved in dichloromethane and added dropwise to
1:1 diethyl ether/hexane to precipitate the product. The number-average molecular weight
(Mn) and PLA/PEG block ratio were calculated from 1H NMR spectra obtained in
CDCl3. The chemical shifts (in ppm) are assigned as follows: 1.56-1.6 (d, CHCH3), 3.63.7 (m, OCH2CH2), 4.2-4.3 (m, COOCH2 for the oxymethylene connected to lactate
repeating units), 4.3-4.4 (m, CHOH, end group CH of the lactate repeating units) and 5.15.2 (q, CHCH3, of lactate repeating units).
5.2.3 Micelle Formation
The micelle solutions of the PLA-PEG-PLA triblock copolymers were prepared
using the nanoprecipitation method. Briefly, the PLLA-PEG-PLLA or the PDLA-PEGPDLA copolymers were dissolved in THF. The transparent organic solution was added
dropwise into D2O with an ultrasonic wave applied at ~4°C. The organic solvent (THF)
was then evaporated from the suspension in a fume hood under a gentle stream of air to
acquire an aqueous micelle solution. Micelle concentration 5 % was prepared for SANS
analysis.
5.2.4 Characterization
The chemical structure and composition of the PLA-PEG-PLA triblock
copolymers were determined using nuclear magnetic resonance (1H NMR) on a FTNMR-JOEL GSX-270 MHz instrument with CDCl3 as the solvent. The molecular weight
and polydispersity (PDI) were determined using gel permeation chromatography (GPC)
on a Shimadzu LC-20AD with two Jordi DVB 500 Ǻ (250 x 10 mm) columns calibrated
with polystyrene standards at 35°C. The flow rate was 1.0 mL/min with THF as the
mobile phase. The hydrodynamic size of the polymer micelles were determined using
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dynamic light scattering (DLS) on a Malvern Zetasizer Nano ZS90 at 1, 5 and 10 %
concentrations at room temperature in triplicate. The crystallization of PLLA and PDLA
were determined using wide-angle X-ray diffraction (WAXS) on a Bruker AXS D8
advance X-ray diffractometer for lypholized powder samples. The instrument was
operated at 40 kV and 40 mA and scanned in the 2θ range of 5-40°C. The SANS
experiment was conducted on the NG-7 30m beamline at the National Institute for
Standard and Technology (NIST), Gaithersburg, MD. Scattering range used in this timeresolved study was 0.1<q<0.01 which correspond to a detector distance of 4.0 m. All
measurements were run on quartz sample cells with path length of 2 mm and an incident
wavelength of 6.0 Å with a wavelength spread ((Δλ/λ) of 0.12 was used. All
measurements were done in 100 % D2O medium at 25°C, 37°C and 50°C. For kinetic
measurement studies, scattering was collected every minute for 20 minutes for blend
solution (PLLA + PDLA) and 10 minutes for non-blend solutions (PLLA). For nonkinetic measurements, spectra were collected between 10 to 30 minutes. The following
equation was used to calculate the scattering length density (SLD) of the monomers,196

𝜌b =

ρ𝑏NAV

(3)

M

where b, ρ, NAV, and M represent the total scattering length of all the atoms in the
monomer, the bulk density of polymer, Avogadro’s number and monomer molecular
weight respectively. The scattering and transmission of each sample was measured at
each temperature, scattered data was corrected for transmission and background. The
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scattered data were reduced and modeled using data reduction and modeling software
provided by NIST197 and reported on an absolute scale except where noted.
5.3 Results and Discussion
5.3.1 Gelation mechanism of stereo-enantiomeric micelles
Amphiphilic block copolymers, PLA-PEG-PLA, self-assemble into micelles
when placed in an aqueous environment. The hydrophobic PLA outer blocks aggregate in
the core stabilized by a corona of the hydrophilic PEG middle blocks. Chain exchange of
block copolymer micelles has been studied by various methods, both experimentally and
computationally.71 In this study, we examine the dynamic behavior of a micelle
containing single enantiomeric PLA block, PLLA-b-PEG-b-PLLA; and a stero-mixture
of two micelles comprising of PLLA-b-PEG-b-PLLA and PDLA-b-PEG-b-PDLA. Figure
5.1 illustrates the plausible mechanisms of those micelles in relatively dilute aqueous
solution (5-10 wt%). The exchange of polymer chains between micelles is the motivation
of the structural changes. For the L-isomeric micelles, the chain exchange is not
immediately the driving force of network formation as PLLA blocks in every micelle
core still keep their mobility (Figure 5.1a). Therefore, gel formation does not occur, or
negligible. In the same condition, if 50 % of micelles are from D-isomeric copolymer, the
chain exchange between L-micelles and D-micelles causes stereocomplex crystal
formation in the core, which irreversibly changes the core properties (Figure 5.1b).
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Figure 5.1. Proposed chain exchange mechanism of triblock copolymer micelles, a)
single enantiomeric micelles, b) equimolar mixture of both enantiomeric micelles.

We used WAXS analysis to confirm the formation of stereocomplex crystals
during sol-to-gel transformation with increasing temperature. Figure 5.2 shows the
WAXS profiles of the freeze-dried micelles used in this study. The diffraction curve (a-d)
for the stereo-mixed micelles of L-short/D-short system shows PLLA homo-crystal
peaks at 2θ = 17° and 19°, crystalline PEG at 2θ = 19° (overlapped with PLLA peak) and
23°, and the stereocomplex diffraction pattern at 2θ = 12° and 21°. The stereocomplex
peaks increase at high temperature indicating continuous chain exchange of PLLA and
PDLA blocks between micelles. The long PEG micelles also displayed a similar trend,
however, the growth of stereocomplex crystal was slower than short PEG system as
observed at 50°C for the mixed micelles of L-short/D-short (Figure 5.2c) and L-long/Dlong (Figure 5.2e).
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Figure 5.2. WAXS profiles of L-short/D-short mixed micelles lyophilized after immersed
at the temperatures 10°C (a), 25°C (b), 50°C (c), 80°C (d), and L-long/D-long mixed
micelles lyophilized from 50°C (e).

The repeating unit number of lactate in our copolymer systems is approximately
11. This is the lower critical size for PLA to form homo-crystals. The lower critical
number for stereocomplex crystal formation at 1:1 PLLA/PDLA mixture is 7. Also, it
was reported that the stereocomplex formation is thermodynamically favorable.98 Our
previous work reported the sol-to-gel phase behavior for 10 wt% micelle solutions of Lshort/D-short and L-long/D-long systems; unlike the homo-PLA micelle systems (Lshort or L-long) that showed no gelation, the sol-to-gel transition was observed for L/D
mixed micelle systems at around 10°C (short PEG) and 70°C (long PEG).67 In this study,
we used 5 wt% of micelle solutions for all 4 micelle systems. As expected, 5 wt% Lshort and L-long micelles stayed as a solution up to 80°C. The long PEG stereo-mixed
micelle system, L-long/D-long (5 wt%) also did not show a transition to a gel form by
heating to 80°C. Only short PEG stereo-mixture, L-short/D-short (5 wt%) had a sol-togel transition at 60°C. SANS experiments were conducted at 25°C and 37°C for stereo-
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mixed micelles. Discussions of all systems henceforth only concerns the initial chain
exchange process of micelles in a solution.

short-L/D, t=10
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Figure 5.3. Scattering curves of L-short (blue), L-short/D-short (red), L-long (green), and
L-long/D-long (pink) at 25°C; time = 1 min (open marks) and time = 10min (closed
marks). All freshly prepared single micelle solutions were kept at 4°C right before
collecting data in temperature controlled sample bath.

5.3.2 SANS profiles of single and enantio-mixture micelles.
SANS was used to characterize structural properties of PLA-PEG-PLA
copolymer micelle systems. As illustrated in Figure 5.1, The initial micelles prepared in
D2O (5 wt%) has a spherical core-shell structure, where the PLA blocks aggregate in the
core and the PEG middle blocks exist as loops on the surface, extending into solution
resulting in a flower-type micelle. Figure 5.3 shows the typical TR-SANS curves of
single isomeric copolymer micelles, L-short: PLLA-PEG-PLLA (800-2000-800), Llong: PLLA-PEG-PLLA (800-3350-800), and 1:1 mixtures of L- and D-copolymer
micelles, L-short/D-short and L-long/D-long measured at 25°C. The chart contains only
time = 1 (min) and time = 10 (min) plots for each sample although data was collected
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every 1 min in 10 or 20 min duration. All micelle solutions were prepared on site just
before the SANS measurement, and kept at 4°C until the start of data collection. The L
and D micelle solutions for stereo-mixed systems were then mixed at 1:1 (vol/vol) and set
in the temperature-controlled sample chamber immediately before the data collection.
The inset plot with expanded y-axis in Figure 5.3 emphasizes the differences between; (1)
the single and stereo-mixed micelles and (2) short-PEG and long-PEG micelle behaviors.
The former difference is seen particularly for L-short (blue diamond) and L-short/Dshort (green square). From time = 1 (open marks) to time = 10 (closed marks), the
scattering intensity of stereo-mixed micelles considerably increased relative to the small
increase of single isomeric micelles at low-q range. Long-PEG series also showed the
same trend (blue circle and green triangle). This result indicates a specific interaction
between PLLA micelle and PDLA micelle occurred even at room temperature. The latter
difference, that is, the scattering intensity of short PEG micelles (L-short, L-short/Dshort) are higher than long PEG micelles (L-long, L-long/D-long), also kept increasing
at low q = 0.01 (A-1). Further analysis of SANS curves by model fitting will be provided
later for more detailed discussion on micelle dynamics.
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Figure 5.4. Scattering curves of L-short (blue), L-short/D-short (red), L-long (green), and
L-long/D-long (pink) at 37°C; time = 1 min (open marks) and time = 10min (closed
marks). All freshly prepared single micelle solutions were kept at 4°C right before
collecting data in temperature controlled sample bath.

Figure 5.4 includes SANS curves of those four micelle solutions at time = 1 and
10 min at 37°C. Similar trends were observed for all 4 micelle systems; however,
intensity increases at t = 10 min were greater than that observed in measurements at
25°C. The short PEG micelles, particularly L-short/D-short system, does not reach the
plateau at q = 0.01 (A-1). SANS measurement at lower q range (q < 0.01) would be
needed for short PEG series to discuss the structural events in larger range (> 80 nm).
The long PEG micelle systems displayed relatively small changes at 37°C.
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Figure 5.5. Comparison of the sol-to-gel transitions: PLA-PEG(2000)-PLA and PLAPEG(3350)-PLA.

Our previous studies using 10 wt% stereo-mixed micelles clearly exhibited the
difference of gelation rate and temperature between short PEG (MW 2000) and long PEG
(MW 3350) stereo-mixed micelles as illustrated in Figure 5.5.67 With 5 wt% of diluted
systems in current study, sol-to-gel transition temperatures increased as expected; 60°C
for the L-short/D-short mixed micelle system, and no gelation was observed between 480°C for the L-long/D-long system. Therefore, at SANS experiment temperatures (25
and 37°C), all four systems (L-short, L-long, L-short/D-short, and L-long/D-long)
were still in solution state. However, their SANS profiles revealed considerable
difference on the degree of chain mobility and structural transformation between short
PEG and long PEG stereo-mixed micelles even at room temperature, and more
significantly at 37 °C.
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Figure 5.6. Scattering curves of stereo mixture of L-short/D-short micelles at 25°C
(diamond), 37°C (square), and 45°C (circle); time = 1 min (open marks) and time =
10min (closed marks).

Figure 5.6 shows SANS curve changes of L-short/D-short system at each
temperature. As observed, higher temperature induced an increase of scattering intensity
within the first 10 minutes. The scattering intensity of this stereo-mixed micelle system
is likely to continuously increase at the q range lower than 0.01, in which larger structural
events can be expected at size ranges greater than 100 nm. Temperature dependent SANS
experiments have been reported for several triblock copolymer micelle-hydrogel systems
such as PEO-PPO-PEO63, 198 and PLA-PEG-PLA.76 For non-equilibrium chain exchange
systems, the scattering intensity is related to the reorganization of micelles mediated by
chain exchange between micelles. For our stereo-mixed micelle mixtures, the driving
force of structural reorganization should be related to the stereocomplex crystal formation
after the chain exchange event.
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Figure 5.7. Shifts in Time-resolved SANS curves for initial 20min at 37°C upon mixing
L/D micelles; a) L-long/D-long and b) L-short/D-short at 37°C.

The same trend in SANS curve shifts during the first 20 minutes were observed
for all stereo-mixed micelle solutions. Figure 5.7 shows 20 curves for L-long/D-long (a)
and L-short/D-short (b) mixtures at 37°C. In our time-resolved studies, regardless of
concentration, the scattering profile of stereo-mixed micelle solutions shifted to the lower
q-range as indicated by arrows in the graphs. Particularly, short PEG stereo-mixed
micelles exhibited distinct peak shift to low-q at higher temperature. This result indicates
that some aggregation, self-assembling process, or structural reorganization occurred
between L- and D-micelles. Further analysis of structural information by fitting model
was performed (vide infra).
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Figure 5.8. DLS curves of L-short and L-long micelles in 1, 5, and 10 wt% aqueous
solutions at 25°C.

5.3.3 Micelle sizes of short and long PEG copolymers
The aqueous micelles of PLA-PEG-PLA triblock copolymers were
homogeneously transparent or slightly turbid solutions without any precipitation or
visible aggregation. Table 2 lists DLS result for L-short (PEG 2000) and L-long (PEG
3350) micelles. Both micelles showed bimodal peak profiles for relatively high
concentration solutions, (1, 5, and 10 wt%). Hydrodynamic diameters of peak-1 indicate
individual micelle size, and those of peak-2 are detected as an aggregation peak. Relative
intensity of the aggregation peak increased as polymer concentration increases as shown
in the scattering curves in Figure 5.8. An interesting trend was seen for the aggregation
peaks in which L-short micelle aggregation was larger in size than L-long aggregation in
any concentration at room temperature. Furthermore, the individual micelle sizes
observed in peak-1 are consistent whereas the aggregation size drastically increases with
increasing concentration. This result is consistent with other reported PEGylated micelles
and their aggregation beahviour.199 All samples showed the existence of mono-dispersed
individual micelles in the range of 20-24 nm. TR-SANS study in this report was
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performed focusing on the range of structural size, ca. 5-80 nm, which covers the size of
individual micelles. Therefore, we can say with confidence the results presented in this
work arise from individual micelle interactions.

Table 5.2. Hydrodynamic diameters of L-short and L-long micelles by DLS
Micelle ID

L-short

L-long

Conc.

Diameter (nm)

(w/v %)

Peak-1

Peak-2

1

22.7

276

5

20.0

584

10

22.4

1969

1

23.2

173

5

23.8

371

10

24.1

1243

Copolymer

PLLA11-PEG45-PLLA11

PLLA11-PEG76-PLLA11

5.3.4 Kinetic analysis: Guinier plot analysis
The Guinier plot (ln[I(Q)] vs Q2) was used in order to examine the radius of
gyration (Rg). The slope of the Guinier region was modelled as a spherical scattering
entity which gives the value of Rg^2/3. Figure 5.9 shows typical Guinier plots for Llong/D-long (a) and L-short/D-short (b). The y-axis was offset to show each plot.
Fitting was applied in the q-range 0.026-0.046 Å, and obtained Rg data had a standard
deviation within 0.2 Å. All Rg data obtained were plotted against time in Figure 5.10. For
the initial L-long and L-short micelles at 25°C, Rg/Rh was calculated as 0.5-0.55 using
DLS data shown above, which is considered very low for spherical objects (typically
0.75). However this has been observed for extensively hydrated PEGylated aqueous
micelles. The radius of stereo-mixed micelles were shown to increase with time,
particularly at higher temperatures, which indicates an increase of aggregation number in
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each micelle. The L-long/D-long micelles (Figure 5.10a), however, displayed minimum
change (below 2 Å increase) at 25°C. At 37°C, the L-long/D-long system showed a delay
in radius increase in contrast to the immediate increase for the L-short/D-short micelle
system (Figure 5.10b). This result is reasonable from the slow chain exchange in our
hypothesis.

(a)

(b)
20 min: Rg=59.5 Å
15 min: Rg=59.3 Å
10 min: Rg=58.3 Å
5 min: Rg=57.3 Å
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Figure 5.9. Typical Guinier plots for SANS data taken from a) L-long/D-long and b) Lshort/D-short micelle mixtures at 37°C (y-axis offset); fitting q-range: 0.026-0.046Å.
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Figure 5.10. Time-resolved plots for radius of gyration (Rg) form SANS Guinier plot
fitting; a) long-PEG and b) short-PEG micelle series.
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5.3.5 Theoretical modeling of scattering data
The PLA-PEG-PLA triblock copolymers reported in this study are expected to
form flower-type spherical micelles. The scattering data were analyzed using the coreshell model for spherical particles having a polydisperse core with a constant shell
thickness. As illustrated in Figure 5.11, the model accounts for a spherical core composed
of the hydrophobic PLA blocks surrounded by a shell of PEG having a constant shell
thickness. Tew et al. and coworkers reported detailed SANS study on the nanostructure
of PLA-PEG-PLA triblock copolymer micelles in solution and gel state.76 Some of the
fitting parameters and assumptions have been adopted in this study.

Shell: hydrated PEG, ρ(s) = (5~6) x 10-6 (Å-2)
rc
t

rm

Core: oligo-LA, ρ(c) = 1.38 x 10-6 (Å-2)
Solvent: D2O, ρ(solv) ≈ 6.40 x 10-6 (Å-2)

Figure 5.11. Spherical core-shell particle illustration, rc (core radius), rm (micelle
radius), t (shell thickness), ρ(s), ρ(c), ρ(solv) are the scattering length densities of the
shell (PEG), core (PLA) and solvent (D2O) respectively.

The total small angel scattered intensity I(Q) of a core-shell particle in solution
can be expressed by Eq 4. Where Δρ is the contrast between the micelle and the solvent,
ρ is the term for scattering length density (SLD), N is the volume fraction of solute
particles (particle number density), P(Q) is the particle form factor, S(Q) is the particle
structure factor and bkg is the incoherent scattering background of the solvent. The form
factor P(Q) describes the shape (morphology) and size of the scattering particles and for a
spherical core-shell system it is expressed by Eq 5.
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𝐼(𝑄) = 𝑁(𝛥𝜌)2 𝑃(𝑄)𝑆(𝑄) + 𝑏𝑘𝑔

𝑃(𝑄) =

𝑆𝑐𝑎𝑙𝑒 3𝑉𝑐 (𝜌𝑐 −𝜌𝑠 )𝑗1 (𝑞𝑟𝑐 )
𝑉𝑠

(

𝑞𝑟𝑐 ]

+

(4)
3𝑉𝑠 (𝜌𝑠 −𝜌𝑠𝑜𝑙𝑣 )𝑗1 (𝑞𝑟𝑠 ) 2
𝑞𝑟𝑠

) + 𝑏𝑘𝑔

(5)

where, 𝑗1 (𝑥) = sin(𝑥) − cos(𝑥)⁄𝑥 2 , 𝑟𝑠 = 𝑟𝑐 + 𝑡, and 𝑉𝑖 = (4𝜋⁄3)𝑟𝑖3

The SLD of the core (ρc), shell (ρs) and surrounding medium (ρsolvent) are used to
determine the contrast between the core and shell and between the shell and surrounding
medium (Figure 5.11). The SLD of the polymer segments were calculated using the
molecular structure of the constituents and the density of each block, their numerical
values are summarized in Table 3. The density of oligo-PLA was used instead that of
bulk crystalline PLA since the degree of polymerization for the PLA block is only ~11
repeating monomer units. Contrast match experiments confirmed the SLD of PLA to be
that calculated using oligo-PLA density. The SLD of the core (ρc) and solvent (ρsolvent)
were held fixed, while SLD of shell (ρs) was allowed to float during model fitting. The
PLA core was assumed to be dry (anhydrous) as others have done previously.76, 195 The
core and shell sizes (micelle dimensions) are determined from the two terms in Eq 5 and
the polydispersity in micelle size is calculated by averaging Eq 5 over a Schulz
distribution of radii. The chain aggregation number (Nagg) and degree of hydration of the
shell (Φsh) are in-turn calculated using Eq 6 and 7, respectively.
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𝑁𝑎𝑔𝑔 =

4⁄3𝑅13

(6)

𝑉𝑃𝐿𝐴

𝑁𝑎𝑔𝑔 𝑉𝑃𝐸𝐺

𝛷𝑠ℎ = 1 − 4⁄3𝜋(𝑅3 −𝑅3 )
𝑚

(7)

𝑐

Table 5.3. Parameters used for model fitting
Scattering
length
∑ bi (10-15
m)

Scattering
length
Density (10-6
Å-2)

64.83

4.26

0.659

1.127

2947

191.7

0.659

3350

1.127

4936

323.76

0.659

—(CH3CHCOO)—

72

1.03

116.1

16.09

1.38

PLLA

—
(CH3CHCOO)16—

1600

1.03

2580

257.44

1.38

Solvent

D2O

20

1.11

29.92

19.153

6.39

Compoun
d

Chemical formula

Mola
r
Mass

Densit
y

Molecula
r volume
(Å3)

EO

—(CH2CH2O)—

44

1.127

PEG

—(CH2CH2O)45—

2000

PEG

—(CH2CH2O)76—

LA

The 5 % micelle solutions used in this SANS study are considered non-dilute
solutions; therefore, the interference between particles is no longer negligible and the
inter-particle structure factor S(Q) contributes to the overall scattered intensity. The timeresolved scattering profiles of the L-long and L-long/D-long micellar solutions show the
possible emergence of a correlation peak at q value between 0.02-0.03 Å-1, while no such
correlation peak is observed for the L-short and L-short/D-short polymer solutions
(Figures 5.3, 5.4). We considered attractive rather than repulsive micelle-micelle
interactions and the Baxter model for hard spheres with short-range attractive interactions
was used to describe the time resolve data. The model assumes the micelles are not
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smooth surfaced hard spheres but have an adhesive “sticky” surface of interpenetrating
polymer chains between neighboring micelle. The model has been applied previously to
describe the intermicellar correlation of PEO-PPO-PEO200, 201 and PPO-PEO-PPO62
spherical micelles. The hard sphere intermicellar interactions and adhesion of the PEG
rich surface are shown to depend on temperature and concentration. Baxter introduced a
“stickiness parameter” τ defined as τ = 1/12ϵ exp(U0/kT) to express the attractive
potential of the square well. The value of tau is directly related to the strength of the
interaction with lower values indicating stronger attraction. The sticky hard sphere
(SHS) structure factor is expressed by Eq 8, detailed analytical expression can be found
elsewhere.201, 202 We found fine fits to the time resolved data using the core-shell_SHS
model, and temperature effects on scattered intensity did not produce non-physical
solutions to the model fit (i.e. PDI was within the expected range). Therefore, the model
dependent discussion of the L-long and L-long/D-long time resolved data will focus on
the results obtained from the core-shell_SHS model.
1
𝑆(𝑄)

1

− 1 = 24𝛷 [𝛼𝑓2 (𝑄) + 𝛽𝑓3 (𝑄) + 2 𝛼𝛷𝑓5 (𝑄)] + 𝛷2 𝜆2 𝑓1 (𝑄) − 2𝛷𝜆𝑓0 (𝑄)

(8)

The scattering profile from Short PEG micelles shows no correlation peak at all
temperatures and concentrations measured. The time resolved scattering profiles for the
L-short and L-short/D-short samples possess characteristic features for scattering from
clusters or aggregates (i.e., lack of an intermicellar correlation peak and increase in
intensity at low-q), rather than from individual micelles interacting though a hard sphere
potential. The micelle stability and rate of chain exchange is observed to depend on the
PEG segment block length, micelles composed of PEG (2000) are shown to have
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relatively faster chain exchange evidenced by the low gelation temperature for Lshort/D-short blends and existence of stereocomplex crystal peaks by WAXS as low as
4°C.{Abebe, 2012 #890} Thus, micelle aggregation and cluster formation for the PEG
(2000) polymer solution occurs rather readily and gives different SANS profile than the
PEG (3350) polymer solutions. We modeled the scattering data for the L-short and Lshort/D-short polymer solutions using Teixeira’s model for scattering from fractal-like
cluster/aggregates.203, 204 The structure factor is expressed by Eq 9.

𝑆(𝑄) = 1 +

sin[(𝐷𝑓 −1) tan−1 (𝑞𝜉)]
(𝑞𝑅𝑜

𝐷
) 𝑓

𝐷𝑓 𝛤(𝐷𝑓 −1)
(𝐷 −1)⁄2
[1+1⁄(𝑞 2 𝜉 2 )] 𝑓

(9)

Where Γ(x) is the gamma function,  is the large size cut off in the aggregates
density distribution function and Df is the fractal dimension. The cut-off distance  can
be used to describe the size of the aggregate or the correlation length between scattering
mass centers.
5.3.6 Kinetic analysis of the fitting data: long PEG micelles
As described above, the SANS data of the series of long PEG block copolymers
were well analyzed using core-shell model fitting. Table 4 lists selected data obtained
from core-shell SHS model fitting. Both core radius and shell thickness were obtained to
show the increase for all samples. The micelle diameter was calculated from those values
and showed slight or moderate increase in size. As the original 5 wt% micelles were
characterized to be ca. 20 nm in hydrodynamic diameter by DLS (Table 2), this SANS
fitting data showed good agreement for spherical micelles. The micelle diameter (core
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radius + shell thickness) obtained by this model fitting corresponded to the radius of
gyration analyzed by Guinier plot in Figure 5.10.

Table 5.4. Selected data form SANS curve fitting (Core-Shell SHS model) for PEG-3350
series
Sample ID

Time
(min)

Temperature

Volume
Fraction

(°C)

Core
Radius
(Å)

Core
Poly
dispersity

Shell
Thickness

Micelle
Diameter

SLD
Shell

Stickiness

(Å)

(nm)

(A^2)

(1/tau)

L-long

2

25

0.1

31.0

0.5

34.3

13.1

5.98E-06

10.80

L-long

10

25

0.1

31.5

0.5

34.3

13.2

6.03E-06

0.83

L-long

2

37

0.1

31.4

0.5

33.9

13.1

5.89E-06

0.63

L-long

10

37

0.1

31.6

0.5

34.1

13.1

5.89E-06

0.46

L-long/Dlong

2

25

0.1

33.0

0.5

35.6

13.7

6.04E-06

3.46

L-long/Dlong

10

25

0.1

34.1

0.5

36.0

14.0

6.08E-06

2.53

L-long/Dlong

20

25

0.1

35.2

0.5

36.6

14.4

6.12E-06

1.98

L-long/Dlong

2

37

0.1

33.6

0.5

35.7

13.9

6.02E-06

1.70

L-long/Dlong

10

37

0.1

36.1

0.5

37.4

14.7

6.01E-06

0.92

L-long/Dlong

20

37

0.1

37.6

0.5

38.8

15.3

6.01E-06

0.83
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Figure 5.12 plotted the time40
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Figure 5.12. Time-resolved plots for long-PEG
series form SANS core-shell SHS model fitting
data; a) core radius, b) corona thickness, and c)
stickiness.

factor). Each discussion is as follows. 1) The scattering length density of PEG shell layer
showed negligible changes within 10 or 20 minutes for all samples. Hence, contribution
of the contrast changes between D2O and shell, and shell and core to the scattering
intensity would be quite small compared to the particle size contribution. 2) The inter-
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micelle interaction can be estimated by the parameter, stickiness (tau). Figure 5.12c plots
time-resolved stickiness values of L-long micelle and L-long/D-long micelle solutions at
different temperature. The graph shows immediate inter-micelle interaction by the sudden
drop of 1/tau values, and then linear slow decrease. The stickiness larger at higher
temperature is reasonable as the inter-micelle interaction is to be large. Note that the
micelle interaction for the single micelle (L-long) and stereo-mixture (L-long/D-long)
are identical, which is theoretically reasonable. Consequently, the structure factor does
not explain the unique increase of scattering intensity only for stereo-mixed micelle
solution. 3) Core radius and shell thickness in Figure 5.12a, 5.12b showed unique
increases for only stereo-mixed micelle system. Similar to the data in Guinier analysis
(Figure 5.10a), delayed, but significant size increase for both core and shell are seen at
higher temperature. The increase in SANS scattering intensity for L-long/D-long system
shown in SANS curves is considered due to the increase of aggregation numbers in
micelles and probably the structural reorganization driven by stereocomplexation of
PLLA and PDLA blocks. The model fitting data explained well; the particle form factor,
P(Q), of the single isomeric micelles is very small or negligible, whereas P(Q) of stereomixed micelles is significant. These results have agreed our hypothesis illustrated in
Figure 5.1, which is, the single micelles and stereo-mixed micelles are equilibrium and
non-equilibrium chain exchange systems, respectively.
5.3.7 Kinetic analysis of the fitting data: short PEG micelle
The SANS data of PEG 2000 series were also analyzed using Core-Shell SHS
model fitting. Using reasonable fixed parameters, we obtained decent fitting results for all
SANS data (Table 5). Figure 5.13 plotted the time-resolved data of core radius (a), shell
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thickness (b), and stickiness (c) for short PEG micelle series. Large increase in core
radius can be seen for stereo-mixed micelles even at 25°C (Figure 5.13a), but the change
in shell thickness was not conclusive (Figure 5.13b). The core and shell size ranges,
temperature dependence, and uniqueness of stereo-mixed micelles were all agreed with
other analyses thus far, and similar discussion with long-PEG series can be applied to
these short-PEG systems. The form factor (P(Q)) and structure factor (S(Q)) contribute
to the increase of SANS intensity particularly at high temperature, while uniqueness of Lshort/D-short system would be from the increase of aggregation number in each micelle
due to the irreversible chain exchange mechanism.
Table 5.5. Selected data form SANS curve fitting (Core-Shell SHS model) for PEG-2000
series
Sample ID

Time
(min)

Temperature

Volume
Fraction

(°C)

Core
Radius

Core
Poly
dispersity

(Å)

Shell
Thickness

Micelle
Diameter

SLD
Shell

Stickiness

(Å)

(nm)

(A^2)

(1/tau)

L-short

2

25

0.07

31.0

0.5

23.3

10.9

5.00E-06

1.19

L-short

10

25

0.07

31.2

0.5

23.4

10.9

5.00E-06

1.05

L-short

2

37

0.07

32.5

0.5

23.6

11.2

5.00E-06

0.52

L-short

10

37

0.07

33.7

0.5

23.7

11.5

5.00E-06

0.42

L-short/Dshort

2

25

0.06

32.4

0.5

21.2

10.7

5.00E-06

2.20

L-short/Dshort

10

25

0.06

34.4

0.5

21.1

11.1

5.00E-06

0.30

L-short/Dshort

20

25

0.05

36.1

0.5

19.1

11.0

5.00E-06

0.20

L-short/Dshort

2

37

0.07

31.5

0.5

25.5

11.4

5.00E-06

0.45

L-short/Dshort

10

37

0.06

35.4

0.5

25.5

12.2

5.00E-06

0.17

L-short/Dshort

20

37

0.06

37.1

0.5

24.7

12.4

5.00E-06

0.14
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As previously discussed, SANS
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As seen in SANS profile in Figure
0

5.7b, L-short/D-short system
doesn’t show the peak in the range of
0.01-0.1 q (A-1). By extremely rapid
chain exchange between L- and D-

0
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Figure 5.13. Time-resolved plots for short-PEG
series form SANS core-shell SHS model fitting
data; a) core radius, b) corona thickness, and c)
stickiness.

micelles, it is considered that the
original micelles become the cluster form because of the PEG bridges. Although
hydrogel formation is recognized around 60°C for 5 wt% L-short/D-short system,
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SANS data clearly indicates the chain exchange and cluster forming as a seed of the
network gel rapidly at 37°C and in slower rate at room temperature.

Table 5.6. Selected data form SANS curve fitting (Fractal-PolyCore model) for L/D
2000 series
Sample
ID

Time
(min)

Temperature

Volume
Fraction

(°C)

Block
Radius

Block
Poly
dispersity

(Å)

Shell
Thickness

Fractal
Dimension

(Å)

SLD
Shell

Correlaion
Length

(A^2)

(Å)

Lshort/Dshort

3

37

0.05

36.7

0.3

28.6

1.55

5.46E-06

72

Lshort/Dshort

6

37

0.05

39.0

0.3

29.6

1.55

5.67E-06

115

Lshort/Dshort

10

37

0.05

42.9

0.3

30.5

1.55

6.01E-06

177

Lshort/Dshort

15

37

0.05

46.6

0.3

31.7

1.55

6.28E-06

275

Lshort/Dshort

20

37

0.05

47.2

0.3

32.2

1.55

6.31E-06

427

Figure 5.14 plots changes in sizes (left axis) and correlation length (right axis)
which is related to the distance between the cluster centers. With fully hydrated and
homogeneous original micelle form, inter-micelle distance is supposed to be small
enough. As micelles associate by chain exchange to grow clusters, inter-cluster distance
must increase at time as explained above in fitting theory. The correlation length is
related to either the cluster size or distance between centers of the clusters, of which we
observe rather exponential growth in Figure 5.14. This L-short/D-short micelle mixture
exhibits a rapid chain exchange and stereocomplex formation in each micelle core.
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Extended PEG bridges form the clusters as illustrated in Figure 5.16, and then, those
clusters continue to grow towards fully networked hydrogel form. As increasing the
degree of extended PEG bridge formation, micelle shell thickness would also increase as
the model fitting data shows.
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Figure 5.14. Time-resolved plots for short-PEG series at 37°C by SANS Fractal
PolyCore model fitting; block radius (square), shell thickness (triangle), and correlation
length (circle).

X

1. chain exchange
2. sc/bridge forma on
3. cluster-like micelles

Figure 5.15. Conceptual illustration of the chain exchange, stereocomplex formation,
and structural reorganization of the mixture of PLLA-PEG-PLLA/PDLA-PEG-PDLA
micelles (non-equilibrium micelle system).
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5.4 Conclusions
The dynamic chain behavior of the micelles consisting of the triblock copolymers,
PLA-PEG-PLA, in aqueous media was analyzed using TR-SANS technique. The
scattered data of the single and stereo-mixed micelles showed dependence on the PEG
block length, temperature and time. The SANS data of 2000 and 3350 PEG length
micelles displayed distinct difference in kinetics during the chain exchange process,
specifically in the scattered profiles. The PEG 3350 samples indicated scattering arising
from individual micelles interacting though a hard sphere potential; while the scattering
from the PEG 2000 sample was indicative for scattering from fractal-like
cluster/aggregates. The effects of temperature were monitored by the shift in the
correlation peak. For both single and stereo-mixed micelles, increase in temperature
resulted in correlation peak shifting towards low q range. No dramatic difference on q
values were shown between single micelles and stereo-mixed micelles. Shift in the
correlation peak towards low q range was also seen to be time dependent. For time
dependency, a considerable difference was observed between single micelles (small or
negligible) and stereo-mixed micelles (extreme for 2000 series and larger at high
temperature). Increase in scattered intensity was mainly due to the particle form factor by
the increase of aggregation number. Appreciable difference was observed between single
micelles (small or negligible) and stereo-mixed micelles (larger at higher temp and time).
Model dependent analysis of the scattered data allowed interpretation of the
kinetics occurring with the chain exchange. For the PEG-3350 series data: (1) Micelle
interaction (tau) increases at higher temperature, but there was no or little difference
between single-enantiomeric and stereo-mixed micelles. (2) Core radius stays similar for
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single micelles, whereas it shows sigmoidal growth (delay) for stereo-mixed micelles. (3)
Shell thickness stays similar for single micelles, while it shows also sigmoidal growth for
stereo-mixed micelles. Combining (1) to (3) data, chain exchange of the single
enantiomeric micelles occurs in reversible manner, whereas that of the stereo-mixed
micelles occurs in irreversible manner. The chain exchange occurs slowly after L- and Dmicelles are mixed, and became more active with time, and the restriction of “exit” of the
core chains from stereocomplex interaction results the increase of core and corona
thickness (would be correlated with inter-micelle distance). For the PEG-2000 series
data: Similar, but more substantial increase of core size for stereo-mixed system was
observed. Correlation length calculated using the Fractal-Polycore model was used to
estimate the distance between scattering clusters.205 In the irreversible exchange micelles
of the stereo-mixture, it correlates to an inter-core distance after some degree of cluster
formation by stereocomplexation. The results of time-resolved SANS studies have well
agreed with our hypothesis, which is, the single enantiomeric micelles and stereo-mixed
micelles are equilibrium and non-equilibrium chain exchange systems, respectively. A
size of the shell block of the flower-type micelles affected to the kinetics of micelle chain
exchange, and that was well agreed to the observed sol-to-gel temperatures in Lmicelle/D-micelle stereo-mixtures.
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CHAPTER 6.
Conclusion and Future Outlook
6.1 Conclusion
The work discussed in this dissertation focused on the preparation and
characterization of gene delivery vectors with the focus on low toxicity, high
encapsulation efficiency, prolonged stability, and controllable release profiles. The
application of the non-viral vectors as localized delivery systems, particular the
development and characterization of an injectable hydrogel is a central theme. Chapter 2
examined the preparation of hybrid micelles composed of enantiomeric PLLA-PEGPLLA and PDLA-PEG-PDLA triblock copolymers. Hydrogels with controllable sol-gel
transitions and high mechanical strength are produced through stereocomplexation of
between PLLA/PDLA blocks. The resulting hydrogels can be applied as injectable
systems by simply controlling the micelle composition. In Chapter 3, a non-viral gene
delivery system composed of low MW and non-toxic PEI is examined. The three-layered
micelle (3LM) system was shown to efficiently condense and encapsulate high MW
DNA biomolecule as a compact polyplex core. The 3LM showed excellent stability in
neutral pH (~7.4), while at lower pH (~4.5) rapid release of encapsulated DNA was
observed. The controlled release profile triggered by low pH could be beneficial for the
endoytotic escape of cell internalized delivery vectors. Additionally, ligand targeting of
the 3LM showed a dramatic increase in cellular uptake, indicating receptor mediated
uptake could be utilized for specific targeting of a particular cell line. Chapter 4
summarized a brief work on formulation of the 3LM into an injectable hydrogel system
utilizing the stereocomplexation method covered in Chapter 2. 3LM prepared with
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dextran sulfate as a DNA analogous polyanions, showed sol-gel transition can be
obtained at around body temperature by controlling the formulation recipe. Chapter 5
examined the chain-exchange behavior for stereocomplexed micelles of PLA-PEG-PLA
triblock copolymers discussed in Chapter 2. Model dependent analysis of the scattered
data, showed non-equilibrium chain exchange occurred in stereocomplexed systems
which explain the irreversibility and eventual hydrogel formation. While nonstereocomplexed systems showed equilibrium chain exchange which corresponds with
the reversibility of sol-gel transition occurred. In conclusion, design and development of
block copolymer micelles utilizing existing or new engineering techniques was
accomplished and new systems are introduced. Additionally, understanding fundamental
or basic structure-function relationships can aid in the optimization of already existing
systems
6.2 Future outlook
6.2.1 In-vitro characterization of 3LM physicochemical properties: cell uptake,
transfection and expression studies
The in-vitro characterization of 3LM needs to be performed to determine the
transfection and gene expression efficiency of the system. Preliminary work on cell
uptake study has already been performed. The cell targeting ligand, folic acid, was
successfully conjugated to the core forming copolymer using a well-established coupling
method to yield PLLA-PEG-Folate. 3LM with ligand conjugated surface were
successfully taken up by primary macrophages through receptor mediated endocytosis.
Detailed cell culture works are however needed to accurately quantify the uptake and
transfection efficiency of the 3LM system.
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The stability of the 3LM under in-vitro conditions is an important
physicochemical property which requires further investigation. Gene delvery vectors
often fail during in-vitro application due to the rapid recognition by the MPS (immune)
system, which leads to sequestration and clearance. The pre-requisite step for MPS
recognition and clearance of delivery vectors is the adsorption of serum proteins,
opsonins. Additionally, gene delivery vectors can dissociate collapse or aggregate under
in-vitro conditions such as presence of biological fluids and high salt concentration. The
stability of the 3LM in the presence of complete serum, individual serum proteins, salt
solution and synovial fluids needs to be investigated.
6.2.2 Analysis of chain exchange behavior for PLA-PEG-PLA Hybrid Micelles:
Preparation of well-defined deuterated PLLA (dPLLA) for TR-SANS Contrast
Match studies
SANS study on homo-micelles of PLA-PEG-PLA (800-2000-800) and PLAPEG-PLA (800-3350-800) has yielded a wealth of information regarding the influence of
PEG MW on micelle dimensions and micelle structural reorganization in response to
temperature. The SANS data analysis approach described in Chapter 4 can be readily
adopted for the analysis of hybrid micelle (800-2000-800 + 800-3350-800) scattered data.
We obtained SANS scattered data profiles. Additionally, model dependent SANS data
analysis has shown that stereocomplexation leads to non-equilibrium chain exchange
between neighboring micelles. Non-equilibrium chain exchange followed by st study
was also conducted on the hybrid micelles We established an analysis approach The
model dependent SANS data analysis was performed

and behavior of PLA-PEG-PLA

Stereocomplexed micelles. The micellar systems discussed in Chapter 4 focus
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exclusively. We have performed SANS analysis for the hybrid micelles (800-2000-800 +
800-3350-800)

Figure 6.1. Synthesis approach to yield well-defined dPLLA-PEG-dPLLA block
copolymers

SANS is well suited technique for contrast match studies using isotope labeling.
In contrast match studies, deuterated block copolymers are utilized to specifically
visual/investigate a particular phase. Understanding the kinetic of the chain exchange
process for the stereocomplexed PLA-PEG-PLA micelles is an interesting scientific goal.
The rate of chain exchange has a direct influence on the rate of gel formation, which is
turn could determine the biomedical efficacy of the system. Additionally, the hybrid
PLA-PEG-PLA micellar systems present a multitude of interesting questions in regards
to the influence of the PEG length on the chain exchange behavior. To investigate these
topics, selective isotope labeling (deuteration) of the PLA blocks of the triblock
copolymer is needed. In a preliminary work, deuterated PLLA (dPLLA) blocks were
synthesized using the polycondensation method. Deuterated L-lactic acid (commercially
obtained) underwent condensation polymerization in the presence of PEG-macroinitiator
to produce dPLLA-PEG-dPLLA triblock copolymer (Figure x). The degree of
polymerization of the dPLLA was however half the amount required for stereocomplex
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formation. The use of these triblock copolymers for SANS contrast match studies was not
successful due to the low degree monomer conversion. Optimization of polycondensation
method of deuterated L-lactic acid and preparation of well-defined triblock copolymers
will be further investigated.
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Appendix A

Figure 1: DSC spectra of PLLA-PEG-PLLA block copolymer with PLLA having ~7
lactic acid repeating units. The sample underwent an initial scan to erase the
crystallization history and to become homogenous and a second scan to analyze its
thermal properties. (a) Shows the 1st and 2nd scan for the block copolymer. The 1st scan
was performed from 0°C to 190°C and after cooling at 100K/min using liquid nitrogen,
the 2nd scan was collected again from 0°C to 190°C. PEG crystal peaks are shown for
both scans appearing at ~40-50°C. The PEG crystal peaks decrease in intensity and shift
slightly to the left during the 2nd scan. (b) Shows the 2nd scan, particularly in the region
where PLLA homocrystal typical appears. Although pure PLLA has a crystal melting
temperature of ~170°C, copolymerization with PEG is expected to decrease its melting
temperature. No PLLA homocrystal peaks are detected.
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Figure 2: DSC spectra of PLLA-PEG-PLLA block copolymer with PLLA having ~11
lactic acid repeating units. The sample underwent an initial scan to erase the
crystallization history and to become homogenous and a second scan to analyze its
thermal properties. (a) Shows the 1st and 2nd scan for the block copolymer. The 1st scan
was performed from 0°C to 190°C and after cooling at 100K/min using liquid nitrogen,
the 2nd scan was collected again from 0°C to 190°C. PEG crystal peaks are shown for
both scans appearing at ~40-50°C. The PEG crystal peaks decrease in intensity and shift
slightly to the left during the 2nd scan. (b) Shows the 2nd scan, particularly in the region
where PLLA homocrystal typical appears. Although pure PLLA has a crystal melting
temperature of ~170°C, copolymerization with PEG is expected to decrease its melting
temperature. No PLLA homocrystal peaks are detected.
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Figure 3: DSC spectra of PLLA-PEG-PLLA block copolymer with PLLA having ~11
lactic acid repeating units. The sample underwent an initial scan to erase the
crystallization history and to become homogenous and a second scan to analyze its
thermal properties. (a) Shows the 1st and 2nd scan for the block copolymer. The 1st scan
was performed from 0°C to 190°C and after cooling at 100K/min using liquid nitrogen,
the 2nd scan was collected again from 0°C to 190°C. PEG crystal peaks are shown for
both scans appearing at ~40-50°C. The PEG crystal peaks decrease in intensity and shift
slightly to the left during the 2ndscan. (b) Shows the 2nd scan, particularly in the region
where PLLA homocrystal typical appears. Although pure PLLA has a crystal melting
temperature of ~170°C, copolymerization with PEG is expected to decrease its melting
temperature. PLLA crystal peaks are detected with peak-top at 117°C.
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Figure 4: DSC spectra of (50:50) PLLA-PEG-PLLA and PDLA-PEG-PDLA blend,
having ~7 lactic acid repeating units. The sample underwent an initial scan to erase the
crystallization history and to become homogenous and a second scan to analyze its
thermal properties. (a) Shows the 1st and 2nd scan for the block copolymer. The 1st scan
was performed from 0°C to 240°C and after cooling at 100K/min using liquid nitrogen;
the 2nd scan was collected again from 0°C to 240°C. PEG crystal peaks are shown for
both scans appearing at ~40-50°C. The PEG crystal peaks decrease in intensity and shift
slightly to the left during the 2nd scan. (b) Shows the 2nd scan, particularly in the region
where the homocrystal and stereocomplexed crystal typical appears. Neither homocrystal
nor stereocomplexed crystal formation are detected. PLA needs above 7 repeating units
to form a stereocomplex crystal.
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Figure 5: DSC spectra of (50:50) PLLA-PEG-PLLA and PDLA-PEG-PDLA blend,
having ~11 lactic acid repeating units. The sample underwent an initial scan to erase the
crystallization history and to become homogenous and a second scan to analyze its
thermal properties. (a) Shows the 1st and 2nd scan for the block copolymer. The 1st scan
was performed from 0°C to 240°C and after cooling at 100K/min using liquid nitrogen;
the 2nd scan was collected again from 0°C to 240°C. PEG crystal peaks are shown for
both scans appearing at ~40-50°C. The PEG crystal peaks decrease in intensity and shift
slightly to the left during the 2nd scan. (b) Shows the 2nd scan, particularly in the region
where the homocrystal and stereocomplexed crystal typical appears. Stereocomplexed
crystal formation is detected with peak-top at 131.9°C and no homocrystal.
Stereocomplexed crystal is preferentially formed with repeating lactic acid units of <11.
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Figure 6: DSC spectra of (50:50) PLLA-PEG-PLLA and PDLA-PEG-PDLA blend,
having ~11 lactic acid repeating units. The sample underwent an initial scan to erase the
crystallization history and to become homogenous and a second scan to analyze its
thermal properties. (a) Shows the 1st and 2nd scan for the block copolymer. The 1st scan
was performed from 0°C to 240°C and after cooling at 100K/min using liquid nitrogen;
the 2nd scan was collected again from 0°C to 240°C. PEG crystal peaks are shown for
both scans appearing at ~40-50°C. The PEG crystal peaks decrease in intensity and shift
slightly to the left during the 2nd scan. (b) Shows the 2nd scan, particularly in the region
where the homocrystal and stereocomplexed crystal typical appears. Stereocomplexed
crystal formation is detected with peak-top at 155.7°C and no homocrystal.
Stereocomplexed crystal is preferentially formed with repeating lactic acid units of <11.
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Appendix B

Figure 1: GPC spectra of different molecular weight synthesized copolymer. (a) Shows
the PEG-diol macroinitiator used for lactide ROP with an average Mw of 2089 (blue
curve). The two triblock copolymers elute at an earlier time that the PEG-diol
macroinitiator indicating an increase in Mw. The PLLA-PEG-PLLA (red curve) and
PDLA-PEG-PDLA (green curve) with theoretical Mw of 3600 Da give Mw of 3695 and
4023 Da respectively. (b) Shows the PEG-diol macroinitiator with an Mw of 3635 used
for lactide ROP. The two triblock copolymers elute at an earlier time that the PEG-diol
macroinitiator indicating an increase in Mw. The PLLA-PEG-PLLA (red curve) and
PDLA-PEG-PDLA (green curve) with theoretical Mw of 4950 Da give Mw of 6634 and
6549 Da respectively.
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Appendix C

Figure 1: DLS spectra of the tri-block copolymers with different PEG Mw. The
copolymers with PEG Mw of 2000 show a hydrodynamic size of ~60nm while the
copolymers with PEG Mw of 3350 show a hydrodynamic size of ~40nm. The copolymers
with longer PEG form larger micelles due to less steric interference of the smaller corona
compared to the longer PEG which would cause steric interference resulting in decreased
number of chain aggregation leading to smaller size.
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Figure 2: DLS spectra of pre-mixed copolymers and comparison with homopolymer
micelles. (a) Shows the pre-mixed copolymer with short-PEG ratio of 40, 40, 60, and
70% have hydrodynamic sizes which are between the two homopolymer micelles
composed of 100% short-PEG or 100% long-PEG copolymers. (b) Shows the premixed copolymers with short-PEG ratio of 10, 20, 50, 80 and 90% to have
hydrodynamic sizes which are larger than either homopolymer micelle.
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